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SUMMARY 
 
Polycyclic aromatic hydrocarbons (PAH), a group of carcinogenic and mutagenic 
pollutants, are byproducts of incomplete combustions of organic materials such as wood, 
fossil fuels, meat, and tobacco, and are therefore distributed ubiquitously in the ambient 
air, soil and water environments. PAH in the atmosphere, especially in densely populated 
areas, is significantly affected by anthropogenic emissions, such as automobile exhaust, 
fossil fuel combustion, biomass burning, cigarette smoking, and industrial activities. 
Particulate matter (PM) air pollution, especially fine particles with aerodynamic 
diameters less than 2.5 µm (PM2.5), has been linked to increased morbidity and mortality 
rates, as well as various adverse health effects such as respiratory and cardiovascular 
diseases. The association of PM2.5 with toxic compounds such as PAHs could further 
increase the health effects. Human exposure to PAHs can occur through three routes, i.e. 
inhalation, ingestion and dermal absorption. For the general population, the main 
exposure routes are inhalation of polluted air or cigarette smoke and ingestion of food 
containing PAHs. 
Atlanta is a rapidly growing city with high PM air pollutant. However, little is 
known on PAHs levels, especially PM2.5-bound PAHs concentrations in this area. To 
characterize PM2.5-bound PAHs in Atlanta, a method was developed to provide sensitive 
and reliable measurements of 28 PAHs and methyl-PAHs (Me-PAH) in archived daily 
PM2.5 samples collected with low flow rate (16 L/min or 24 m3 air/sample). Then PM2.5 
samples taken at three sampling sites (urban, suburban-highway and rural) in the 
metropolitan Atlanta area during 2003-2004 were analyzed and the levels, seasonal and 
spatial variation of PAHs were studied. Correlation analyses between PAHs and other air 
pollutants such as PM2.5, OC, EC and potassium ion (K+) were conducted and the results 
indicated that PAHs had common sources as other pollutants, but with a distinct seasonal 
 xvii
effect. Retene, a proposed biomass burning tracer, captured both the high leaves-grasses-
bushes-branches burning season and the high wood burning months, suggesting that it 
might be a more general indicator of biomass burning than potassium, which is more 
specific to wood burning.  
Assessment of human exposure to environmental chemicals such as PAHs can be 
accomplished either through environmental monitoring in which concentrations of PAHs 
in environmental samples (air, food, water, soil, etc.) are determined, or through 
biomonitoring in which internal levels of PAHs in human body (e.g. urinary hydroxy 
PAHs, or OH-PAHs) are measured as indicators for assessing overall exposure to PAHs. 
A lot of studies have been reported since the early 1990’s to assess high occupational 
exposure to PAHs; however, limited information is available on non-occupational 
exposure of the general populations to PAHs in the environment. Even less information is 
available on the temporal, intra- and inter-subject variability of these biomarkers. A 
method was developed to measure hydroxyl PAH metabolites (OH-PAH) in urine 
samples. A study was carried out to study the variability of the urinary biomarker levels 
in a non-occupationally exposed non-smoking reference group. Levels of urinary PAH 
metabolites varied widely both within-subject and between-subjects and the within-day 
variance far exceeded the between-day variance. There were also considerable temporal 
correlations for these biomarkers. Sample size calculations were conducted and taking 
24-hour voids would require the least number of subjects, which can be used for future 
epidemiological study design. Finally, a study was conducted to evaluate exposure to 
PAHs in an urban setting among a group of non-occupational exposed non-smokers 
employing both personal air sampling and urine biomonitoring. PAH levels varied largely 
in air samples taken at home, at work, and while driving or jogging. Monitoring urinary 
OH-PAH levels can capture both inhalation and dietary exposures. Total inhaled PAH 
was correlated with total excreted OH-PAHs, suggesting that by combining personal air 
 xviii
sampling and biomonitoring, exposure to environmental PAHs can be well characterized 
even for low-level exposure.  
 1 
CHAPTER 1 
INTRODUCTION 
 
Particulate matter (PM) air pollution has been linked to increased morbidity and 
mortality rates, as well as various adverse health effects such as respiratory and 
cardiovascular diseases (Cakmak et al., 2007; Kappos et al., 2004; Lebowitz, 1996; Ostro 
et al., 2007; Pope, III et al., 2004).  Particulate matter with aerodynamic diameters less 
than 2.5 µm (PM2.5 or fine particulate matter) are of special concern because, when 
inhaled, they can penetrate effectively into the respiratory system and deposit deeply in 
the bronchioles and alveoli of the lungs.  The association of fine particles with mutagenic 
and carcinogenic chemicals — such as polycyclic aromatic hydrocarbons (PAHs) — may 
contribute to these acute health effects or potentially result in long-term health risks. 
Polycyclic aromatic hydrocarbons (PAHs) are a group of toxic pollutants formed 
during incomplete combustion of organic materials such as wood, fossil fuels, meat, and 
tobacco. They are found in automobile exhaust, wood smoke, cigarette smoke, and also 
found at high concentrations in certain food such as barbequed food (ATSDR, 1995; 
Bostrom et al., 2002; Guillen et al., 1997; IARC, 1983); thus this class of compounds is 
ubiquitously distributed in ambient air, food, soil, as well as in many occupational 
environments.  
PAHs have generated considerable interest, not only because of their wide 
distribution in the environment, but also their carcinogenic and mutagenic potential 
(ATSDR, 1995; IARC, 1983). PAHs, such as benzo[a]pyrene (BAP), which is present in 
cigarette smoke and certain occupational environments, have been positively associated 
with lung cancer (Armstrong et al., 2004; Denissenko et al., 1996). In addition, PAHs 
have also been reported to have reproductive, developmental, hemato-, cardio-, neuro-, 
and immuno-toxicities in humans and laboratory animals (ATSDR, 1995; IARC, 1983). 
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Given their carcinogenic and mutagenic potential and their wide distribution resulting in 
exposure in the general population, PAHs have generated considerable interest; 16 PAHs 
have been included in U.S. EPA’s list of 188 hazardous air pollutants (U.S.EPA, 1990).   
In ambient air, PAHs are found in both gaseous and particle phases. PAHs with 2-
3 aromatic rings exist almost exclusively in the gaseous phase, while compounds with 4 
or more aromatic rings are primarily associated with the particulate fraction (Eiguren-
Fernandez et al., 2004; Li et al., 2006; Re-Poppi and Santiago-Silva, 2005). In addition, it 
has been reported that PAH-associated particles exist predominantly as fine particles, i.e., 
in the PM2.5 size range, especially in areas with heavy traffic (Cancio et al., 2004; Duan 
et al., 2005; Ohura et al., 2004). Because the carcinogenic PAHs (e.g. benzo[a]pyrene and 
benz[a]anthrene) are mostly associated with the particulate matter, many studies on PAHs 
in ambient air have been focused on PAHs bound to PM, particularly PM2.5 (Borlakoglu 
et al., 1993; Bourotte et al., 2005; Ohura et al., 2004; Papageorgopoulou et al., 1999; 
Sanderson et al., 2004; Sklorz et al., 2007). 
Human exposure to PAHs can occur through inhalation of polluted air or cigarette 
smoke, ingestion of food containing PAHs, as well as dermal absorption from soil or 
material that contains PAHs. For the general population, ingestion and inhalation are the 
two major routes of exposure (ATSDR, 1995; Bostrom et al., 2002; Ramesh et al., 2004). 
For certain occupations, such as coal tar roofers and coke oven workers, dermal 
absorption can become the primary route of PAH exposure (ATSDR, 1995). After 
entering the human body, PAHs undergo a series of biotransformation processes. In 
Phase I metabolism, PAHs are oxidized by the cytochrome P450 enzymes to form 
reactive epoxide intermediates, followed by reduction or hydrolysis to hydroxylated 
derivatives (OH-PAHs). In Phase II metabolism, the OH-PAHs are conjugated to 
glucuronic acid and/or sulfate to increase the water solubility of the metabolite and to 
facilitate elimination through urine, bile, or feces (Grover, 1986; Pelkonen and Nebert, 
1982). Urinary OH-PAHs have been used as biomarkers to assess human exposure to 
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PAHs, with 1-hydroxypyrene (1-PYR) as the most commonly used indicator in 
biomonitoring studies (Jacob and Seidel, 2002). 
Assessment of human exposure to PAHs in the ambient air can be accomplished 
either through environmental monitoring in which concentrations of PAHs in air samples 
are used to assess human intakes, or through biomonitoring in which internal levels of 
PAHs in human body (e.g. urinary OH-PAHs) are measured as indicators for assessing 
overall exposure to PAHs. The objectives of this dissertation were, (i) to develop a 
method measuring PAHs in ambient PM samples; (ii) to characterize PM2.5-bound PAHs 
in Atlanta; (iii) to develop a method measuring OH-PAHs in urine samples; (iv) to study 
variability of urinary OH-PAHs in a reference population; and (v) to assess non-
occupational exposure to PAHs in ambient air through both personal air sampling and 
biomonitoring. .  
Structure and Scopes of the Thesis  
Chapter 2. Determination of Twenty-eight Polycyclic Aromatic Hydrocarbons in 
Air Particulate Matter using Direct Elution and Isotope Dilution GC/MS 
 Chapter 2 introduces a newly developed method for measuring 28 PAHs and their 
methylated derivatives (Me-PAHs) in PM samples using a novel direct elution extraction 
method followed by isotope dilution gas chromatography/ high resolution mass 
spectrometry (GC/HRMS). 
Chapter 3. Characterization of PM2.5-bound PAHs in Atlanta  
 Chapter 3 describes two studies characterizing PM2.5-bound PAHs at three 
sampling sites (urban, suburban-highway and rural) in Atlanta, i.e. a pilot study reporting 
PAHs from PM2.5 samples taken during December 2003 and June 2004 and a year-around 
study on samples taken in the whole year of 2004. In this chapter, discussions were 
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carried out on the concentrations, seasonal and site variations, specific source markers, 
and correlations of PAHs to other air pollutants.    
Chapter 4. Measurement of Urinary Mono-Hydroxy Polycyclic Aromatic 
Hydrocarbons Using Automated Liquid-Liquid Extraction and Gas 
Chromatography/Isotope Dilution High Resolution Mass Spectrometry 
 Chapter 4 described the development of a method measuring hydroxylated PAH 
(OH-PAHs) metabolites in human urine samples using automated liquid-liquid extraction 
and GC/HRMS determination. Urinary OH-PAHs have been used as biomarkers for PAH 
exposure and this method has been used in biomonitoring studies assessing human 
exposure to PAHs in the environment.  
Chapter 5. Variability of Urinary Polycyclic Aromatic Hydrocarbon Metabolite 
Levels in Adults 
 Chapter 5 studied variability of urinary OH-PAH metabolites in a group of non-
occupationally exposed adult over a period of a week. Effect of creatinine adjustment was 
evaluated. Sample size requirements were calculated to reflect three sampling methods: 
spot urine, first morning void and 24-hour void sampling. Results from this variability 
study can be applied to the design of future epidemiological studies. 
Chapter 6. Assessment of Non-occupational Exposure to Polycyclic Aromatic 
Hydrocarbons through Personal Air Sampling and Urinary Biomonitoring 
Chapter 6 described a study aimed at assessing inhalation exposure to ambient 
PAHs in a group of non-smoking adults who were not non-occupationally exposed. Eight 
subjects collected personal air samples and all urinary excretions over 8 days, while 
following a recommended dietary plan. Exposure assessments were carried out using 
both information from personal air samples and urinary biomonitoring.  
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Chapter 7. Conclusion  
Chapter 7 provides conclusions of the dissertation and gives recommendations on 
the future directions in this field. 
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CHAPTER 2 
DETERMINATION OF TWENTY-EIGHT POLYCYCLIC 
AROMATIC HYDROCARBONS IN AIR PARTICULATE MATTER 
USING DIRECT ELUTION AND ISOTOPE DILUTION GAS 
CHROMATOGRAPHY/MASS SPECTROMETRY 
(Li Z, Porter EN, Romanoff LC, Trinidad DA, Mulholland JA and Sjodin A. 
International Journal of Environmental Analytical Chemistry, submitted) 
 
Abstract 
We are reporting a method for measuring 28 polycyclic aromatic hydrocarbons 
(PAH) and their methylated derivatives (Me-PAHs) in air particulate matter (PM) 
samples using isotope dilution gas chromatography/high resolution mass spectrometry 
(GC/HRMS). In this method, PM samples collected on quartz filters were spiked with 
internal standards, loaded into solid phase extraction cartridges, and eluted by 
dichloromethane. The extracts were concentrated under a gentle stream of nitrogen, 
spiked with a recovery standard, and analyzed by GC/HRMS at 10,000 resolution. 
Sixteen 13C-labeled PAHs and 2 deuterated Me-PAHs were used as internal standards to 
account for instrument variability and losses during sample preparation. Recoveries of 
labeled internal standards were in the range of 95-129% which was comparable to the 
commonly used sonication-assisted extraction and higher than accelerated solvent 
extraction (ASE). Furthermore, the proposed method is less time-consuming than the 
comparative methods and eliminates the need of a filtration step required after the 
sonication extraction method. Limits of detection ranged from 41 to 366 pg/sample for 
the 28 analytes. This method was used to analyze reference materials from the National 
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Institute of Standards and Technology (NIST). The results were consistent with those 
from ASE and sonication extraction, and were also in good agreement with the inter-
laboratory comparison results. The proposed method was then used to measure PAHs on 
PM2.5 samples collected at three sites (urban, suburban and rural) in Atlanta, USA, and 
the results were consistent with an earlier study measuring PM2.5 samples using ASE. 
2.1 Introduction 
Particulate matter (PM) air pollution has been linked to increased morbidity and 
mortality rates, as well as adverse health effects such as respiratory and cardiovascular 
diseases (Ostro et al. 2007; Pope, III et al. 2004). Particles with aerodynamic diameters 
less than 2.5 µm (PM2.5) are of special concern because, when inhaled, such particles can 
penetrate and deposit deep in the bronchioles and alveoli of the lungs. Further, the 
association of fine particles with mutagenic and carcinogenic chemicals — such as 
polycyclic aromatic hydrocarbons (PAHs) — may increase the health effects of such 
particulates.  
PAHs are a group of carcinogenic and mutagenic pollutants formed during 
incomplete combustion of organic materials and are ubiquitously present in the ambient 
air, soil and water (ATSDR 1995; IARC 1983). PAHs, exemplified by benzo[a]pyrene, 
have been shown to be causative agents of lung, esophageal, gastric, colorectal, bladder, 
skin, prostate and cervical cancers in humans and animal models (ATSDR 1995). The 
general population is primarily exposed to PAHs through inhalation of polluted air or 
cigarette smoke and through ingestion of PAH-containing foods (Bostrom et al. 2002; 
Ramesh et al. 2004). PAHs have generated considerable interest due to their carcinogenic 
and mutagenic potential and the fact that humans are exposed to PAHs on a daily basis. 
This is exemplified by the inclusion of 16 PAHs (Figure 2.1) on the U.S. EPA’s list of 
188 hazardous air pollutants (U.S.EPA 1990).  
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Figure 2.1. Molecular structures of PAHs measured in this method 
 
In ambient air, PAHs with 2-3 aromatic rings exist almost exclusively in the 
gaseous phase, while compounds with 4 or more aromatic rings are primarily associated 
with the particulate fraction (Eiguren-Fernandez et al. 2004; Re-Poppi and Santiago-Silva 
2005). In addition, it has been reported that particulate PAHs bound predominantly to 
fine particles, especially in areas with heavy traffic (Cancio et al. 2004; Duan et al. 2005). 
Because carcinogenic PAHs (e.g. benzo[a]pyrene and benz[a]anthrene) are mostly 
associated with particulate matter, many studies on PAHs in ambient air have focused on 
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PAHs bound to PM, particularly PM2.5 (Ohura et al. 2004; Bourotte et al. 2005; 
Sanderson et al. 2004). 
Typically, PAHs in ambient air are collected using high-volume samplers 
(U.S.EPA 1999), and the sample preparation involves extraction by either ultrasonic 
(Christensen et al. 2005) or Soxhlet extraction (U.S.EPA 1999; U.S.EPA 1995), both of 
which are laborious and time-consuming methods requiring large amounts of solvent. 
Other methods have been reported for extraction of PAHs from solid matrices, including 
microwave-assisted extraction (Pino et al. 2000), agitation (Pleil et al. 2004), supercritical 
fluid extraction (Chester et al. 1998), and Accelerated Solution Extraction (ASE) 
(Lintelmann et al. 2005; Burkhardt et al. 2005; Olivella 2005). Specifically, ASE has 
been reported to give higher extraction efficiency than sonication (Berset and Holzer 
1999) and has been used in the analysis of PM and soil samples (Hollender et al. 2003). 
However, the instrument requires relatively high investment and maintenance costs, and 
the assembly and disassembly of sample extraction cells can be time-consuming.  
We have developed a method for measuring 28 PAHs and Methyl-PAHs (Me-
PAH) in ambient PM filter samples using a novel direct elution extraction method 
followed by isotope dilution gas chromatography/high resolution mass spectrometry 
(GC/HRMS) analysis. The proposed method requires a lower volume of solvent (10 mL) 
compared to reference methods (sonication 15 mL; ASE 30 mL), uses inexpensive 
consumables, and allows high sample throughput. The measured recovery is comparable 
or higher than commonly used sonication and ASE methods. The accuracy of the direct 
elution method was assessed by analyzing Reference Materials (RM 8785, Air particulate 
matter on filter media) from the National Institute of Standards and Technology (NIST). 
The developed method was then used to measure PAHs on PM2.5 samples collected at 
three sites in the metropolitan Atlanta area.  
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Table 2.1. List of PAH analytes, abbreviations, isotopically labeled internal standards 
(IS) and quality control parameters 
 
Concentration in RM 8785 (µg/g) 
No1 Analyte Abbr. Internal Standard 
LOD2 
(pg per 
sample)
CV3 
(%) Direct 
elution  ASE Sonication
NIST-
ASE4 
1 naphthalene NAP 13C6 NAP 216 14 1418 4744 <LOD 1422 
2 2-methylnaphthalene 2M-NAP D10 2M-NAP 213 6.3 920 1231 914 N/A5 
3 1-methylnaphthalene 1M-NAP D10 1M-NAP 204 8.7 545 808 503 N/A 
4 biphenyl BIPH 13C6 ANYL 136 N/A <LOD <LOD <LOD N/A 
5 acenaphthylene ACNYL 13C6 ANYL 41 3.8 145 666 217 N/A 
6 acenaphthene ACNAP 13C6 ANAP 50 3.4 <LOD <LOD <LOD N/A 
7 fluorene FLUO 13C6 FLUO 169 6.3 191 686 <LOD 236 
8 dibenzothiophene DBT 13C6 PHEN 41 5.3 437 3728 314 N/A 
9 phenanthrene PHEN 13C6 PHEN 366 6.2 1780 4282 2073 4632 
10 anthracene ANTH 13C6 ANTH 69 6.1 281 867 374 457 
11 3-methylphenanthrene 3M-PHEN 13C6 PHEN 96 9.8 705 2197 769 554 
12 2-methylphenanthrene 2M-PHEN 13C6 PHEN 68 13 671 2065 832 779 
13 9-methylphenanthrene 9M-PHEN 13C6 PHEN 78 10 395 971 459 434 
14 1-methylphenanthrene 1M-PHEN 13C6 PHEN 57 9.9 338 823 494 462 
15 fluoranthene FLRAN 13C6 FLRAN 143 3.6 3096 4975 3258 5887 
16 pyrene PYR 13C6 PYR 53 2.7 2680 3550 2888 3829 
17 retene RET 13C6 PYR 203 N/A 894 711 1839 339 
18 benzo(c)phenanthrene BCP 13C6 BAA 41 N/A 286 354 281 N/A 
19 benzo(a)anthracene BAA 13C6 BAA 41 6.3 953 1384 1072 2123 
20 chrysene CHRY 13C6 CHRY 41 5.1 3551 4492 3366 N/A 
21 benzo(b)fluoranthene BBF 13C6 BBF 41 5.4 8791 10948 8903 8155 
22 benzo(k)fluoranthene BKF 13C6 BKF 41 4.5 1786 2202 2001 2197 
23 benzo(e)pyrene BEP 13C4 BAP 41 N/A 3516 4249 3712 4013 
24 benzo(a)pyrene BAP 13C4 BAP 41 3.5 1213 1525 1717 2413 
25 perylene PER 13C4 BAP 41 N/A 368 415 408 391 
26 indeno(123-cd)pyrene IP 13C6 IP 41 4.7 3802 4910 4100 4159 
27 dibenz(a,h)anthracene DBA 13C6 DBA 41 4.6 367 487 419 <500 
28 benzo(ghi)perylene BP 13C12 BP 41 5.7 5103 6525 5008 6892 
 
1.  The numbers in this table correspond to the peak numbers in Figure 2.2 
2. LOD – limits of detection 
3.  CV – coefficients of variation from 42 quality control samples run over 2 months 
4.  NIST – National Institute of Standards and Technology. Concentrations on RM 8785 from 
the NIST lab were referenced from NIST, 2005 
5.   N/A – not available 
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2.2 Experimental 
2.2.1 Chemicals 
Dichloromethane (DCM) and toluene were of pesticide grade (>99.9% purity) and 
obtained from Tedia Company Inc. (Fairfield, OH, USA). Ultra-high purity nitrogen and 
helium were obtained from Airgas South Co. (Chamblee, GA, USA). Individual neat 
material of benzo(e)pyrene, benzo(c)phenanthrene, perylene, retene and a standard 
mixture containing the 16 priority pollutant PAHs were purchased from Sigma-Aldrich 
Corporation (St. Louis, MO, USA). Methyl-PAHs and dibenzothiophene were obtained 
from Chiron AS (Trondheim, Norway). 13C12-labeled 2,3,3’,4,4’-pentachlorobiphenyl  
(13C12-CB105, neat material), deuterated 1- and 2-methyl naphthalene, and a standard 
mixture of sixteen 13C-labeled PAHs were purchased from Cambridge Isotope Laboratory 
(Andover, MA). All native PAH analytes and their respective isotopically labeled internal 
standards are listed in Table 2.1. Quartz filters (Whatman, 4.7mm, Grade 5, 2.5 µm) used 
for method development were purchased from VWR International LLC (West Chester, 
PA). The PM2.5 filters used in the method evaluation was a reference material (RM 8785) 
from NIST (Gaithersburg, MD, USA).  
We prepared stock solutions (1 mg/mL) from neat materials by weighing 
approximately 5 mg of each compound into a silanized amber vial and dissolving it in 
toluene. The internal standard solution contained sixteen 13C-labeled PAHs and 2 
deuterated Me-PAHs (200 pg/µL in toluene). The recovery standard solution contained 
13C12-CB105 (200 pg/µL in toluene). Six calibration standards were prepared in toluene 
spanning the range of 4.1–1000 pg/µL for each of the 28 analytes, with the 18 internal 
standards present at a constant concentration of 200 pg/µL.  
2.2.2 Filter Extraction Procedure  
 12
The quartz filters were punched twice using a stainless steel cutter (14 x 9.5mm) 
pre-rinsed with methanol. Two punches from each filter were combined for extraction 
and were loaded into a cartridge lined with a frit (Reservoir-2 Frits, Varian Inc., Palo 
Alto, CA, USA). The sample was fortified with isotopically labeled internal standards at 
2 ng per compound, and then topped with another frit. Samples were extracted with DCM 
(5 x 2 mL) at approximately 1 mL/min. All cartridges, frits and liners were pre-rinsed 
with DCM prior to use. The extracts were concentrated to ~50 µL in a TurboVap LV 
evaporator (Caliper Life Sciences, Hopkinton, MA) under a gentle stream of nitrogen (5-
10 psi) at 40ºC. The extracts were then spiked with toluene (40 µL) and recovery 
standard (13C12-CB105, 4 ng per sample, 20 µL). Finally, the samples were transferred to 
GC vials for analysis.   
Accelerated solvent extraction (ASE) was carried out on a Dionex ASE 200 
system (Dionex Corp., Sunnyvale, CA, USA) using Ottawa sand (20-30 mesh, pre-rinsed 
by DCM) as filler material. The filters were extracted through two cycles by DCM at 120 
ºC and 1500 psi. The heat time was 6 minutes, static time was 5 minutes, purge time was 
60 seconds, and flush volume was 50%. The extracts (~30 mL) were evaporated as 
described above.  
Sonicate extraction was carried out by placing filter samples in a capped glass 
tube and sonicating the samples in an ultrasonic bath for 20 minutes (3 x 5 mL DCM). 
The extracts were then filtered and evaporated using the same method described above.  
2.2.3 Gas Chromatography/High Resolution Mass Spectrometry   
GC/HRMS analyses were performed on a MAT 95 XL HRMS instrument 
(Thermo Scientific, Waltham, MA, USA), coupled with a 6890 GC (Agilent 
Technologies, Palo Alto, CA, USA). The chromatographic separations were carried out 
on a RTX-440 column (30 m, 0.25-mm i.d., 0.25-µm film thickness; Restek Inc.) using 
helium (1 mL/min) as the carrier gas. The injector was operated in split-less mode at 270 
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°C. The GC oven was programmed from 80°C (hold for 1 min) to 150 °C (50 °C/min, 
hold for 0.5 min), then ramped to 310 °C (10 °C/min, hold for 6 min). The source 
temperature was 250°C in electron impact mode (50 eV). The mass spectrometer was 
operated under selected ion monitoring (SIM) mode. The two most abundant ions from 
each compound were monitored as the quantification ion and confirmation ion. For most 
PAH analytes, the molecular ion was the most abundant ion and was used for 
quantification, with the exception of retene; its M-15 ion (m/z 219) was the most intense 
fragment, and thus was used as the quantification ion.  
The sensitivity of the instrument, operated at 10,000 resolution, was verified daily 
by the analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD, 20 fg/µL, 1 µL 
injection) in SIM mode (m/z 319.8965, 321.8937, 331.9368 and 333.9338). A signal-to-
noise ratio greater than 5:1 was set as sensitivity threshold for the daily sensitivity test of 
2,3,7,8-TCDD (m/z 321.8937). 
2.2.4 Quality Assurance and Quality Control  
Quality control (QC) samples were prepared by spiking a known amount of 
standard mixtures onto blank filters. In this method, a set of samples was defined as 16 
unknown samples, prepared and analyzed along with 2 filter blanks and 2 filter QC 
samples. In addition, an external recovery standard and a calibration standard were 
analyzed on the GC/HRMS in parallel with the sample extracts. The external recovery 
standard contained the 18 isotopically labeled PAH internal standards and the recovery 
standard (13C12-CB105) and was used as a reference for the recovery calculation. 
Analysis of a set of samples was considered valid only after fulfilling the following 
criteria: (i) relative retention time, defined as the retention time ratio of a native 
compound over its labeled internal standard, must be within ± 2% of the reference ratio 
set by the calibration standard run with the samples, and (ii) recovery of the labeled 
internal standard must be within the range of 25–150%. Furthermore, the following 
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criteria must be fulfilled for a set of samples to pass the QC requirements: (i) the 
measurement of the target analytes in the QC sample must be within 3 standard 
deviations of the established mean, (ii) 2 or more consecutive measurements may not fall 
above or below 2 standard deviations, and (iii) 10 or more consecutive measurements 
may not fall above or below the established mean.  
The limit of detection (LOD) for this method was defined as the higher LOD 
calculated by two methods: (i) in direct relation to method blanks prepared in parallel 
with the unknown samples, as 3 times the standard deviation of the method blanks, and 
(ii) according to the instrumental detection limit defined as the lowest point in the 
calibration curve verified to give a signal with the signal to noise ratio greater than 5:1. 
All measurements were subtracted with the average blank levels to correct for any 
analytical background. 
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Figure 2.2. Chromatogram of the 28 PAH and Me-PAH standard mixture. Peaks are 
numbered according to Table 2.1 
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2.3 Results and Discussion 
2.3.1 Method Development 
We have developed a method for measuring 28 PAHs and Methyl-PAHs (Me-
PAH) in ambient PM filter samples using a novel direct elution extraction method 
followed by isotope dilution GC/HRMS analysis. The PAHs reported in this study, as 
shown in Figure 2.1, include the 16 criteria PAHs that are on the U.S. EPA’s hazardous 
air pollutant list, retene – a proposed biomass burning marker (Ramdahl 1983), 
dibenzothiophene – a distinct component in petroleum fuel (Bence et al. 1996), as well as 
methylnaphthalenes and methylphenanthrene.  
We tested several GC columns, including commonly used DB-5MS and DB-
XLB, and found that full separation for all 28 analytes and the 18 labeled internal 
standards can be achieved by using an RTX-440 column (Figure 2.2). Chromatographic 
separation of benzo(b)fluoranthene and benzo(k)fluoranthrene may be difficult to achieve 
due to their structural similarities. In our method, we reached 25% valley-separation of 
these analytes, and thus, allowed us to report them individually.  
The sample extraction was conducted by direct elution of PM samples. DCM was 
chosen as the extraction solvent because of its extraction strength that gives high 
recovery of PAHs. In addition, given its high volatility (b.p. 39.8 °C), the DCM extract 
(~10 mL) can be evaporated within 10–15 minutes, thus minimizing analyte loss during 
evaporation. We determined the extraction condition in a series of experiments using a 
Rapid Trace® SPE workstations (Caliper Life Sciences, Hopkinton, MA). First, an 
experiment was set up to determine the amount of solvent required to achieve complete 
extraction of labeled internal surrogates and reach maximum concentration of target 
analyte concentration on the filter samples. We collected 5 fractions of DCM extracts (2 
mL in each fraction) from each sample and found that the five fractions contained on 
average 84%, 11%, 4%, 1% and 0% of the labeled internal standards, respectively, which 
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indicated complete extraction after elution with five 2mL volumes of DCM. In a follow-
up experiment, we varied solvent flow rate between 0.2 mL/min and 5 mL/min and found 
that the flow rate was not critical at or below 1 mL/min; however, when solvent flow-rate 
was over 1 mL/min, lower recoveries were obtained. Therefore, we determined the direct 
elution extraction condition as 5 x 2 mL of DCM at a flow rate of 1 mL/min to ensure 
maximum extraction efficiency.   
This method can be performed on a 24-port vacuum manifold routinely used for 
solid phase extraction. The first step in the sample preparation is setting up the extraction 
cartridges on the manifold and pre-cleaning the tubes and liners with 5 mL DCM (~ 15 
min), followed by filter sample preparation and internal standard addition (~ 15 min). 
Extraction of the 24 samples required approximately 20 minutes. The total time per 
sample is hence approximately 2 minutes, which makes the proposed method one of the 
most time-efficient method for extracting PAHs from PM samples. Due to the built-in frit 
inside each cartridge, no post-extraction filtration step was needed, which can further 
reduce human labor and increase sample throughput, in comparison to commonly used 
sonication extraction and Soxhlet extraction methods.  
Two deuterated methyl PAHs and sixteen 13C-labeled PAH internal standards, 
corresponding to the 16 EPA criteria PAHs, were used for quantification. The 13C-labeled 
standards elute at the same time as the native analytes, allowing accurate analyte 
identification in complex samples where retention times may shift due to potential 
interference from co-extracting compounds. The isotope dilution method, i.e. the use of 
isotopically labeled PAHs as internal standards, can also correct for analyte loss during 
sample preparation and instrument performance fluctuation and, thus, ensure accurate 
quantification.  
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Figure 2.3. Concentration plots for pyrene, benzo(b)fluoranthene and indeno(123-
cd)pyrene from 42 spiked filter samples (quality control samples) over a 2-month period 
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Figure 2.4. Average (with standard deviation) recoveries of the isotopically labeled 
internal standards from three extraction methods – direction elution, accelerated solvent 
extraction (ASE) and sonication extraction 
 
2.3.2 Method Evaluation 
The LODs for this method ranged from 41 to 366 pg per sample for all analytes 
(Table 2.1). PAHs with low molecular weight (2-3 aromatic rings) tended to have higher 
background levels in method blanks; therefore, their LODs were set by 3 times the 
standard deviation of 25 method blanks analyzed in parallel with the unknowns over a 
period of one month. PAHs with higher molecular weights (4 or more aromatic rings) had 
no or low background levels, and their LODs were determined by the lowest point of the 
calibration curve. Compared to other published methods measuring ambient PAHs 
(Ravindra et al. 2006; Burkhardt et al. 2005), the LODs achieved by this method were up 
to two orders of magnitude lower and, thus, enabled the detection of particulate-PAHs 
collected on air samplers running at relatively low flow rates, in contrast to high-volume 
samplers.  
Along with the analysis of unknown filter samples and method blanks, two spiked 
filter QC samples were also analyzed as part of the quality control system. The overall 
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coefficients of variance (CV) for 42 QC samples prepared over a 2-month period were at 
≤10% or below for most of analytes, with the exception of naphthalene (14%) and 2-
methylphenanthrene (13%, cf. Table 2.1), demonstrating the reproducibility of this 
analytical method. QC charts for pyrene, benzo[b]fluoranthene, and indeno[123-
cd]pyrene (representatives of 4, 5 and 6-ring PAHs) are given in Figure 2.3.  
Recovery of the isotopically labeled internal standards spiked to all samples prior 
to extraction were close to 100% in the proposed method, which is comparable to 
sonicate extraction (Figure 2.4). Recoveries from ASE, however, ranged from 15-47% 
for small PAHs (2-3 rings) to 67-119% for PAHs with 4 or more aromatic rings (Figure 
2.4), despite the fact that ASE extraction is known for its high extraction efficiency by 
employing high pressure (1000 psi), elevated temperature (120 ºC) and multiple 
extraction cycles (Prycek et al. 2006; Lintelmann et al. 2005; Bergvall and Westerholm 
2008). Therefore, the recovery loss for the small PAHs using ASE most likely took place 
in the evaporation step (~30 mL extract, in comparison to 10-15 mL extracts from the 
direct elution method and sonication extraction), during which compounds with lower 
boiling points were affected more adversely than larger compounds.  
To evaluate the accuracy of the proposed method, we analyzed RM8785, a 
reference material of PM2.5 filter samples, which is a fine fraction of the urban dust 
standard reference material (SRM 1649a) obtained from NIST (NIST 2005). As a 
comparison, we also analyzed the RM8785 filters using ASE and sonication extraction. 
The results demonstrate that the direct elution performance is similar to that of the 
commonly used ASE and sonication extraction methods, which were also in good 
agreement with analytical results from NIST (Table 2.1). Figure 2.5 demonstrates 
agreement of the concentrations of pyrene, benzo(b)fluoranthene and indeno(123-
cd)pyrene as determined by our laboratory using direct elution, ASE, and sonication 
extraction, with those reported by NIST (ASE extraction) and 8 other laboratories that 
used ASE, sonication or microwave-assisted extraction, a variety of  sample clean-up 
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procedures, and GC/MS or LC-fluorescence detection (Table 2.2) (NIST 2005). Overall, 
among the 19 analytes reported by both NIST and our method, analytical results from the 
direct elution extraction were on average 12% lower than those from the NIST lab. 
Results obtained from direct elution were also consistent with those from sonication 
extraction, with on average 8.8% difference between these two methods. It is a potential 
risk that small PAHs with low molecular weight (2-3 rings) may re-volatilize during PM 
sample storage which could lead to inconsistent results, and therefore, they are often not 
included in studies reporting particle-bound PAH concentrations (Tsapakis and 
Stephanou 2005; Pleil et al. 2004). When excluding the small PAHs and only considering 
PAHs with 4 and more aromatic rings, the differences were 7.5%, 10%, and 19% 
between direct elution results and those from NIST, sonication extraction, and ASE, 
respectively. 
 
Table 2.2. Brief description of methods used in the NIST interlaboratory comparison  
 
Lab code 
in this 
paper 
Lab code 
in NIST 
report 
Extraction 
method Extraction solvent 
Extract 
clean-up 
method 
Instrument 
method 
NIST 1a ASE1 DCM2 SPE3 GC/MS4 
Lab1 1b ASE DCM silica  GC/MS 
Lab2 1c ASE DCM SPE GC/MS 
Lab3 3a ASE DCM filtration HPLC FLD5 
Lab4 3b Sonication 2x5mL cyclohexane/DCM (4:1) centrifuge GC/MS 
Lab5 4 ASE acetone/DCM (1:4) alumina  GC/MS 
Lab6 7 Microwave-assisted extraction acetone/hexane (1:1) silica GC/MS 
Lab7 9 ASE toluene none HPLC FLD, GC/MS 
Lab8 14 Sonication DCM/acetonitrile (2:1) filtration HPLC FLD
 
1. ASE: Accelerated solvent extraction, or other equivalent pressuized fluid extraction systems 
2. DCM: dichloromethane 
3. SPE: solid phase extraction 
4. GC/MS: gas chromatography mass spectrometry 
5. HPLC FLD: high performance liquid chromatography fluorescence detection 
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Figure 2.5. Inter-laboratory comparison on PM2.5-bound PAH concentrations in NIST 
Reference Material 8785. Results from our lab are labeled as DE (direct elution), ASE 
(accelerated solvent extraction) and SON (sonication); results from the NIST lab are 
labeled as NIST 
 
2.3.3 Concentrations of PM2.5-bound PAHs in Atlanta 
The developed direct elution method was used to analyze PM2.5 samples taken 
from three sites (urban, suburban and rural) in the metropolitan Atlanta area during 2004, 
as described in Chapter 2. Six 24-hour samples from each site and month were analyzed, 
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and the results were compared to a pilot study reporting levels of 19 PAHs on PM2.5 
samples taken from the same sites but measured using a different method (Li et al. 2009). 
As shown in Figure 2.6, results from the current method were consistent with findings 
from the earlier study during which samples from December 2003 and June 2004 were 
extracted by ASE and analyzed by an Agilent GC/MSD system. These findings 
demonstrate comparability between the current direct elution method and the more 
established and commonly used ASE method.  
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Figure 2.6. Average (with standard deviation) summed concentration of 19 PAHs from 
PM2.5 samples taken in Atlanta, comparison between results from current study (DE or 
direction elution) and an earlier pilot study using ASE as extraction method. Also given 
are numbers of samples in each category 
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CHAPTER 3 
CHARACTERIZATION OF PM2.5-BOUND POLYCYCLIC 
AROMATIC HYDROCARBONS IN ATLANTA  
(Li Z, Sjodin A, Porter EN, Patterson Jr. DG, Needham LL, Lee S, Russell AG 
and Mulholland JA. Atmospheric Environment, 43:1043-1050, 2009  
Li Z, Porter EN, Sjodin A, Needham LL, Lee S, Russell AG and Mulholland JA, 
Atmospheric Environment, Submitted) 
 
Abstract 
Twenty-eight polycyclic aromatic hydrocarbons (PAH) and methylated PAHs 
(Me-PAH) were measured in daily PM2.5 samples collected at an urban site, a suburban 
site, and a rural site in and near Atlanta during 2004 (5 samples/month/site). The 
suburban site, which is impacted by a nearby major highway, had higher PM2.5-bound 
PAH concentration than did the urban site, and the rural site had the lowest PAH levels. 
Monthly variations are described for concentrations of total PAHs and individual PAHs. 
PAH concentrations were much higher in cold months than in warm months, with 
average monthly total PAH concentrations at the urban and suburban-highway 
monitoring sites ranging from 2.12 to 6.85 ng/m3 during January-February and 
November-December 2004, compared to 0.38-0.98 ng/m3 during May-September 2004. 
Total PAH concentrations were found to be well correlated with PM2.5 and organic 
carbon (OC) within seasons but not over the entire year, and the fractions of PAHs in 
PM2.5 and OC were higher in winter than in summer. Methyl phenanthrenes (MePhe) 
were present at higher levels than their un-substituted homologue (phenanthrene or Phe), 
suggesting a significant petrogenic (unburned petroleum products) input. Retene, a 
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proposed tracer for biomass burning, peaked in March, the month with the highest 
prescribed burning and unplanned fires, and in December during the high wood-burning 
season, which gives a strong indication that retene might be a good marker for burning of 
all biomass materials; in contrast, potassium peaked more sharply in December, 
indicating that it might be a more specific tracer for wood burning.  
3.1 Introduction 
Particulate matter (PM) air pollution has been linked to increased morbidity and 
mortality rates, as well as various adverse health effects such as respiratory and 
cardiovascular diseases (Cakmak et al., 2007; Kappos et al., 2004; Lebowitz, 1996; Ostro 
et al., 2007; Pope, III et al., 2004).  Particulate matter with aerodynamic diameters less 
than 2.5 µm (PM2.5 or fine particulate matter) are of special concern because, when 
inhaled, they can penetrate effectively into the respiratory system and deposit deep in the 
bronchioles and alveoli of the lungs.  The association of fine particles with mutagenic and 
carcinogenic chemicals — such as polycyclic aromatic hydrocarbons (PAHs) — may 
contribute to these acute health effects or potentially result in long-term health risks. 
PAHs are a group of environmental pollutants formed during incomplete combustion of 
organic materials and are ubiquitously present in the ambient air, soil/sediments, water, 
and food such as grilled meat (ATSDR, 1995; Bostrom et al., 2002; Guillen et al., 1997; 
IARC, 1983). Several PAHs, including benzo(a)pyrene, benz(a)anthracene and chrysene, 
have been classified as probable human and animal carcinogens (ATSDR, 1995). PAHs 
have also been reported to possess reproductive, developmental, hemato-, cardio-, neuro-, 
and immuno-toxicities (ATSDR, 1995). The general population is primarily exposed to 
PAHs through inhalation of polluted air or cigarette smoke and through ingestion of 
PAH-containing foods (ATSDR, 1995; Bostrom et al., 2002; Ramesh et al., 2004). Given 
their carcinogenic and mutagenic potential and their wide distribution resulting in 
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exposure in the general population, PAHs have generated considerable interest; 16 PAHs 
have been included in U.S. EPA’s list of 188 hazardous air pollutants (U.S.EPA, 1990).  
PAHs in the atmosphere can come from natural sources, such as forest fires and 
volcanic eruptions. However, their presence, especially in densely populated areas, is 
significantly affected by anthropogenic emissions, such as automobile exhaust, fossil fuel 
combustion, biomass burning, cigarette smoking, and industrial activities. On the other 
hand, alkylated PAHs have often been found at comparable or even higher levels than 
their un-substituted parent compounds and have been primarily attributed to mature 
organic matter or petrogenic sources (Bostrom et al., 2002; Yunker et al., 2002). 
Examples of such sources that can be significant in urban areas include evaporation of 
fossil fuel drippings on the roadway, evaporative losses during motor vehicle refueling, 
and venting of restaurant frying oils. The ratio of methylated PAHs (Me-PAH) to their 
un-substituted homologue has been used as an indicator to un-burnt fossil fuel sources in 
the atmosphere, soil and aquatic environments (Simo et al., 1997; Vondracek et al., 2007; 
Yunker et al., 2002). Me-PAHs, specifically monomethylated phenanthrenes (MePhe) 
and naphthalenes (Me-Nap), have been recommended for inclusion in ambient air 
monitoring based on their high abundance in air samples and association to un-combusted 
petroleum fuel (Bostrom et al., 2002).  
Atmospheric PAHs are found in both gaseous and particle phases. PAHs with 2-3 
aromatic rings exist predominantly in the gaseous phase, while compounds with 4 or 
more aromatic rings are primarily associated with the particulate fraction (Eiguren-
Fernandez et al., 2004; Li et al., 2006; Re-Poppi and Santiago-Silva, 2005). In addition, it 
has been reported that PAH-associated particles exist predominantly as fine particles, i.e., 
in the PM2.5 size range, especially in areas with heavy traffic (Cancio et al., 2004; Duan et 
al., 2005; Ohura et al., 2004). Because the carcinogenic PAHs (e.g. benzo[a]pyrene and 
benz[a]anthrene) are mostly associated with particulate matter, many studies on PAHs in 
ambient air have been focused on PAHs bound to PM, particularly PM2.5 (Borlakoglu et 
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al., 1993; Bourotte et al., 2005; Ohura et al., 2004; Papageorgopoulou et al., 1999; 
Sanderson et al., 2004; Sklorz et al., 2007). 
Particulate matter pollution is of interest in metropolitan Atlanta, Georgia, one of 
the fastest growing regions in the United States. Atlanta’s traffic congestion is the second 
worst in the country, following Los Angles, CA (Texas Traffic Institute, 2007). Air 
quality in this region is often problematic; currently, the twenty-county Atlanta 
metropolitan area is in non-attainment for PM2.5 and ozone (U.S.EPA, 2007). PM source 
apportionment analyses by two groups of researchers indicated that 30 to 40% of 
Atlanta’s PM2.5 can be attributed to mobile sources and biomass burning (Kim et al., 
2004; Marmur et al., 2007), and a recent epidemiologic study indicated that these 
components are associated with both cardiovascular and respiratory emergency room 
visits in Atlanta (Sarnat et al., 2008).  
We conducted two studies characterizing PAHs in PM2.5 samples collected at 
three sites (urban, suburban-highway and rural) in the metropolitan Atlanta area. First, a 
pilot study was conducted reporting levels of 19 particle-bound PAHs in daily PM2.5 
samples taken in December 2003 and June 2004 (Li et al., 2009b). We found strong 
seasonal variation for particulate PAHs and positive correlations of PAHs to other 
pollutants including PM2.5, organic carbon (OC) and elemental carbon (EC). As an 
expansion of the pilot study, we conducted a year-round study by measuring 28 
particulate PAHs and Me-PAHs in outdoor PM2.5 samples collected at the three sites 
during the year of 2004 (5 samples/month/site). We examined the concentrations and 
profiles of these pollutants by month and site. We investigated the potential of retene as a 
marker for biomass burning and relative concentration of methyl phenanthrenes as an 
indicator for petrogenic sources. We also examined correlations of PAH levels with other 
air pollutants such as PM2.5 mass and OC and the temperature dependency of these 
correlations. 
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3.2 Experimental 
3.2.1 Sampling Sites and Method 
Three sampling sites in the metropolitan Atlanta region were chosen to 
characterize particle-bound PAHs (Figure 3.1). The sampling sites were selected from the 
Assessment of Spatial Aerosol Composition in Atlanta (ASACA) network, a project 
started in early 1999 to study the spatial and temporal variation of PM2.5 and its chemical 
components in Atlanta (Butler et al., 2003). One of the sites, Fort McPherson (FM), is 
located in southwest urban Atlanta on a military base, well within I-285, the Atlanta 
perimeter interstate highway. A second site, South Dekalb (SD), is located in a primarily 
residential suburban area less than 1 km south of the I-285, which carries on average over 
130,000 vehicles per day and is the main detour route around Atlanta for large, heavy 
service diesel trucks. The third sampling location, Fort Yargo (YG), is a rural site at a 
state park with heavy vegetation about 80 km northeast of Atlanta.  
 
FM SD
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Urban Area
County boundary
Interstate highway
0 10 20 30 405
Kilometers
 
Figure 3.1. Map of the metropolitan Atlanta area with major interstate highways, county 
boundaries, and air monitoring stations. Data for this study were taken from three sites, 
Fort McPherson (FM, urban), South Dekalb (SD, suburban-highway), and Fort Yargo 
(YG, rural) 
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The PM2.5 particle composition monitor (PCM) sampling system has been 
described in detail previously (Butler et al., 2003), and is only briefly described here. 
Twenty-four hour PM2.5 samples were collected using three-channel PCM systems placed 
on top of single-story trailers, with sampling inlets located approximately 4 m above 
ground level, except at YG, where the inlet is approximately 2 m above ground. Particle-
bound PAHs were captured on a quartz filter (Whatman, 4.7mm, Grade 5, 2.5 µm) after 
the ambient air sample has passed through a Teflon-coated cyclone with a 10 µm cut-
point, an activated carbon parallel-plate denuder to remove organic gases, and a Well 
Impactor Ninety Six (WINS) impactor with a 2.5 µm cut-point. The flow rate was 16.7 
L/min, resulting in a total sampled air volume of 24 m3 for each sample. Prior to 
sampling, quartz filters were baked at 550 ºC for 12 hours to remove organic impurities. 
After sampling, the filters were put into individual Petri dishes and kept in a -20 ºC 
freezer until analysis. Samples analyzed in the pilot study were taken in December 2003 
and June 2004. For the expanded year-round study, five samples each month in 2004 
from each of the 3 sampling sites were analyzed for PAHs.  
3.2.2 Sample Analysis 
The detailed methods for measuring concentrations of PM2.5, OC, EC and ionic 
species have been described elsewhere (Cobb, 2006). Briefly, continuous PM2.5 mass 
concentrations (at 10 min sampling intervals) were collected using tapered element 
oscillating microbalances (TEOM), with which we calculate 24-hr averaged PM2.5 mass. 
OC and EC concentrations were quantified using thermal optical transmittance (Sunset 
Labs Inc., Tigard, OR). Major ion species were analyzed on a Dionex Ion 
Chromatography system (Dionex Corp., Sunnyvale, CA). Metals were analyzed using x-
ray fluorescence (XRF).    
3.2.2.1 Extraction and Instrument Methods in Pilot Study 
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Nineteen PAHs were measured in all samples using a method that included 
Accelerated Solvent Extraction (ASE) and isotope-dilution GC/MS quantification. Filter 
samples were cut in half and weighed. One half was extracted and analyzed for PAHs, 
while the other half was used for OC and EC analysis. The filters were fortified with a 
mixture of 15 13C-labeled internal standards in toluene, at 2 ng per compound per sample, 
then loaded onto a pressurized solvent extraction system (ASE 200, Dionex Corp., 
Sunnyvale, CA) using hydromatrix (pre-rinsed by dichloromathene) as filler. The filters 
were extracted three times by dichloromethane, at 120 ºC and 1500 psi. The extracts (~25 
mL) were concentrated to ~100 µL in a TurboVap LV evaporator (Caliper Life Sciences, 
Hopkinton, MA), under a gentle stream of nitrogen (5-10 psi) at 40ºC, then spiked with a 
recovery standard (13C12 labeled 3-methoxy-3,3’,4,5’-tetrachlorobiphenyl, 3 ng per 
sample, in toluene) to track recovery from the sample preparation process. Finally, the 
samples were transferred to GC vials for analysis. 
GC/MS analyses were performed on a 6890 GC coupled with a 5973 mass 
selection detector and a 7683 auto-injector (Agilent Technologies, Palo Alto, CA). The 
chromatographic separations were carried out on an RTX-440 column (30 m, 0.25-mm 
i.d., 0.25-µm film thickness; Restek Inc.) using helium (1 mL/min) as the carrier gas. The 
injector was operated in the splitless mode at a temperature of 270 °C. The GC oven was 
programmed from 100°C (hold for 1 min) to 200 °C (30 °C/min), then ramped to 290 °C 
(10 °C/min), and finally to 320 °C (20 °C/min, hold for 4 min). The mass spectrometer 
was operated under the selected ion monitoring (SIM) mode. Only the two most abundant 
ions from each compound were monitored as the quantification ion and confirmation ion. 
For most PAH analytes, the molecular ion was the most abundant ion and was used for 
quantification, with the exception of retene, the only alkylated PAH (1-methyl-7-
isopropyl phenanthrene) on the analyte list. Retene’s M-15 ion (m/z 219) was the most 
intense fragment, and thus was used as the quantification ion. The 19 PAHs measured in 
this study are listed in Table 3.1, along with their formulas, molecular weights, vapor 
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pressures, 13C labeled internal standards, limits of detection (LOD), and recoveries. 
Retene, an alkylated phenanthrene, has 18 carbons and it elutes after pyrene, therefore, it 
is included in the 4-ring or C16-C18 group (Table 3.1). 
 
Table 3.1. List of PAHs reported in the pilot study, including the abbreviations, formula, 
molecular weights, vapor pressure, 13C-labeled internal standards, limits of detection, and 
percent recoveries 
 
Compound Abbr. Formula Molecular weight 
Vapor 
pressure (mm
Hg) a 
Internal 
standard 
LOD  
(pg/m3) b
Recovery 
(%) 
3-ring, C12-C14        
acenaphthylene acny C12H8 152 0.029 acny 13C6 9.4 32% 
acenaphthene acne C12H10 154 4.47x10-3 acne 13C6 9.4 36% 
fluorene fluo C13H10 166 3.2x10-4 fluo 13C6 24.6 55% 
phenanthrene phen C14H10 178 6.8x10-4 phen 13C6 51.8 68% 
anthracene anth C14H10 178 1.7x10-5 anth 13C6 9.4 64% 
4-ring, C16-C18        
fluoranthene flran C16H10 202 5.0x10-6 flran 13C6 11.3 91% 
pyrene pyr C16H10 202 2.5x10-6 Pyr 13C6 9.4 92% 
retenec retene C18H18 234 n/a Pyr 13C6 9.4 92% 
benzo(c)phenanthrene bcp C18H12 228 n/a baa 13C6 9.4 110% 
benzo(a)anthracene baa C18H12 228 2.2x10-8 baa 13C6 9.4 110% 
chrysene chry C18H12 228 6.3x10-7 chry 13C6 9.4 103% 
5-ring, C20        
benzo(b)fluoranthene bbf C20H12 252 5.0x10-7 Bbf 13C6 9.4 102% 
benzo(k)fluoranthene bkf C20H12 252 9.59x10-11 Bkf 13C6 9.4 97% 
benzo(e)pyrene bep C20H12 252 5.7x10-9 bap 13C4 9.4 98% 
benzo(a)pyrene bap C20H12 252 5.6x10-9 bap 13C4 9.4 98% 
perylene per C20H12 252 n/a bap 13C4 9.4 98% 
6-ring, C22        
benzo(ghi)perylene bgp C22H12 276 1.03x10-10 bgp 13C6 9.4 112% 
dibenz(a,h)anthracene dba C22H14 278 1.0x10-10 dba 13C6 9.4 108% 
indeno(123-cd)pyrene inp C22H12 276 ~10-11-10-6 Inp 13C6 9.4 104% 
 
a As compiled in ATSDR, 1995 
b Limit of detection, based on 16.7 L/min flow rate and 24 hour air sampling 
c Full nomenclacture: 1-methyl-7-isopropyl phenanthrene 
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3.2.2.2 Extraction and Analysis Methods in Year-round Study 
Filter samples in the year-round study were extracted through direct elution and 
quantified by isotope-dilution gas chromatography/high resolution mass spectrometry 
(GC/HRMS). The method has been described in detail in Chapter 2 (Li et al., 2009a). 
Briefly, each filter sample was loaded into a cartridge lined with a frit, fortified with a 
mixture of 18 isotopically labeled internal standards, and then topped with another frit. 
Samples were extracted with dichloromethane (DCM, 5 x 2 mL) at approximately 1 
mL/min. The extracts were concentrated to ~50 µL under a gentle stream of nitrogen (5-
10 psi, 40ºC), spiked with toluene (40 µL) and a recovery standard (13C12-labeled 
PCB105, 4 ng per sample). Finally, the samples were transferred to GC vials for analysis.   
GC/HRMS analyses were performed on a MAT 95 XL HRMS instrument 
(Thermo Scientific, Waltham, MA, USA), coupled with a 6890 GC (Agilent 
Technologies, Palo Alto, CA, USA). The chromatographic separations were carried out 
on an RTX-440 column (30 m, 0.25-mm i.d., 0.25-µm film thickness; Restek Inc.) using 
helium (1 mL/min) as the carrier gas. The injector was operated in split-less mode at 270 
°C. The GC oven was programmed from 80°C (hold for 1 min) to 150 °C (50 °C/min, 
hold for 0.5 min), then ramped to 310 °C (10 °C/min, hold for 6 min). The mass 
spectrometer was operated under selected ion monitoring (SIM) mode. Only the two most 
abundant ions from each compound were monitored as the quantification ion and 
confirmation ion.  
3.2.3 Quality Assurance and Quality Control 
Field and method blanks were analyzed to monitor background contamination. 
Method blanks were measured along with samples, and all results reported here were 
blank-subtracted. Secondary filters were installed after the primary filters in the PCM 
sampler to study the breakthrough of particulate PAHs. Levels of particulate PAHs on the 
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secondary filters were very low — in most cases, they were below the limit of detection 
(LOD).  
Deuterated or 13C-labeled PAH internal standards were used for quantification. 
The 13C-labeled standards elute at the same time as the native analytes, allowing accurate 
analyte identification in complex samples where retention times may shift due to 
potential interference from co-extracting compounds. The isotope dilution method, i.e. 
the use of isotopically labeled PAHs as internal standards, can also correct for analyte 
loss during sample preparation and instrument performance fluctuation and, thus, ensure 
accurate quantification.  
Quality control (QC) samples were prepared by spiking a known amount of 
standard mixtures onto blank filters. In this method, a set of samples was defined as 16 
unknown samples, prepared and analyzed along with 2 filter blanks and 2 filter QC 
samples. In addition, an external recovery standard and a calibration standard were 
analyzed on the GC/HRMS in parallel with the sample extracts. Analysis of a set of 
samples was considered valid only after fulfilling a series of criteria on elution time, 
recovery and QC concentrations as described in Chapter 2 (Li et al., 2009a).  
3.2.4 Data and Statistical Analysis 
All concentrations were blank-subtracted; concentrations below the LOD were 
replaced with the LOD divided by the square root of 2 prior to statistical analysis. Fire 
data were obtained through personal communication with Georgia Forestry Commission. 
All statistical analyses were performed using the Statistica 7.1 software (StatSoft Inc., 
Tulsa, OK). Results were considered statistically significant if the p-value was equal to or 
less than 0.05. 
3.3 Results and Discussion 
3.3.1 Results and Discussion from the Pilot Study 
 33
3.3.1.1 Ambient Levels of Particulate PAHs – Seasonal Variation  
Median concentrations of the 19 particle-bound PAHs obtained in this study are 
presented in Table 3.2, arranged by sampling site and month. The median total PAH 
concentrations were 3.40, 4.13, and 3.16 ng/m3 in December, and 0.24, 0.74, and 0.60 
ng/m3 in June, for YG, SD, and FM, respectively (Figure 3.2). At all three sites, there 
were large differences between the winter month (December) and the summer month 
(June); total PAH concentrations in December were 4.2, 5.6, and 5.3 times higher than in 
June for YG, SD, and FM, respectively. As shown in Table 3.3, the PAH concentrations 
observed in this study are similar to those reported in Chapel Hill, NC, USA (Pleil et al., 
2004), Los Angeles, CA, USA (Eiguren-Fernandez et al., 2004) and Japan (Tham et al., 
2008). But the concentrations are lower than those in urban environments in Croatia 
(Sisovic et al., 2005), Brazil (Bourotte et al., 2005), China (Li et al., 2006), and Greece 
(Tsapakis and Stephanou, 2005b).  
The increase in particulate PAH concentration during the winter time has been 
reported in a number of previously published studies (Eiguren-Fernandez et al., 2004; Li 
et al., 2006; Papageorgopoulou et al., 1999; Sanderson et al., 2004; Sisovic et al., 2005; 
Tsapakis and Stephanou, 2005b). Several factors may contribute to the strong seasonal 
trend. During the cold season, PAH emissions from automobile exhaust are higher due to 
low ambient temperature and increased cold start impacts (Ludykar et al., 1999). Biomass 
burning and fireplace usage are also likely to contribute to increased PAH emissions in 
winter. Reduced atmospheric dispersion and atmospheric reaction can lead to higher PAH 
concentrations in winter as well. Furthermore, low atmospheric temperature can affect 
the distribution of PAHs between the gas and particle phases and result in a relatively 
larger portion of PAH partitioning to the particle phase in winter. Finally, potential re-
volatilization of PAHs, particularly smaller PAHs, may also contribute to relatively lower 
particle phase concentrations during the summer season. 
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Table 3.2. Median PAH concentrations (pg/m3) from three sampling sites during June 
2004 and December 2003  
 
YG (rural)   SD (suburban-highway)   FM (urban) PAH Analytes  
June  December   June  December   June  December 
acenaphthylene <LOD <LOD  <LOD 8.6  <LOD <LOD 
acenaphthene <LOD <LOD  <LOD 36.4  <LOD 68.3 
fluorene <LOD <LOD  <LOD <LOD  <LOD <LOD 
phenanthrene <LOD 38.7  47.0 151.8  <LOD <LOD 
anthracene <LOD <LOD  <LOD 15.7  <LOD 7.3 
fluoranthene 12.8 101.9  35.6 140.9  32.9 110.9 
pyrene 10.3 119.5  39.1 167.4  31.7 140.5 
retene <LOD 290.3  <LOD 137.1  <LOD 175.6 
benzo(c)phenanthrene <LOD 22.0  <LOD 25.3  <LOD 21.0 
benzo(a)anthracene <LOD 123.9  26.3 188.6  16.5 120.8 
chrysene 10.6 153.8  49.3 233.1  33.9 156.0 
benzo(b)fluoranthene 19.6 544.4  78.6 607.6  59.0 468.9 
benzo(k)fluoranthene <LOD 139.7  22.3 179.4  17.4 140.7 
benzo(e)pyrene 14.4 307.0  54.5 375.2  46.3 345.6 
benzo(a)pyrene <LOD 234.3  48.8 415.5  29.1 275.1 
perylene <LOD 53.1  9.1 90.9  <LOD 160.7 
benzo(ghi)perylene 16.8 257.2  64.6 312.7  56.7 244.0 
dibenz(a,h)anthracene <LOD 15.7  <LOD 18.1  <LOD 12.3 
indeno(123-cd)pyrene 25.2 372.2  131.0 585.9  110.1 514.8 
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Figure 3.2. Median and quartile ranges of summed PAH concentration from three 
sampling sites, in June 2004 and December 2003. Also shown are the numbers of valid 
sampling days under each category 
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Figure 3.3. Distribution of individual PAHs (A) and grouped PAHs by ring size (B). Data 
are taken from all three sites 
 
 
We also found large differences in concentrations among different PAHs, 
spanning several orders of magnitude (Table 3.2). Generally, the concentrations were 
related to the size of the compounds; i.e., the higher the molecular weight, the higher the 
particle-bound PAH concentrations. The median concentrations for PAHs with 3 
aromatic rings were less than 100 pg/m3 or at the LOD, while concentrations of PAHs 
with 5–6 rings were elevated, with benzo(b)fluoranthene and indeno(123-cd)pyrene being 
the most abundant compounds (Figure 3.3A). As a result, 55–70% of total PAH 
 37
concentrations consisted of PAHs with 5–6 rings while less than 20% (in June) or 10% 
(in December) consisted of PAHs with 3 rings (Figure 3.3B). This distribution pattern is 
similar to that found in a study conducted in Brazil (Bourotte et al., 2005). The low 
concentrations of small PAHs are consistent with their physio-chemical properties. With 
high vapor pressure and high volatility, these compounds exist primarily in the gaseous 
phase (Re-Poppi and Santiago-Silva, 2005; Tsapakis and Stephanou, 2005b; Tsapakis and 
Stephanou, 2005a). Pleil et al. (2004) assessed the measurement of particle-bound PAHs 
in archived filter samples and concluded that the 5-6 ring PAH measurements are 
quantitatively robust, as are the measurements of 4-ring compounds — if filter samples 
are stored under refrigeration. Because of re-volatilization, concentrations of small PAHs 
(i.e. those with fewer than 4-rings) in archived PM filters can be biased and are therefore 
excluded from further analysis in this study.    
3.3.1.2 Ambient Levels of Particulate PAHs – Site Variation 
SD is located about 1 km from a major highway and — not surprisingly — 
recorded significantly higher levels than did FM, the more central site (Wilcoxon 
Matched Pairs Test, p = 0.013). The median total PAH concentrations at SD were 31% 
and 23% higher than those at FM in December and in June respectively (Figure 3.2). The 
urban site (FM) and suburban site (SD) had significantly higher particulate PAH levels 
than did the rural site (YG) (Mann-Whitney U test) in June. This is consistent with their 
locations in densely populated and heavily trafficked areas with a high PAH contribution 
from traffic emission and anthropogenic input. In December, however, between YG and 
the urban/suburban sites, no significant differences appeared in total PAH concentrations. 
That said, the sample size for YG in December was small (n = 4), preventing us from 
drawing any conclusion from this observation. An expanded follow-up project that 
studies PAH levels from the same three sampling sites throughout the year 2004 is 
currently underway, which will give more insight into the site variation. 
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Figure 3.4. Median ratio of individual PAH concentration at Fort Yargo (YG, rural) to 
South Dekalb (SD, highway) and Fort McPherson (FM, urban). Samples were taken 
during December 2003 
 
To examine the site variation of individual PAHs, we calculated the ratios of PAH 
concentrations measured at YG to those at SD and FM on the same day (paired data were 
available on 3 days in December 2003, i.e. 12/25/2003, 12/28/2003, and 12/31/2003). As 
shown in Figure 3.4, the median ratios of PAH concentrations on those 3 days were at or 
below 1 for most of the 4-or-more aromatic ring PAHs, with the exception of retene, an 
alkylated phenanthrene. Collectively, the median retene concentration at YG in 
December was 290 pg/m3 (n = 4), higher than the urban site (FM, 176 pg/m3, n = 27) and 
the suburban site (SD, 137 pg/m3, n = 22). Furthermore, linear regression analysis 
showed that retene was either not correlated or correlated poorly with the other PAHs 
measured (Table 3.4), indicating a different source/formation mechanism or 
environmental fate pathway for this compound. The different patterns of retene compared 
with other PAHs has been noted in several other studies, including a temporal PAH 
deposition study (Lima et al., 2003) and a year-round Mexican City air study (Villalobos-
Pietrini et al., 2006). The uniqueness of retene might be related to its source-specific 
formation mechanism. Ramdahl (1983) has demonstrated the formation of retene by 
thermal degradation of resin compounds in wood and proposed it as a marker in ambient  
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air for wood combustion. McDonald et al. (2000) further identified this compound as an 
indicator for softwood burning. Retene has also been found at levels similar to our results 
(in pg/m3 range) in aerosols over the rural western U.S (Simoneit and Mazurek, 1982). 
Our observation of the high retene concentration at YG is consistent with that air monitor 
located in a heavily vegetated rural forest park with wood burning as a potential prime 
source for atmospheric PAHs in the area.    
3.3.1.3 Relationship of PAH Concentrations with Other Air Pollutants  
Correlation analysis between concentrations of PAH and other air pollutants has 
been used to deduce the emission source, fate and transportation pathway for these 
compounds in the atmosphere (Crimmins et al., 2004; Lodovici et al., 2003; Ohura et al., 
2004; Papageorgopoulou et al., 1999; Wu et al., 2005). We performed linear regression 
analyses on the concentrations of individual PAHs as well as between the total PAH 
concentration and other pollutants concurrently measured on all samples. Not 
surprisingly, individual PAHs of similar size were well correlated with each other (Table 
3.4), and overall, larger PAHs are more correlated than smaller PAHs. An exception is 
the case of retene, which is an alkyl-substituted three-ring PAH. The correlation 
coefficients (r) were -0.11 – 0.67, 0.16 – 0.99, and 0.46 – 0.99 between PAHs with 3, 4, 
and 5–6 aromatic rings, respectively (Table 3.4). Similar observation for the correlation 
among PAHs has also been reported in dust fall samples in China (Wu et al., 2005) where 
PAHs with comparative ring sizes were better correlated, suggesting a similarity both in 
source and in physico-chemical properties (i.e. similar atmospheric fate). 
Correlations between total PAH concentration and PM2.5 mass and its chemical 
components, i.e., OC, EC, potassium ion (K+), sodium ion (Na+), ammonium ion (NH4+), 
nitrite ion (NO3-), and sulfate ion (SO42-), were season-specific. The total PAH 
concentrations were significantly correlated with total PM2.5, OC and EC in both 
December and June (Figure 3.5). However, in these two months, there was a large  
 41
Dec 03 Jun 04
A
R2 = 0.36
p = 0.002
R2 = 0.51
p < 0.001
0
3
6
9
12
15
10 20 30 40
PM2.5 (µg/m3)
P
AH
 (n
g/
m
3 )
R2 = 0.40
p < 0.001 
R2 = 0.73
p < 0.001 
B
0
3
6
9
12
15
5 10 15 20
OC (µg/m3)
R2 = 0.66
p < 0.001
R2 = 0.78
p < 0.001 
C
P
AH
 (n
g/
m
3 )
0
3
6
9
12
15
0.5 1.0 1.5 2.0 2.5 3.0
EC (µg/m3)
R2 = 0.025
p = 0.40
R2 = 0.39
p = 0.014
D
0
3
6
9
12
15
0.03 0.06 0.09 0.12 0.15
K (µg/m3)
P
AH
 (n
g/
m
3 )
P
AH
 (n
g/
m
3 )
P
AH
 (n
g/
m
3 )
P
AH
 (n
g/
m
3 )
 
Figure 3.5. Correlations of the total PAH concentration to (A) PM2.5, (B) OC, (C) EC, (D) 
potassium ion. Data from all sites are used, with the exception of the PAH vs. PM2.5 plot 
(A) in June 2004. In this latter instance only data from South Dekalb (suburban, highway) 
were used, given that in June 2004 the PM2.5 data were not available from the Fort 
McPherson (urban) and Fort Yargo (rural) sites 
 
difference in the percent-fraction contribution of the PM2.5 and in the OC concentrations 
from PAHs. The total PAH concentration represented on average 0.033% of the PM2.5 
mass and 0.137% of the OC concentrations in December, compared with 0.006% and 
0.017% of the PM2.5 and OC in June. This is a 30-fold lower percent fraction which is 
possibly a result of lower particle phase partition and higher atmospheric degradation 
caused by higher ambient temperature in June. Potassium ion, a tracer for biomass 
burning, was positively associated with PAH concentration in December (r2 = 0.39, p = 
0.014), but not in June (Figure 3.5), suggesting biomass burning can potentially be an 
 42
important source for particulate PAH in winter. On the other hand, PAHs were also 
associated with NH4+, NO3-, and SO42- in June (r2 = 0.53, 0.51, and 0.52, p < 0.001, data 
not shown), but not in December. Our findings differ from a study conducted on the 
northern Indian Ocean atmosphere, where particulate PAHs were correlated with SO42-, 
K+ and EC, but not with OC (Crimmins et al., 2004). Still, such differences are not 
surprising, given the various sources and atmospheric chemistry affecting the Atlanta 
airshed as compared with air over the northern Indian Ocean.  
3.3.2 Results and Discussion from the Year-round Study 
3.3.2.1 Ambient Levels of Particulate PAHs – Seasonal Variation  
Average concentrations of the 28 particle-bound PAHs obtained in this study are 
presented in Table 3.5, arranged by sampling site and quarters of the year. Figure 3.6 
illustrates the average total PAH concentrations (sum of the 28 analytes) at the three 
sampling sites in each month as well as in the whole year of 2004. Strong monthly trends 
were observed for both individual compounds and the total PAH concentrations at all 
three sites (Table 3.5 and Figure 3.6). Particle-bound PAH concentrations varied 
inversely with temperature; i.e. high in the cold months and low in the warm months 
(Figure 3.7A). For example, monthly average total PAH concentrations were 0.38 ng/m3 
to 0.98 ng/m3 during May-September 2004 (monthly average of daily maximum 
temperature 26-31ºC), compared to 2.12-6.85 ng/m3 during January-February and 
November-December 2004 (monthly average of daily maximum temperature 11-18ºC) at 
the urban and surburban-highway sites (Figure 3.6). The particle-bound PAH levels and 
seasonal trend in the current study are consistent with the pilot study and has been 
discussed in the previous section 3.3.1.1 (Li et al., 2009b).  
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Figure 3.6. Average concentrations of total PAHs at three sampling sites in 2004. All 
shown are monthly average of daily maximum temperatures in Atlanta during year 2004 
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Figure 3.7. Relationship between ambient temperature and total PAH concentrations (A), 
PAH/OC ratio (B) and PAH/PM2.5 ratio (C). Data from South Dekalb (suburban-
highway) site were used 
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Figure 3.8. Correlations between concentration of total PAHs and PM2.5 (A) and OC (B). 
Data from South Dekalb (suburban-highway) site were used 
 
3.3.2.2 Relationship of PAH Concentrations with PM2.5, OC and Other Air Pollutants  
Overall, PAHs were poorly correlated to PM2.5 and OC when combining the data 
from the whole year. However, when considering individual seasons, as shown in Figure 
3.8, total PAH concentration was positively correlated to PM2.5 and OC, which is 
consistent with the pilot study (Li et al., 2009b). Specifically, the slopes of the 
correlations, i.e. fractions of particulate PAHs in the PM2.5 and OC, were highest during 
the October-December period, followed by the first quarter of the year (January-March), 
and were lower during the spring and summer quarters (April-September). Similar to the 
particle-bound PAH concentrations, the PAH fractions in PM2.5 and OC were inversely 
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related to the temperature (Figures 3.7 B and C), which is likely due to the semi-volatile 
nature of PAHs. At the higher temperatures of summer, a larger fraction of PAHs will be 
in the gas phase instead of the particulate phase. Moreover, sulfate, a secondary air 
pollutant and a major component of PM2.5 in this region (Butler et al., 2003), is formed 
more at higher temperatures, contributing to higher PM2.5 concentrations in summer. 
Thus, the opposite seasonal variation of total PM2.5 mass further drives the seasonal trend 
of lower PAH-to-PM2.5 in the summer.  
While PAHs in ambient air are mostly from primary sources (i.e., from direct 
emissions), sources of OC in the atmosphere are both primary and secondary. Although 
overall OC concentrations peaked in winter, the secondary components of OC tend to be 
higher in summer when elevated ozone oxidizes gaseous organics to form compounds in 
the particle phase (Marmur et al., 2007). On the other hand, ozone has been found to be 
negatively correlated with PAH concentrations in the atmosphere, suggesting that 
oxidation by ozone is a potential sink for atmospheric PAHs (Tham et al., 2008). 
Therefore, the PAH-to-OC ratio is inversely related to temperature.   
3.3.2.3 Ambient Levels of Particulate PAHs – Site Variation 
Not surprisingly, the suburban site (SD), located about 1 km from a major 
highway, recorded significantly higher PAH levels than did FM, the more central urban 
site (paired t-test, p = 0.005, Figure 3.6). PAH emissions from roadways are known to be 
a significant contributors to airborne PAHs in the central parts of large cities (Bostrom et 
al., 2002; Narvaez et al., 2008). On the other hand, the rural site (YG) had the lowest 
PAH levels of the three sampling locations (paired t-test, p < 0.01, Figure 3.6). The 
average total PAH concentration over the whole year at YG was 1.78 ng/m3, compared to 
2.92 ng/m3 and 1.92 ng/m3 at SD and FM, respectively. This is consistent with the 
locations of the samples sites – the rural site was in a heavily vegetated forest park with 
minimum anthropogenic PAH emissions, whereas the urban and suburban-highway sites 
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were located in densely populated and heavily trafficked areas with a high anthropogenic 
PAH input.     
3.3.2.4 Methyl Phenanthrenes – Indicator for Fuel Sources 
PAHs in aerosols can come from two types of sources, petrogenic (i.e. unburned 
petroleum products) or pyrogenic (i.e. combustion of fossil fuels and biomass) (Simo et 
al., 1997). Pyrogenic PAHs are generally abundant with non-substituted or parent PAHs, 
whereas petrogenic PAHs include more alkylated PAHs than their parent homologues 
(Simo et al., 1997; Yunker et al., 2002). Therefore, the relative concentration of the sum 
of methylated phenanthrenes (MePhe) to their un-substituted parent compound 
(phenanthrene or Phe), i.e. MePhe/Phe or MePhe/(MePhe+Phe), has been used as an 
indicator for petrogenic inputs (Yunker et al., 2002; Zakaria et al., 2002).  
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Figure 3.9. Average (with standard deviation) ratio of summed methyl phenanthrenes 
(MePhe) to the total of phenanthrene and methyl phenanthrenes, stratified by month. Data 
from the urban and suburban-highway sites were used 
 
Among the four methyl-substituted phenanthrenes measured in this study, 2-
MePhe was present at the highest levels (Table 3.5), consistent with what was found in 
used crankcase oil samples (Zakaria et al., 2002) and in the urban air particulate Standard 
Reference Material (SRM) 1649 from the National Institute of Standards and Technology 
(NIST), USA (NIST, 2007). Interestingly, 2-MePhe was also reported to have the highest 
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aryl hydrocarbon receptor (AhR) inducing potency in rat liver cell lines among the four 
Me-Phe compounds (Vondracek et al., 2007). The MePhe/(MePhe+Phe) ratio from the 
urban and suburban-highway sites averaged 0.69 and ranged from 0.62 in February to 
0.78 in June (Figure 3.9), indicating that petrogenic input is an important source for 
PM2.5-bound PAHs in this area. Our MePhe/(MePhe+Phe) ratios are in good agreement 
with findings from aerosol samples taken in high traffic urban area and a power plant in 
Spain (Simo et al., 1997), but are higher than three previous studies of urban air samples, 
including a study in Los Angeles and NIST SRM 1648 and 1649a (Fraser et al., 1998; 
NIST, 2007; Wise et al., 1988). The relative abundance of MePhe isomers to their parent 
compound were slightly higher during the warmer months than the cooler months (Figure 
3.9), which is consistent with a greater contribution from unburned fossil fuel (e.g. fuel 
evaporation from the roadway) with higher ambient temperature. However, the difference 
of the ratios between seasons was not statistically significant, suggesting that such ratios 
should be used with caution and can only serve as a crude source indicator. 
3.3.2.5 Retene – a Marker for General Biomass Burning 
In the current study, retene had a distinct monthly variation (Figure 3.10A), 
different from the rest of the PAHs and other pollutants such as K+ (Figure 3.10B). The 
highest retene concentrations at all three sites occurred in March, ranging from 0.81 to 
1.10 ng/m3 between the three sampling sites (Figure 3.10A). The levels in March are 3.0 
to 4.2 times higher than levels in December, the month with the second highest retene 
concentration. Interestingly, both the subscribed burning and reported unplanned fires 
(wildfires) in the state of Georgia (Personal communication from the Georgia Forestry 
Commission) also peaked dramatically in March in 2004, in terms of total acreage burnt 
(Figure 3.10C) and total number of fires recorded (data not shown). Prescribed burning, a 
practice commonly used in forest resource management in the southeastern United State, 
is used primarily to burn forest fuels (a.k.a. “roughs”) accumulated under southern pine  
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Figure 3.10. Average retene (A) and potassium ion (B) concentrations from three sites, as 
well as reported non-prescribed and prescribed burning (C) in Georgia during 2004 
 
 
stands, e.g. brushes, branches, small plants and debris. Unlike intense forest fires in 
which large amounts of tree wood are burned, unplanned fires in this region are 
comprised of mostly burning of leaves and branches. December had the second highest 
retene concentration in the year 2004, possibly due to increased wood burning during this 
cold time of the year. In contrast, K+, a tracer for biomass burning, was not elevated in 
March, but was higher in December and the other winter months and was lower during 
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warmer months. K+ is considered to be present at relative high concentration in wood 
burning plumes, and its concentrations are readily available; therefore, it has been used as 
a biomass burning tracer in source apportionment studies (Sheffield et al., 1994). 
However, recent studies have shown that K+ has other significant sources in urban areas, 
including refuse incinerators, meat cooking, and coal usages, which could lead to the 
application of K+ as the biomass burning marker problematic (Wang et al., 2007). 
Overall, retene concentrations were correlated with K+ (all sites included, correlation 
coefficient r = 0.46, p < 0.001) and this correlation improved when the high fire days in 
March were excluded (r = 0.62, p < 0.001). These results suggest that retene might be a 
better marker for all biomass burning because it captured both the high leaves-grasses-
bushes-branches burning season in March and the high wood burning in winter; K+, on 
the other hand, might be a more specific tracer for wood burning with its peak in 
December. Further, levoglucosan (1,6-anhydro-β-D-glucopyranose) has been used as a 
marker for biomass burning, because it is a pyrolysis product of cellulose and is one of 
the major organic components in ambient PM emitted from biomass combustion. 
However, measurement of levoglucosan can be more difficult than K+ and retene. 
Therefore, retene, in comparison to K+ and levoglucosan, might be a better and readily 
measurable tracer for biomass burning.  
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CHAPTER 4 
MEASUREMENT OF URINARY MONO-HYDROXY POLYCYCLIC 
AROMATIC HYDROCARBONS USING AUTOMATED LIQUID-
LIQUID EXTRACTION AND ISOTOPE DILUTION GAS 
CHROMATOGRAPHY/HIGH RESOLUTION MASS 
SPECTROMETRY 
 (Li Z, Romanoff LC, Trinidad DA, Hussain N, Jones RS, Porter EN, Patterson Jr. 
DG, and Sjodin A. Analytical Chemistry, 78:5744-51, 2006)  
  
Abstract 
A method for the measurement of 24 hydroxylated polycyclic aromatic 
hydrocarbon metabolites (OH-PAHs) in urine has been developed. The method is based 
on enzymatic deconjugation, automated liquid-liquid extraction, and isotope dilution gas 
chromatography/high resolution mass spectrometry (GC/HRMS) after derivatization of 
the OH-PAHs to the trimethylsilylated derivatives. The metabolites included in the 
current method are formed from eight different parent compounds. The limits of 
detection were below 7 pg/mL when using a sample size of 2 mL urine, except for 1- and 
2-naphthols (12 and 18 pg/mL respectively). The enzymatic deconjugation efficiency, 
verified by deconjugation of urine samples spiked with α-naphthyl-β-D-glucuronide 
sodium salt (1-NAP-GLU) and pyrene-1-sulfate potassium salt (1-PYR-SULF), was 
determined to be 97% for 1-NAP-GLU conjugate, and 84% for 1-PYR-SULF. The 
overall coefficients of variance (CV) for six batches of quality control samples (n=42), 
was 2.9–11%. Mean method recoveries of the 13C-labeled internal standards were 66–
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72%, except for 13C6-1-naphthol (46%). The throughput of this method has been 
determined to be 40 samples per day per analyst. This method is currently applied to 
epidemiological studies, such as the National Exposure and Nutrition Examination 
Survey (NHANES), to measure human exposure to PAHs 
4.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are a group of environmental 
pollutants formed during incomplete combustion of organic materials such as wood, 
fossil fuels, meat, and tobacco. They are found in automobile exhaust, wood smoke, 
cigarette smoke, and also found at high concentrations in certain food such as barbequed 
food (ATSDR, 1995; Bostrom et al., 2002; Guillen et al., 1997; IARC, 1983); thus this 
class of compounds is ubiquitously distributed in ambient air, food, soil, as well as in 
many occupational environments. 
PAHs have generated considerable interest, not only because of their wide 
distribution in the environment, but also their carcinogenic and mutagenic potential 
(ATSDR, 1995; IARC, 1983). PAHs, such as benzo[a]pyrene (BAP), which is present in 
cigarette smoke and certain occupational environments, have been positively associated 
with lung cancer (Armstrong et al., 2004; Denissenko et al., 1996). In addition, PAHs 
have also been reported to have reproductive, developmental, hemato-, cardio-, neuro-, 
and immuno-toxicities in humans and laboratory animals (ATSDR, 1995; IARC, 1983). 
Because of their toxicity and carcinogenicity potential, 16 PAHs have been included in 
the U.S. Environmental Protection Agency’s list of 188 hazardous air pollutants (EPA, 
1990). Humans are exposed to PAHs through inhalation of ambient air or cigarette smoke 
and ingestion of food containing PAHs, as well as dermal absorption from soil or 
material that contains PAHs. For the general population, ingestion and inhalation are the 
two major routes of exposure, with the former as the main route of PAH exposure 
(ATSDR, 1995; Bostrom et al., 2002; Ramesh et al., 2004). For certain occupations, such 
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as coal tar roofers and coke oven workers, dermal absorption can become the primary 
route of PAH exposure (ATSDR, 1995).  
 
 
 
 
 
Figure 4.1. Schematic illustration of the metabolic formation of hydroxy-naphthalene 
glucuronic acid and sulfate conjugates demonstrating that multiple metabolic products 
can be formed from a single parent compound 
 
 
After entering the human body, PAHs undergo rapid initial distribution to fatty 
tissues. The liver is often regarded as a primary site for biotransformation of PAHs 
regardless of the route of entry, because this organ contains many of the enzymes needed 
in the biotransformation of the parent compounds (Bostrom et al., 2002; Miller and 
Ramos, 2001; Ramesh et al., 2004). However, at lower levels of inhalation exposure, 
metabolism in the lungs can dominate (Bostrom et al., 2002). The biotransformation 
process, as illustrated in Figure 4.1, starts with Phase I metabolism in which PAHs are 
oxidized by the cytochrome P450 enzymes to form reactive epoxide intermediates, 
followed by reduction or hydrolysis to hydroxylated derivatives (OH-PAHs). In Phase II 
metabolism, the OH-PAHs are conjugated to glucuronic acid and/or sulfate to increase 
the water solubility of the metabolite and to facilitate elimination through urine, bile, or 
feces (Grover, 1986; Pelkonen and Nebert, 1982). These biological processes lead to the 
formation of multiple metabolites including epoxide, dihydrodiols, mono- and 
polyhydroxy PAHs. Generally, metabolites of smaller PAHs with two to three rings are 
excreted preferentially in the urine, whereas larger PAHs with higher molecular weight 
are excreted primarily in the feces (Ramesh et al., 2004). The P450 enzyme used in the 
Phase I and UDP-glucuronyl transferases in the Phase II metabolism are both 
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2-NAP
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OH
OH
Naphthalene
Epoxide
Hydroxylase
O S
O
O
OH
O
HO
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microsomal, while the sulfotransferase enzyme responsible for catalyzing the sulfate 
conjugation is cytosolic (Grover, 1986; Hakk et al., 2001). Due to the short half-lives 
(12~15 hours) of the urinary OH-PAH elimination (Buckley and Lioy, 1992; Viau and 
Vyskocil, 1995), quantitative determination of OH-PAH metabolites provides 
information on a subject’s recent exposures to environmental PAHs.  
 Urinary OH-PAHs have been used as biomarkers to assess total human exposure 
to environmental PAHs, with 1-hydroxypyrene (1-PYR) as the most commonly used 
indicator in biomonitoring studies (Jacob and Seidel, 2002). Jongeneelen et al. (1985) 
reported one of the first analytical methods to measure 1-PYR and other OH-PAHs in 
urine, using enzymatic deconjugation, solid phase extraction (SPE), HPLC separation, 
and fluorescence detection (Jongeneelen et al., 1985; Jongeneelen et al., 1987). Gundel et 
al. (2000) expanded the HPLC method to include more analytes such as phenanthrene 
metabolites, and applied the method to various occupational exposure studies. Grimmer 
et al. (1997) developed a method utilizing gas chromatography/mass spectrometry 
(GC/MS) to measure methylated derivatives of the hydroxylated metabolites of 
phenanthrene, pyrene, fluoranthene, chrysene, and benzo[a]pyrene in urine. One of the 
most extensive OH-PAH methods which measured up to 23 OH-PAHs was developed at 
the Centers for Disease Control and Prevention (CDC), using enzymatic hydrolysis, solid 
phase extraction, derivatization of OH-PAHs to trimethylsilylated derivatives, and 
isotope-dilution gas chromatography/high-resolution mass spectrometry (GC/HRMS) 
(Romanoff et al., 2006; Smith et al., 2002). The method was used to analyze samples 
from the National Health and Nutrition Examination Survey (NHANES 1999–2002) 
(Grainger et al., 2006; Grainger et al., 2004; Huang et al., 2004), an on-going 
comprehensive survey CDC performs to assess exposure of the U.S. general population 
to environmental and industrial chemicals. 
With increased interest in the biomonitoring approach for exposure assessment 
and with requirements for large epidemiological studies such as NHANES, it is necessary 
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to have a versatile, robust, and high-throughput method that measures multiple 
metabolites in a minimum amount of sample. In this paper, we present a new method for 
measuring 24 OH-PAHs (Figure 2.2) in urine using enzymatic deconjugation, liquid-
liquid extraction, and GC/HRMS. We studied extensively the enzymatic hydrolysis to 
provide maximum deconjugation efficiency for all analytes, and we further automated the 
liquid-liquid extraction step not only to increase the throughput, but also to reduce 
variability caused by manual sample handling. 
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Figure 4.2. Molecular structures of the 24 OH-PAH analytes 
 
4.2 Experimental 
4.2.1 Safety Considerations 
All laboratory work involving human specimens must follow universal 
precautions to minimize the risk of exposure. This includes the use of personal protective 
equipment such as gloves, lab coat, and protective eyewear. Any potential spills of 
human urine are decontaminated with a 10% bleach solution with a minimum contact 
time of 15 minutes. Any glassware or other items that come in contact with the samples 
are autoclaved or decontaminated with bleach prior to reuse or disposal. The 
experimenter must further be aware of the presence of 2,3,7,8-tetrachlorodibenzo-p-
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dioxin (TCDD) in the instrument sensitivity verification solution and the potential health 
effects from exposure to TCDD (Myers and Patterson, Jr., 1987). 
4.2.2 Chemicals 
All reagents and solvents used in the current method were of the highest available 
grade or intended for pesticide residue analysis and were used only after verification by 
GC/HRMS. Pentane, n-hexane, acetonitrile, and toluene were of pesticide grade 
(>99.8%) and obtained from Tedia Company Inc. (Fairfield, OH). The glacial acetic acid 
(>99.8%) was purchased from J.T. Baker (Phillipsburg, NJ). Sodium acetate (>99.0%), 
dodecane (99%), α-naphthyl-β-D-glucuronide sodium salt, and N-methyl-N-
(trimethylsilyl)-trifluoroacetamide (MSTFA) were purchased from Sigma-Aldrich (St. 
Louis, MO). Pyrene-1-sulfate potassium salt was purchased from Midwest Research 
Institute (Kansas City, MO). De-ionized water (D.I. water) was purified by the 2000TM 
Solution Consultants Inc. Solution Water Purification System (Jasper, GA). Ultra-high 
purity nitrogen, helium and argon were obtained from Airgas South Co. (Chamblee, GA). 
13C12-labeled 3-hydroxy-3,3’,4,5’-tetrachlorobiphenyl was purchased from Cambridge 
Isotope Laboratory (Andover, MA) and methylated in house to its methoxy derivative 
(13C12-3-MeO-CB79). β -Glucuronidase type H-1 enzyme with sulfatase activity, isolated 
from Helix pomatia (Helix pomatia enzyme), was obtained from Sigma-Aldrich (St. 
Louis, MO). β -Glucuronidase enzyme, isolated from Escherichia coli (E. Coli) K12 (E. 
coli enzyme), was purchased from Roche Diagnostic (Indianapolis, IN). All native and 
13C-labeled mono-hydroxylated PAH analytes, their abbreviations, together with their 
suppliers are listed in Table 4.1. 
4.2.3 Standard Preparation 
We prepared stock solutions (1 mg/mL) from neat materials by weighing 
approximately 5 mg of each compound into a silanized amber vial and dissolving it in 
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acetonitrile. The internal standard spiking solution contained thirteen 13C-labeled OH-
PAHs (100 pg/µL in toluene). The recovery standard solution contained 13C12-3-MeO-
CB79 at a concentration of 300 pg/µL in toluene. Eight calibration standards were 
prepared in toluene spanning the range of 0.5–1000 pg/µL for each of the 24 analytes, 
except for 1- and 2-OH-naphthalene (1-NAP and 2-NAP), which were present at four 
times higher concentration. The thirteen 13C-labeled OH-PAHs were present in each 
calibration standard at a constant level (100 pg/µL).  
4.2.4 Sample Preparation Procedure 
Urine samples (2 mL) were aliquoted into glass test tubes (16 x 100 mm) and 
fortified with internal standards (1000 pg/compound). Sodium acetate buffer (pH 5.5; 1 
M; 1 mL) containing β-glucuronidase enzyme from Helix pomatia (10 mg enzyme/1 mL 
buffer) was added to the samples. Incubation was done at 37 °C overnight (~18 hours). 
D.I. water (2 mL) was then added and the samples were extracted twice with 
pentane using the automated Gilson 215 liquid handler (Gilson Inc., Middleton, WI). The 
liquid handler was equipped with an 818 automix (Gilson), and fitted with a 402 syringe 
pump (Gilson), which was connected to a septum-piercing probe via a coiled transfer 
tubing. A reservoir containing n-hexane was connected to the syringe pump and used to 
purge the transfer tubing and rinse the probe after drawing and dispensing reagent. The 
samples to be extracted were placed in the automix tray and the extraction procedure was 
initiated. First, pentane (5 mL) was added to all samples and the samples were mixed by 
rotating in the automix for 5 minutes (20 rpm). The procedure was paused and the 
samples were centrifuged at 2800 rpm on an AllegraTM 6 centrifuge (Beckman Coulter 
Inc., Fullerton, CA) for 20 minutes. After returning the samples to the automix tray, the 
procedure was resumed and the organic phase was transferred by the probe to clean 
collection tubes. This extraction procedure was repeated again with additional pentane (5 
mL).  
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Table 4.1. Measured OH-PAH metabolites, abbreviations, 13C-labeled internal standards 
and mass spectral descriptors 
Analyte Name Abbr. Internal Standard (I.S.)
Masses 
Analyte 
Masses 
I.S. 
Mass 
Window
1-OH-naphthalenea 1-NAP 13C6-1-NAPf 216.0970 222.1172 1 
2-OH-naphthalenea 2-NAP 13C6-1-NAPf 216.0970 222.1172 1 
9-OH-fluorenea 9-FLUO 13C6-9-FLUOg 254.1127 260.1329 2 
2-OH-fluorenea 2-FLUO 13C6-2-FLUOg 254.1127 260.1329 2 
3-OH-fluorenea 3-FLUO 13C6-3-FLUOg 254.1127 260.1329 2 
1-OH-phenanthreneb 1-PHEN 13C6-3-PHENh 266.1127 272.1329 3 
2-OH-phenanthrenec 2-PHEN 13C6-2-PHENg 266.1127 272.1329 3 
3-OH-phenanthrenec 3-PHEN 13C6-3-PHENh 266.1127 272.1329 3 
4-OH-phenanthreneb 4-PHEN 13C6-3-PHENh 266.1127 272.1329 3 
9-OH-phenanthreneb 9-PHEN 13C6-3-PHENh 266.1127 272.1329 3 
1-OH-pyrened 1-PYR 13C6-1-PYRi 290.1127 296.1329 4 
1-OH-benzo[c]phenanthrened 1-BCP 13C6-3-BCPi 316.1283 322.1485 4 
2-OH-benzo[c]phenanthrened 2-BCP 13C6-3-BCPi 316.1283 322.1485 4 
3-OH-benzo[c]phenanthrened 3-BCP 13C6-3-BCPi 316.1283 322.1485 4 
1-OH-benz[a]anthracened 1-BAA 13C6-1- BAAh 316.1283 322.1485 4 
3-OH-benz[a]anthracened 3-BAA 13C6-1-BAAh 
9-OH-benz[a]anthracened 9-BAA 13C6-1-BAAh 
316.1283 322.1485 4 
1-OH-chrysened 1-CHRY 13C6-3-CHRYi 316.1283 322.1485 4 
2-OH-chrysened 2-CHRY 13C6-3-CHRYi 316.1283 322.1485 4 
3-OH-chrysened 3-CHRY 13C6-3-CHRYi 316.1283 322.1485 4 
4-OH-chrysened 4-CHRY 13C6-3-CHRYi 316.1283 322.1485 4 
6-OH-chrysenee 6-CHRY 13C6-6-CHRYh 316.1283 322.1485 4 
3-OH-benzo[a]pyrened 3-BAP 13C6-3-BAPh 340.1283 343.1380 5 
7-OH-benzo[a]pyrened 7-BAP 13C6-3-BAPh 340.1283 343.1380 5 
 
a. Sigma-Aldrich, St. Louis, MO; b. Promochem, Teddington, United Kingdom; c. Dr. Ehrenstorfer, 
Augsburg, Germany; d. Midwest Reseach Institute, Kansas City, MO; e. AccuStandard Inc., New Haven, 
CT; f. Synthesized in-house; g. Los Alamos National Laboratory, Los Alamos, NM; h. Cambridge Isotpe 
Laboratories, Andover, MA; i. Chemsyn Laboratories, Lenexa, KS 
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The combined pentane extract was spiked with dodecane (5 µL) as a keeper and 
concentrated to ~ 5 µL in a TurboVap LV® evaporator (Caliper Life Sciences, 
Hopkinton, MA), under a gentle stream of nitrogen (5-10 psi) at 40 °C. The extract was 
then reconstituted into toluene (20 µL), spiked with recovery standard (13C12-3-MeO-
CB79, 300 pg/µL, in toluene, 5 µL), and transferred to GC vials. Finally, prior to 
GC/HRMS analysis, the samples were derivatized to their trimethylsilylated derivatives 
by adding MSTFA (10 µL) and incubating at 60 °C for 30 minutes. 
4.2.5 GC/HRMS Method 
GC/HRMS analyses were performed on a MAT 95 XL HRMS instrument 
(Thermo Finnigan, Bremen, Germany), coupled with a 6890 GC (Agilent Technologies, 
Palo Alto, CA). The chromatographic separations were carried out on a DB-5MS column 
(30m, 0.25 mm i.d., 0.25 µm film thickness; Agilent Technology, Palo Alto, CA) using 
helium (1mL/min) as the carrier gas. The injector was operated in the splitless mode at a 
temperature of 270°C. The column oven was programmed from 95°C (2min) to 160°C 
(15°C/min; 0min), then to 230°C (10°C/min; 5 min), and finally to 320°C (23°C/min; 
3min). The source temperature was 250°C in the electron impact mode (50 eV). The 
descriptor used for the GC/HRMS analyses are given in Table 4.1. The sensitivity of the 
instrument, operated at a resolution of 10,000; was verified daily by the analysis of 
2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD, 20 fg/µL, 1 µL injection) in the 
selective ion monitoring mode (SIM) [m/z 319.8965, 321.8937, 331.9368 and 333.9338]. 
For the daily instrument sensitivity test, the signal-to-noise ratio (S/N) needed to be at a 
minimum of 3 for 2,3,7,8-TCDD (m/z 321.8937). 
4.2.6 Deconjugation Conditions 
We determined conditions for enzymatic deconjugation in a step-wise manner. 
First, an experiment was set up to determine the amount of enzyme needed to achieve 
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maximum yields of deconjugated products, for β-glucuronidase enzymes from E. coli and 
Helix pomatia respectively. We performed this by varying the amount of enzyme for the 
incubation (24 hours, 37 °C), and comparing the yield of deconjugated products. In a 
follow-up experiment, the time required to reach the maximum yield of deconjugated 
products was determined by varying the incubation time using a fixed amount of enzyme.  
The effect of pH on deconjugation kinetics was evaluated using the Helix pomatia 
enzyme. For this experiment, buffers were prepared in the pH range of 3.5 to 7, with 
increments of 0.25 units between pH 4 and 7. Three replicate urine samples were 
prepared for each pH-value, and the deconjugation reaction was interrupted after 3 hours 
(i.e., before complete deconjugation for most of the analytes). Yields of deconjugated 
products were plotted against pH to obtain a relative measure of the reaction kinetics at 
different pH-values.  
With the chosen conditions, deconjugation efficiencies for α-naphthyl-β-D-
glucuronide sodium salt (1-NAP-GLU) and pyrene-1-sulfate potassium salt (1-PYR-
SULF) were determined by analyzing urine samples spiked with a known amount of 
these two conjugates and un-spiked samples. The deconjugation efficiencies were 
calculated as the concentration differences between spiked and unspiked samples 
compared with the spiked amount. 
The relative composition of glucuronic acid and sulfate conjugates in urine was 
determined by deconjugation with Helix pomatia enzyme that contains both 
glucuronidase and sulfatase activity and E. coli enzyme containing only glucuronidase 
activity (Elsohly et al., 2005). The results from the deconjugation with Helix pomatia 
enzyme represent the sum of glucuronic acid and sulfate conjugates, while deconjugation 
with E. coli selectively deconjugates glucuronides. The sulfate conjugate concentration 
was calculated as the difference between these two measurements. 
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Figure 4.3. Gas chromatograms of a calibration standard (A) and a pooled urine sample 
(B, C). 
 
4.2.7 Limit of Detection 
The limit of detection (LOD) for this method was defined as the higher LOD 
calculated by two methods: (i) in direct relation to method blanks prepared in parallel 
with the unknown samples, as 3 times the standard deviation of the method blanks, and 
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(ii) according to the instrumental detection limit defined as the lowest point in the 
calibration curve (5 pg/µL) verified to give a signal with the S/N equal to or greater than 
3. All valid measurements above the LOD are subtracted by the average blank to correct 
for any analytical background. 
4.2.8 Quality Assurance and Quality Control 
Anonymous urine samples were collected from multiple donors, pooled, pressure-
filtered through a 0.45−µm SuporCap – 100 Capsule (Pall Corp. Ann Arbor, MI), diluted 
with D.I. water (1 part D.I. water to 4 parts of filtered urine), and used to prepare quality 
control (QC) materials. The pool was spiked with a standard mixture of the 24 native 
OH-PAHs in acetonitrile (500 pg/mL urine), and homogenized at room temperature 
overnight. The next day the spiked urine pool was aliquoted into 16 x 100 mm glass 
culture tubes (2 mL in each tube), and stored at -70°C until use.  
In this method, a set of samples was defined as 16 urine samples, prepared and 
analyzed together with two water blanks and two QC samples. In addition, an external 
recovery standard (ERS) and a calibration standard were derivatized and analyzed on the 
GC/HRMS in parallel with the sample extracts. The ERS contained the 13C-labeled OH-
PAH internal standards and the recovery standard (13C12-3-MeO-CB79) and was used as 
a reference for the recovery calculation. Analysis of a set of samples was considered 
valid only after fulfilling the following criteria: (i) relative retention time (RRT), defined 
as the retention time ratio of a native compound over its 13C-labeled internal standard, 
must be within ± 2% of the reference ratio set by the calibration standard run with the 
samples, and (ii) recovery of the 13C-labeled internal standard must be within the range of 
25–150%. Further, the following criteria must be fulfilled for this set of samples to pass 
the QA/QC requirements: (i) the measurement of the target analytes in the QC sample 
must be within 3 standard deviations (SD) of the established mean, and (ii) 10 or more 
consecutive measurements may not fall above or below the established mean. A SAS 
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computer program, developed in house, was further used to identify QC samples failing 
any of the criteria as defined elsewhere (Westgard et al., 1981). 
 
Table 4.2. Quality control parameters for measuring urinary OH-PAH metabolites 
 
Analyte Name Recovery (%) 
Conc. 
(pg/mL)
Coefficient of 
variation (%) 
Limit of detection 
(pg/mL) 
1-OH-naphthalene 46 1584 2.9 18a 
2-OH-naphthalene 46 2912 3.3 12a 
9-OH-fluorene 66 596 2.9 3.9a 
2-OH-fluorene 69 559 3.0 4.5a 
3-OH-fluorene 70 485 2.8 6.9a 
1-OH-phenanthrene 70 391 4.4 2.6b 
2-OH-phenanthrene 69 606 3.5 3.8a 
3-OH-phenanthrene 70 533 3.2 2.6b 
4-OH-phenanthrene 70 531 3.9 3.7a 
9-OH-phenanthrene 70 191 7.1 2.6b 
1-OH-pyrene 71 542 3.4 4.9a 
1-OH-benzo[c]phenanthrene 69 925 8.0 2.8b 
2-OH-benzo[c]phenanthrene 69 559 3.3 3.ab 
3-OH-benzo[c]phenanthrene 69 522 3.0 2.6b 
1-OH-benz[a]anthracene 70 528 2.7 2.6b 
3-OH-benz[a]anthracene 
9-OH-benz[a]anthracene 
70 843 10 5.2b 
1-OH-chrysene 69 496 11 2.6b 
2-OH-chrysene 69 565 4.4 2.6b 
3-OH-chrysene 69 510 3.3 2.6b 
4-OH-chrysene 69 468 6.7 2.6b 
6-OH-chrysene 72 509 4.5 2.6b 
3-OH-benzo[a]pyrene 67 686 6.6 2.6b 
7-OH-benzo[a]pyrene 67 722 8.5 2.6b 
a. LOD determined by method blank LOD: 3 x standard deviation of blank levels  
b. LOD determined by the lowest concentration from the calibration curve 
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Figure 4.4. QC plots for (A) 1-naphthol (1-NAP), (B) 3-OH-fluorene (3-FLUO), and (C) 
1-OH-pyrene (1-PYR) from six batches of QC samples (42 QCs in total) 
 
4.3 Results 
The sample preparation method was highly automated and required minimum 
manual labor. Manual tasks were limited to aliquoting the urine samples, centrifugation, 
evaporation, and reconstitution. The sample throughput was 40 samples per day per 
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analyst (including method blanks and QC samples). The current method produced cleaner 
extracts than previous methodology (Romanoff et al., 2006; Smith et al., 2002), with 
fewer interfering compounds that caused ion suppression of the lock mass channels 
during HRMS analysis. Example chromatograms of a standard and a urine sample are 
given in Figure 4.3. The method LOD was below 10 pg/mL urine for all analytes, except 
1-NAP (LOD 18 pg/mL) and 2-NAP (LOD 13 pg/mL). The recoveries were 
approximately 70% for most compounds, with the exception of 13C6-1-NAP (46%). The 
overall CV for six batches of QC samples (n=42) prepared over 3 weeks by four different 
analysts using two automated liquid handlers and two GC/HRMS instruments were at 
10% or below (cf. Table 4.2). QA/QC charts for selected analytes (1-NAP, 3-FLUO, and 
1-PYR) are given in Figure 4.4.  
When using the enzyme derived from E. coli for selective deconjugation of 
glucuronides, the product yields reached maximum within 3 hours (data not shown). On 
the other hand, when using the Helix pomatia enzyme for deconjugation of both sulfates 
and glucuronides, the kinetics were found to be compound-specific and followed one of 
the three trends, as shown in Figure 4.5. One group of analytes, exemplified by 1-NAP in 
Figure 4.5A, followed apparent first-order reaction kinetics. The time required to reach 
the equilibrium phase decreased with the addition of enzyme. The second group as 
exemplified by 1-PYR in Figure 4.5B, reached equilibrium almost instantaneously, 
independent of enzyme amount. The third group, containing only one analyte 9-PHEN, 
reached the maximum yield within 1 hour, then the yield decreased over time (Figure 
4.5C). The deconjugation efficiency was determined to be 97% for 1-NAP-GLU 
conjugate, and 84% for 1-PYR-SULF.  
In Figure 4.6, the yields of deconjugated products for selected OH-PAHs are 
plotted as a function of pH, with a deconjugation time of 3 hours. In this Figure, 1-PYR 
reached the maximum yield within the pH range of 4.5 to 7. The yield of 3-FLUO peaked 
at pH 5.5, while a decrease in yield of 1-NAP was observed at a pH-value higher than 5.5 
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or lower than 4.5. A pH-value of 5.5 was chosen as the most suitable pH for 
deconjugation, considering all analytes. 
 
 
Figure 4.5. Yields of deconjugated (A) 1-naphthol (1-NAP), (B) 1-OH-pyrene (1-PYR), 
and (C) 9-OH-phenanthrene (9-PHEN) normalized to the maximum yield as a function of 
deconjugation time, for three different amounts of enzyme 
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The relative compositions of glucuronide and sulfate conjugates were found to be 
compound-specific, as shown in Figure 4.7. Overall, sulfate conjugates were present at 
lower levels than their glucuronide counterparts. For example, 1-PHEN was present 
almost exclusively as glucuronide, while up to 40% of 3-FLUO was in the form of sulfate 
conjugate. The percentage of sulfate conjugate in a urine pool is given in Figure 4.7B. 
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Figure 4.6. Normalized yields of 1-naphthol (1-NAP), 3-OH-fluorene (3-FLUO), and 1-
OH-pyrene (1-PYR) from pooled urine samples (2-mL), deconjugated with H. Pomatia 
β-glucuronidase Type H-1 enzyme for 3 hours at 37 °C, as a function of pH 
 
4.4 Discussion 
Factors to consider when developing an analytical method for large scale 
biomonitoring or epidemiological studies include but are not limited to (i) identification 
of the chemical or composition of the chemical class investigated, (ii) an understanding 
of the metabolism and identification of suitable marker metabolites in those cases where 
the parent compound is unfeasible to monitor, (iii) choice of suitable matrix to analyze 
(urine, serum, adipose tissue, feces), (iv) sensitivity required for accurate identification 
and quantification at trace level, (v) need for automation for large scale epidemiological 
studies such as the NHANES survey, and (vi) limitations of various analytical 
approaches. In the case of PAH biomonitoring, hydroxylated metabolites (Jacob and 
Seidel, 2002), as well as hemoglobin adducts (Nielsen et al., 1996), have been used as 
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biomarkers in the past. Hemoglobin adducts have a half-life in the body equal to that of 
red blood cells—approximately 120 days (dell'Omo and Lauwerys, 1993). In comparison, 
the urinary PAH metabolites have a relatively short half-life in the range of hours 
(Buckley and Lioy, 1992; Viau and Vyskocil, 1995). Hence, urinary biomonitoring of 
PAHs represents a more recent exposure scenario. This limitation is important to take 
into consideration when planning epidemiological studies aimed at assessing exposure to 
PAHs through urinary biomonitoring or adverse health effects. Another important factor 
to consider is that larger PAHs, such as BAP and BAA, are excreted primarily in feces, 
while smaller PAHs (2–4 aromatic rings) are excreted in urine (Ramesh et al., 2004). 
Therefore, a low level exposure to BAP and BAA may not be detectable using urinary 
biomonitoring.  
The first method for OH-PAH analyses developed in our laboratory utilized solid 
phase extraction (SPE) and included 16 OH-PAH (Smith et al., 2002). This method was 
then automated on the Rapid Trace® SPE workstations (Caliper Life Sciences, 
Hopkinton, MA), and the analyte list was increased to 23 (Romanoff et al., 2006). This 
method was, however, susceptible to blocked SPE cartridges as caused by particulates in 
the urine. When the blockage occurred, the automated process had to be stopped and 
extraction performed manually. Another consideration was interference by biogenic 
material that would lead to suppression of the lock mass channel during HRMS analysis. 
In the current method, we increased the number of analytes to 24 OH-PAHs compared to 
the previous methods (Romanoff et al., 2006; Smith et al., 2002) by adding 7-OH-
benzo[a]pyrene, one of the urinary metabolites of benzo[a]pyrene (Fertuck et al., 2001; 
Miller and Ramos, 2001). We also developed a new extraction step based on liquid-liquid 
extraction and automated this method using the liquid handler. The enzymatic hydrolysis 
of urinary OH-PAHs conjugates was further improved in the current method, and the 
hydrolysis efficiency was verified with synthesized conjugates spiked into urine. 
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The throughput for our current method is 40 samples (including 4 method blanks 
and 4 QA/QC samples) per day per analyst. The sample preparation starts in the 
afternoon of the first day and includes dispensing the samples, adding enzyme-containing 
buffer, and internal standard fortification (time required ~45 minutes). After overnight 
hydrolysis, the samples are extracted through automated liquid-liquid extraction (4 hours 
or ~6 minutes per sample). The evaporation of the extract requires 10–15 minutes, 
followed by reconstitution in toluene, addition of the recovery standard, and MSTFA (30 
minutes). The derivatization reaction with MSTFA requires 30 minutes, followed by the 
GC/HRMS analysis (18 hours overnight for the 40 samples). The sample size for this 
method is 0.25–3 mL, with 2 mL as the standard sample size to produce an adequate 
detection limit of 2.6–18 pg/mL, depending on the target analytes (Table 4.2).  
This method has been applied to several biomonitoring studies, including the 
ongoing NHANES 2003-04 survey. Among over 3000 samples analyzed using the 
current method over a period of 10 months, only one set of samples had to be extracted 
manually due to an error in the automated liquid handling equipment. 
4.4.1 Extraction conditions 
This method employs liquid-liquid extraction to extract free OH-PAHs from the 
urine samples into an organic phase using a liquid handler for automation. Pentane was 
chosen as the extraction solvent because of low amount of co-extracted material and high 
recovery of OH-PAHs. In addition, given its high volatility (b.p. 36 °C), the pentane 
extract (~9 mL) can be evaporated within 10–15 minutes, thus minimizing analyte loss 
during evaporation.  
During the method development, interfering peaks appeared around some of the 
late-eluting analytes such as chrysene and benz[a]anthracene metabolites, which caused 
ion suppression in this region. The source of the contamination was traced to the silicon 
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septa used in the sample tube caps. The interfering peaks and the ion suppression could 
be minimized by heating the septa to 150 ºC overnight prior to use. 
4.4.2 Deconjugation Conditions and Conjugate Composition 
Deconjugation is a critical step in the accurate determination of urinary OH-PAH 
metabolites because they are predominantly present in the conjugated form (93–100%) 
(Romanoff et al., 2006), and only the free OH-PAHs can be extracted from the aqueous 
phase. To maximize the hydrolysis yield, several factors have been evaluated, including 
enzyme type, enzyme amount, hydrolysis time, pH and the buffer concentration.  
Enzymes from different species have different activities. For example, Helix 
Pomatia has β -glucuronidase activity as well as arylsulfatase activity (Elsohly et al., 
2005; Shibasaki et al., 2001), while E. coli only has β-glucuronidase activity (Elsohly et 
al., 2005; Murooka et al., 1978). For this method we chose the partially purified β-
glucuronidase type H-1 powder enzyme extracted from Helix pomatia because it has high 
hydrolysis activity for both conjugates, while having a lower PAH background level than 
the β-glucuronidase / arylsulfatase enzyme solution (from Helix pomatia) used in the 
previous methods (data not shown) (Romanoff et al., 2006; Smith et al., 2002). 
Moreover, every batch of enzyme has to be verified as free of interfering PAH 
metabolites as exemplified by our finding of a batch of enzyme containing a high level of 
1-NAP (data not shown). 
The rate of the hydrolysis reaction is affected by several factors, such as the 
amount of enzyme and pH (Dou et al., 2001; Elsohly et al., 2005). In general, the 
hydrolysis rate increased with increasing amount of enzyme added (Figure 4.5). 
Deconjugation using 10 mg of enzyme for each urine sample (2 mL) at 37 °C for 24 
hours yielded the maximum amount of product, with the exception of 9-PHEN, which 
reached a maximum after 30 minutes and then decreased. We observed that the time 
required for deconjugation is structurally dependent, even among isomers. For example, 
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2-NAP and 3-FLUO were completely hydrolyzed within 1 hour with a small amount of 
enzyme (5 mg per 2-mL sample), while their isomers, 1-NAP and 9-FLUO, required 10 
mg of enzyme and overnight hydrolysis. An overnight deconjugation (18–20 hours) was 
shown to be sufficient for deconjugating the samples (data not shown) and chosen as the 
standard deconjugation time. 
At this time, we do not know the mechanism for the degradation of 9-PHEN 
during the hydrolysis step. We did, however, observe that the magnitude of the 
degradation was sample-dependent. We estimated the amount of the 9-PHEN loss in 
urine samples from six different subjects by calculating the ratio of results from overnight 
deconjugation to 1 hour deconjugation. The losses ranged from 30% to 73%. Thus it is 
not feasible to apply a single conversion factor to correct for the degradation in unknown 
samples. We are in the process of acquiring a custom-synthesized 13C-labeled 9-PHEN 
standard. With this standard we can assume equal degradation of the labeled internal 
standard and the naturally occurring 9-PHEN to account for the loss of 9-PHEN during 
incubation step.  
Enzymes from different species have been shown to have different optimal pH 
ranges when hydrolyzing glucuronides (Dou et al., 2001). To visualize the influence of 
pH in our method, we deconjugated several samples at different pH in the range of 3.5-7. 
The reaction was terminated after only 3 hours—before completion of the deconjugation 
for slow reacting OH-PAHs. Therefore, the quantified amount in the sample at the 
different pH-values is proportional to the reaction speed. Although the reaction kinetics 
can not be determined from this experiment, we have obtained a proportional measure of 
the ideal pH for deconjugation (Figure 4.6). Generally, yields of all analytes were 
influenced by pH, and the effect was more pronounced for some analytes. Low pH (< pH 
4) was profoundly detrimental to the enzymatic hydrolysis reactions, causing yields of all 
analytes to drop below 20% of their maximum. All analytes reached maximum yield at 
pH 5.5. In light of these observations, it is important to keep the samples buffered to pH 
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5.5. Therefore, to provide sufficient buffering strength, we increased the molarity of the 
sodium acetate buffer solution (pH 5.5) from 0.1 M in previous methods (Romanoff et 
al., 2006; Smith et al., 2002) to 1 M in the current method. The more concentrated buffer 
will adjust the pH of the urine to pH 5.5 regardless of the initial pH of the urine. 
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Figure 4.7. Relative distribution of glucuronic acid and sulfate conjugates for OH-PAHs: 
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The majority of OH-PAH metabolites are excreted in urine as conjugates and only 
a small amount as free OH-PAHs (Romanoff et al., 2006). We found that OH-PAHs are 
excreted as a mixture of glucuronide and sulfate conjugates, although glucuronides 
predominate (Figure 4.7). A similar observation has been reported for polychlorinated 
dibenzo-p-dioxin metabolites (Hakk et al., 2001). The reason for the differences in 
conjugate composition is unknown to us, but it is most likely due to enzyme kinetics. 
Glucuronidation is mediated by UDP-glucuronosyl transferases, which is a microsomal 
enzyme as are the Phase I cytochromes, while arylsulfotransferases are cytosolic (Hakk et 
al., 2001). Therefore, OH-PAHs formed during Phase I metabolism in the microsome 
may be more likely to become substrate for UDP-glucuronosyl transferases, which would 
explain the higher percentage of glucuronide conjugates in the urine. 
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CHAPTER 5 
VARIABILITY OF URINARY POLYCYCLIC AROMATIC 
HYDROCARBON METABOLITE LEVELS IN ADULTS  
(Li Z, Romanoff LC, Lewin MD, Porter EN, Trinidad DA, Needham LL, 
Patterson Jr. DG, and Sjodin A. Journal of Exposure Science and Environmental 
Epidemiology, Submitted) 
 
Abstract 
Urinary hydroxy polycyclic aromatic hydrocarbons (OH-PAHs) are commonly 
used in biomonitoring to assess exposure to polycyclic aromatic hydrocarbons (PAHs). 
OH-PAHs have relatively short biological half-lives (4.4-15 hours), yet little information 
is available on their variability over time, which can limit study design and the 
interpretation of analytical results. The study was designed to (i) study the variability of 9 
urinary OH-PAH metabolite concentrations over time and (ii) calculate sample size 
requirements for future epidemiological studies. Individual urine samples were collected 
from 8 non-occupationally exposed adults for one week. Information on the time and 
volume of each urine excretion and dietary and driving history were recorded. Within 
subjects, the coefficients of variation (CV) for the wet weight concentration of OH-PAHs 
ranged from 64% to 297%; creatinine adjustment reduced the CV to 19-288%. The 24 
hour void concentrations were the least variable measure with CVs ranging 13-182% for 
the 9 OH-PAHs. Within-day variability contributed on average 84% and between-day 
accounted for 16% towards the total variance of 1-hydroxypyrene (1-PYR). Intraclass 
correlation coefficients (ICC) of 1-PYR levels were 0.55 for spot urine samples, 0.60 for 
first morning voids, and 0.76 for 24-hour voids, indicating high degree of correlation 
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between urine measurements collected from the same subject over time. Sample size 
calculations were performed to estimate number of subjects needed to detect differences 
in geometric mean at a statistical power of 80% for spot urine, first morning and 24 hour 
void sampling, respectively.  
5.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are a group of pollutants formed during 
incomplete combustion processes and are ubiquitously distributed in the air, soil, water, 
food, and in many occupational settings (IARC 1983). Human exposure to PAHs can 
occur through inhalation of polluted air or cigarette smoke, ingestion of food containing 
PAHs, as well as dermal absorption from soil or other PAH containing materials such as 
coal tar. For the general population, ingestion and inhalation are the two dominant routes 
of exposure with ingestion reportedly being more important in quantity (ATSDR 1995; 
Bostrom et al. 2002). For certain occupations such as coke oven workers, dermal 
absorption can become a major exposure route (ATSDR 1995). PAHs such as 
benzo(a)pyrene, benz(a)anthracene and chrysene have been classified as probable human 
and animal carcinogens (ATSDR 1995). PAHs have also been reported to possess 
reproductive, developmental, hemato-, cardio-, and immuno-toxicities (ATSDR 1995). 
Urinary PAH metabolites, specifically the mono-hydroxy PAH metabolites (OH-
PAHs), have been used as biomarkers for assessing human exposure to PAHs, with 1-
hydroxypyrene (1-PYR) as the most commonly used biomarker (Jacob and Seidel 2002). 
A number of studies have reported the levels of OH-PAHs in various occupational groups 
such as coke oven workers and road pavers (Grimmer et al. 1993; Jongeneelen et al. 
1990; Levin et al. 1995), as well as in general population from various parts of the world 
(Hansen et al. 2005; Mucha et al. 2006). In the United State, OH-PAHs are included in 
the National Health and Nutrition Examination Survey (NHANES) conducted by the 
Centers for Disease Control and Prevention (CDC), an on-going survey reports 
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biannually the level of biomarkers in a statistically representative sample of the U.S. 
population. OH-PAHs are measured in a one-third subset of samples, corresponding to 
approximately 3,000 samples every two years (Li et al. 2008).  
The half-life for urinary 1-PYR in humans has been reported to be 9.8 hours after 
inhalation exposure (Brzeznicki et al. 1997), 4.4 hours (Buckley and Lioy 1992) and 12 
hours (Viau et al. 1995) after ingestion exposure, and 11.5-15 hours after dermal 
absorption (Viau and Vyskocil 1995). Due to the short half-lives of PAHs, the 
information urinary biomonitoring provides is limited to recent exposure. Further, the 
short half-lives will need to be considered in study design and appropriate samples will 
need to be collected within the window PAHs are excreted in the urine following 
exposure. Theoretically, a 24-hour void specimen represents the average daily metabolite 
excretion more reliably than a spot urine sample. Thus, 24-hour urine collection was 
recommended by the U.S. EPA for evaluating occupational and residential exposure to 
pesticides and other toxic substances (U.S.EPA 1996). However, this sampling method is 
burdensome on the study subjects and non-compliance can lead to compromised or 
biased samples. A common alternative is to collect the first morning urine as has been 
done in many occupational and environmental exposure investigations because the first 
morning urine is often correlated with the 24-hour void (Han et al. 2007; Scher et al. 
2007). In epidemiological studies such as NHANES with thousands of participants, first 
morning voids are often difficult to obtain, hence, spot urine samples have been used as a 
more practical solution. However, a non-standardized sampling increases the variance 
especially for short-lived compounds like OH-PAHs and changes in water consumption 
throughout the day increase the variance even further by diluting or producing more 
concentrated urine. Therefore, concentration adjustments such as creatinine correction 
have often been used to adjust for urine excretion rate and minimize variability of the 
urinary biomarker concentrations caused by different hydration status of participants 
(Barr et al. 2005).  
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Epidemiological study design should include a good understanding of the 
variability within a normal, non-exposed population or group of interest (IPCS 1993). 
Furthermore, since most potential health effects are likely associated with exposure over 
time, understanding the temporal variability of urinary biomarker levels from subjects 
with no occupational exposure is essential for data interpretation and study design. At 
present, little is known about the variability of urinary OH-PAH levels. Siwinska et al. 
(1998) found that concentration of 1-PYR in first morning urine samples collected on 6 
consecutive days in 30 children had a coefficient of variation (CV) within-person ranging 
14-109%, whereas inter-person variation was 69-109%. Grimmer et al. (1993) reported 
the intra-person variation in 24-hour voids during 4 consecutive days from 4 coke 
workers to be 14-41% for 1-PYR and 16-94% for mono-hydroxy phenanthrene 
metabolites. Han et al. (2007) reported that one-third of 50 coke oven workers and 50 
controls had a CV of over 50% in first morning and 24-hour voids.  
The objectives of the present study were to evaluate the variability of 9 commonly 
detectable OH-PAHs, metabolites of naphthalene, fluorene, phenanthrene and pyrene, in 
adults with no occupational exposure over 7 days. Our design allowed us to determine the 
between- and within-subject variability, between- and within-day variability, as well as 
apportion the variance to subject and day effects. In addition, we calculated sample size 
requirements for different sampling regimes such as spot, first morning and 24-hour void 
sampling. The finding of this investigation is applicable to the study design of future 
exposure assessments or epidemiological studies. 
5.2 Methods 
5.2.1 Study Design 
The 8 subjects in this study were healthy volunteers between 26 and 58 years of 
age with no known occupational PAH exposure. They were non-smokers and were not 
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subjected to second-hand smoking. The participants (4 males and 4 females) lived in the 
metropolitan Atlanta area, drove to and from work in the morning and afternoon during 
the weekdays (Monday – Friday) with median driving time 30 minutes (one-way, range 
15 – 60 minutes) and a median distance of 21 km (one-way, range 8 – 40 km). The 
subjects were all working in modern office buildings at the CDC and were not 
occupationally exposed to PAHs. The participants did not work and had sporadic driving 
during the weekend (Saturday – Sunday). During the one-week study period in 
November 2005, participants collected all urine excretions in a graduated beaker, 
recorded the volume and time of each excretion, and transferred a portion (~50 mL) to a 
pre-labeled sterile urine cup which was then stored in an ice cooler. The urine samples 
were retrieved from each participant daily (or after the weekend), brought back to the 
laboratory, and frozen (-70ºC) until analysis. Participants also recorded detailed 
information on dietary intake, driving and other outdoor activities.  
5.2.2 Laboratory Methods 
The method used to measure the urinary OH-PAH metabolites has been described 
in detail previously (Li et al. 2006); hence it is only briefly outlined here. Urine samples 
were spiked with 13C-labeled internal standards and sodium acetate buffer containing β-
glucuronidase enzyme, hydrolyzed overnight at 37 ºC, and then extracted using pentene 
through semi-automated liquid-liquid extraction. The extracts were evaporated, 
derivatized, and analyzed on a 6890 gas chromatograph (Agilent Technology, Palo Alto, 
CA) coupled with a MAT 95XL high resolution mass spectrometer (Thermo Fisher 
Scientific Inc., Waltham, MA). All analyses were subjected to a series of quality control 
and quality assurance checks as described elsewhere (Li et al. 2006). Urinary creatinine 
was measured on a Roche Hitachi 912 Chemistry Analyzer (Hitachi Inc., Pleasanton, 
CA) using the Creatinine Plus Assay, as described in Roche’s Creatinine Plus Product 
Application # 03631761003.  
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5.2.3 Statistical Analysis  
All statistical analyses were performed using SAS 9.1.3 (SAS Institute, Cary, NC) 
and Statistica 7.1 (StatSoft Inc., Tulsa, OK). Concentrations below the limit of detection 
(LOD) were replaced with the LOD divided by the square root of 2 prior to data analysis. 
The urinary metabolite concentrations followed a log-normal distribution; therefore, all 
data were log-transformed before statistical analysis.  
A total of 427 samples were available from 8 subjects over one week. We defined 
the first morning void sample as the first sample collected from each subject after 5 AM 
each day. The 24-hour void concentration was calculated as the volume weighted average 
of all urine specimens collected by an individual during a 24-hour period starting at 
midnight. Subject 8 (S8) had a high dietary intake of PAHs (barbecued chicken) on the 
fourth day of the study period and concentrations of all OH-PAHs increased up to 104-
fold post exposure. Hence, data from this subject for the two days affected by the high 
dietary intake were excluded from further variability and sample size calculations.  
To assess the between and within-subject as well as between and within-day 
variance, we calculated the contributions of each effect toward the total variance for four 
metabolites, i.e. 1-naphthol (1-NAP), 3-hydroxyphenanthrene (3-PHEN), 1-PYR, and 3-
hydroxyfluorene (3-FLUO),. This was done using a random effects model fitted through 
the PROC NESTED, PROC MIXED, and PROC VARCOMP procedures in SAS. Since 
all models produced similar results we chose to only present the results from the PROC 
NESTED model. We calculated intraclass correlation coefficients (ICC), defined as the 
ratio of between-subject variance to the total variance, as an indicator of reproducibility 
of repeated measurements over time (McGraw and Wong 1996). A high ICC value 
indicates high correlation between the repeated measurements from the same subject, or 
in other words, high reproducibility of repeated samples. Using the findings from this 
study, we performed sample size calculations including from 1 to 4 repeated samples 
from each subject. Separate calculations were performed for spot sample, first morning 
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void and 24-hour void. The percent differences in geometric means (GM) used for the 
sample size calculation between the two groups (e.g. control vs. case) were 10%, 25%, 
50%, and 100%. All of our analyses were performed on log-transformed data; hence, we 
converted percent differences in the GM to a difference (d) on the mean of log-
transformed concentrations for the power calculation (Supplemental Material). The 
number of subjects (m) needed per group to achieve desired type I error (α = 0.05) and 
power (P = 0.8) was calculated using the following formula (Diggle et al. 1994),  
m = 2 (Zα + Zβ)2 SD2 [1 + (n-1) ICC]/(nd2) 
    = 2 (Zα + Zβ)2 [1 + (n-1) ICC]/(n∆2) 
where: ∆ = d/SD is the smallest meaningful difference between groups in standard 
deviation (SD) units; n = number of repeated samples per subject; Zy = yth percentile of a 
standard Gaussian distribution; β = type II error = 1-P 
5.3 Results 
We quantified 9 OH-PAH metabolites in 427 samples collected from 8 subjects 
during one week. The detection rates were above 95% for all reported analytes except for 
2-hydroxyphenanthrene (2-PHEN, 82%) and 3-hydroxyfluorene (3-FLUO, 87%). The 
GM, median and quartile concentrations from all samples, first morning voids and re-
constructed 24-hour voids are given in Table 5.1. During the 7-day study period, each of 
the 8 subjects collected on average 53 urine samples (27-74 samples/subject, Figure 5.1). 
Urinary OH-PAH concentrations within subjects varied 2 to 3 orders of magnitude (Table 
5.2). For example, concentration of 2-naphthol (2-NAP) in a subject identified as S7 
ranged from 86 ng/L to 17069 ng/L during the study period. Within subjects, the CVs of 
the 9 OH-PAHs among all samples, first morning voids, and 24-hour voids were 64-
297%, 26-189% and 13-182%, respectively; creatinine adjustment decreased the CV to 
19-228%, 9-176% and 9-154%, respectively (Table 5.3). Levels of urinary PAH 
biomarkers in each subject varied throughout the day, as exemplified in Figure 5.2.  
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Figure 5.1. Wet weight (A) and creatinine-adjusted (B) concentrations of 1-
hydroxypyrene in all individual urine samples from 8 subjects (S1-S8) during 7 days 
 
 
The 1-PYR concentration over time stratified by subject is given in Figure 5.1. 
One of the subjects identified as S8 ate barbecued chicken at a restaurant for lunch on 
Thursday; as a result, levels of all the urinary metabolites increased following that 
exposure (Figure 5.1 and 5.3). For 1-PYR the level increased 104 fold within 12 hours 
after the dietary intake while the median increase in level were 41-fold among the 9 OH-
PAHs monitored. Twenty-four hours after the dietary exposure, the concentration of the 
urinary metabolites monitored returned to pre-exposure levels. The Thursday and Friday 
data from subject S8 were excluded from further variability analysis and sample size 
calculations.  
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Table 5.2. Median, minimum and maximum concentrations of urinary OH-PAHs in each 
subject over 7 days 
 
 1-NAP 2-NAP 9-FLUO 3-FLUO  2-FLUO 3-PHEN 1-PHEN 2-PHEN 1-PYR 
Wet weight concentration (ng/L)      
S1 396  (66-2681) 
593  
(105-2075) 
111  
(30-545)
46  
(10-168)
134  
(19-503)
47  
(10-231)
42  
(10-305) 
18  
(10-88) 
26  
(8-188) 
S2 663  (49-5693) 
2369  
(257-24263) 
127  
(22-911)
30  
(10-160)
80  
(10-419)
45  
(10-327)
62  
(12-369) 
26  
(10-190) 
53  
(8-317) 
S3 1012  (171-3060) 
746  
(197-5818) 
262  
(34-1687)
41  
(10-138)
135  
(27-508)
81  
(16-319)
159  
(21-471) 
47  
(10-173) 
62  
(11-231) 
S4 583  (100-38025) 
714  
(177-3628) 
57  
(12-491)
24  
(10-168)
74  
(16-368)
33  
(10-210)
42  
(14-318) 
16  
(9-100) 
22  
(8-136) 
S5 501  (69-2013) 
814  
(129-4161) 
84  
(11-820)
35  
(10-136)
112  
(10-499)
84  
(10-579)
98  
(12-347) 
44  
(10-255) 
32  
(8-214) 
S6 836  (272-2767) 
1103  
(422-3342) 
258  
(92-936)
48  
(18-172)
148  
(50-442)
80  
(25-313)
76  
(28-194) 
50  
(14-164) 
54  
(16-137) 
S7 981  (163-22705) 
898  
(86-17069) 
128  
(25-829)
18  
(10-86) 
71  
(13-231)
40  
(10-139)
86  
(14-332) 
22  
(9-86) 
19  
(8-90) 
S8 958  (77-42606) 
2759  
(484-22531) 
66  
(12-3094)
38  
(10-755)
96  
(15-1904)
45  
(10-2278)
66  
(11-2027) 
25  
(10-1876) 
30  
(7-1761) 
All 693  (49-42606) 
906  
(86-24263) 
110  
(11-3094)
35  
(10-755)
99  
(10-1904)
51  
(10-2278)
69  
(10-2027) 
25  
(9-1876) 
33  
(7-1761) 
          
Creatinine corrected concentration (ng/g creatinine)  
S1 552  (160-3455) 
935  
(169-1581) 
169  
(51-581)
72  
(10-137)
198 
(27-409)
81  
(16-276)
71  
(23-237) 
33  
(10-96) 
43  
(14-371) 
S2 1300  (425-8705) 
4702  
(1255-29984) 
322  
(94-1121)
62  
(25-267)
166  
(66-551)
93  
(32-366)
157 
(48-437) 
67  
(25-328) 
116  
(46-377) 
S3 1274  (109-4035) 
1021  
(298-3914) 
346  
(22-2459)
44  
(7-319) 
157  
(25-954)
106  
(18-339)
176  
(19-445) 
59  
(10-142) 
76  
(7-188) 
S4 1911  (426-42439) 
2617  
(1076-6385) 
219  
(85-583)
91  
(19-234)
229  
(73-772)
121  
(43-306)
168  
(49-409) 
57  
(18-200) 
78  
(23-193) 
S5 649  (257-1769) 
927  
(493-4152) 
118  
(40-1684)
44  
(22-144)
123  
(75-256)
93  
(48-230)
111  
(65-497) 
50  
(28-154) 
35  
(15-223) 
S6 773  (383-1789) 
981  
(679-2287) 
215  
(155-672)
42  
(26-117)
125  
(102-303)
69  
(38-214)
67  
(54-133) 
42  
(28-112) 
48  
(32-94) 
S7 1207  (765-15289) 
1210  
(414-16072) 
185  
(116-765)
29  
(16-76) 
94  
(71-137)
52  
(32-88) 
105  
(66-239) 
31  
(20-76) 
27  
(17-59) 
S8 1034  (359-18978) 
2689  
(1715-14179) 
63  
(24-1947)
32  
(17-475)
88  
(58-1198)
44  
(28-1762)
58  
(36-1770) 
27  
(13-1181) 
32  
(16-1963)
All 1050  (109-42439) 
1657  
(169-29984) 
203  
(22-2459)
53  
(7-475) 
154  
(25-1198)
87  
(16-1762)
122  
(19-1770) 
45  
(10-1181) 
58  
(7-1963) 
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Table 5.3. Coefficients of variability (CV) for urinary OH-PAH concentrations in all 
samples, first morning voids, and 24-hour voids from 8 subjects 
  
S1   S2  S3   S4 
  all 1stM 24hr   all 1stM 24hr   all 1stM 24hr   all 1stM 24hr
Freshweight concentration (ng/L)           
1-NAP 85% 70% 27% 111% 71% 47% 56% 40% 13%  270% 153% 140%
2-NAP 69% 51% 24% 121% 43% 61% 87% 34% 27%  80% 34% 31%
9-FLUO 81% 60% 23% 96% 54% 24% 85% 127% 61%  99% 51% 29%
3-FLUO 72% 51% 29% 85% 45% 28% 64% 47% 31%  86% 34% 37%
2-FLUO 73% 49% 26% 86% 48% 27% 67% 30% 21%  80% 27% 33%
3-PHEN 80% 66% 24% 97% 60% 26% 70% 50% 23%  87% 34% 32%
1-PHEN 87% 70% 41% 90% 47% 18% 66% 52% 27%  91% 48% 29%
2-PHEN 78% 50% 24% 94% 63% 26% 71% 59% 26%  85% 30% 24%
1-PYR 94% 99% 44% 95% 61% 38% 73% 56% 31%  88% 35% 21%
                
Creatinine-adjusted concentration (ng/g creatinine)       
1-NAPc 66% 32% 34%  100% 72% 59%  47% 37% 21%  182% 169% 127%
2-NAPc 29% 26% 15%  84% 56% 50%  54% 19% 21%  38% 33% 13%
9-FLUOc 59% 41% 23%  53% 50% 32%  82% 142% 67%  46% 31% 23%
3-FLUOc 30% 28% 15%  57% 35% 21%  73% 47% 29%  50% 46% 36%
2-FLUOc 30% 26% 15%  48% 13% 19%  64% 21% 11%  55% 31% 35%
3-PHENc 56% 36% 25%  58% 30% 19%  41% 53% 22%  45% 24% 27%
1-PHENc 46% 58% 37%  40% 19% 23%  36% 57% 27%  38% 26% 21%
2-PHENc 48% 26% 24%  65% 32% 30%  38% 62% 27%  54% 18% 16%
1-PYRc 104% 53% 60%  43% 19% 16%  43% 57% 30%  43% 23% 14%
S5  S6  S7  S8 
 all 1stM 24hr  all 1stM 24hr  all 1stM 24hr  all 1stM 24hr
Freshweight concentration (ng/L)           
1-NAP 72% 47% 22%  61% 51% 41%  197% 131% 111%  205% 180% 124%
2-NAP 85% 57% 39%  52% 29% 25%  169% 140% 111%  99% 35% 64%
9-FLUO 108% 52% 22%  63% 26% 16%  87% 46% 55%  281% 75% 180%
3-FLUO 74% 46% 21%  57% 32% 30%  72% 45% 41%  178% 153% 109%
2-FLUO 83% 54% 25%  49% 30% 21%  66% 40% 31%  187% 63% 117%
3-PHEN 94% 60% 25%  64% 36% 24%  75% 51% 33%  262% 167% 171%
1-PHEN 73% 44% 20%  45% 34% 17%  71% 48% 48%  222% 173% 144%
2-PHEN 88% 55% 23%  55% 33% 26%  77% 44% 39%  297% 150% 182%
1-PYR 96% 67% 34%  48% 30% 21%  77% 44% 37%  273% 189% 177%
                
Creatinine-adjusted concentration (ng/g creatinine)       
1-NAPc 41% 38% 30% 40% 34% 34% 135% 109% 98%  156% 175% 117%
2-NAPc 68% 37% 30% 35% 27% 29% 127% 114% 91%  65% 25% 38%
9-FLUOc 139% 41% 40% 49% 12% 31% 51% 28% 34%  249% 62% 152%
3-FLUOc 44% 25% 24% 37% 15% 20% 36% 28% 22%  135% 133% 93%
2-FLUOc 24% 21% 14% 29% 9% 10% 19% 23% 10%  150% 47% 85%
3-PHENc 39% 31% 24% 42% 16% 12% 28% 29% 11%  256% 153% 143%
1-PHENc 46% 17% 20% 22% 16% 9% 31% 36% 28%  206% 157% 121%
2-PHENc 44% 25% 25% 36% 12% 14% 36% 27% 17%  264% 133% 154%
1-PYRc 67% 38% 38% 31% 20% 12% 28% 26% 16%  288% 176% 151%
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Figure 5.2. Levels of 1-hydroxypyrene in Subject 5 during one week for wet weight (A) 
and creatinine-adjusted concentrations (B) 
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Figure 5.3. Normalized creatinine-adjusted concentrations of 4 OH-PAH metabolites 
from Subject 8. The subject consumed barbecue chicken for lunch on Thursday 
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Figure 5.4. Contribution of between- and within-subject (A), between- and within-day 
(B) effects to total variance for 4 urinary OH-PAH metabolites 
 
 
 
Table 5.4. Variance apportionment for creatinine-adjusted concentrations of 4 PAH 
metabolites in urine samples from 8 subjects over a period of 7 days 
 
    Spot samples  1st morning voids  24 hour voids 
    Variance component 
Percent 
of total 
variance
 Variance component 
Percent 
of total 
variance 
 Variance component 
Percent 
of total 
variance 
1-NAPc         
 Subject 0.20 30%*  0.27 33%  0.33 44%
 Day 0.19 29%  0.55 67%  0.42 56%
 Hour 0.27 41%  - -  - -
          
3-FLUOc         
 Subject 0.14 44%  0.10 50%  0.14 67%
 Day 0.04 13%  0.10 50%  0.07 33%
 Hour 0.14 43%  - -  - -
          
3-PHENc         
 Subject 0.11 40%  0.21 65%  0.25 77%
 Day 0.01 4%  0.12 35%  0.07 23%
 Hour 0.16 56%  - -  - -
          
1-PYRc         
 Subject 0.26 55%  0.13 60%  0.13 76%
 Day 0.03 7%  0.07 40%  0.04 24%
  Hour 0.18 38%  - -  - -
* Numbers in italic are intraclass correlation coefficients (ICC), defined as the ratio of between-subject 
variance to total variance 
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Table 5.5. Estimated number of samples needed to detect a difference of 10, 25, 50, and 
100% in the 1-hydroxypyrene geometric mean concentration with a statistical power of 
80% (p<0.05), for single and repeated sampling for spot, first morning and 24-hour void 
sampling  
 
Number of repeated samples 
Spot samples  First morning voids  24-Hour voids 
Target % 
difference 
on GM 1 2 3 4  1 2 3 4  1 2 3 4 
Wet weight concentration (ng/L urine)      
10% 1069 624 475 401 618 420 353 320 296 230 208 197
25% 195 114 87 73 113 77 64 58 54 42 38 36
50% 59 34 26 22 34 23 20 18 16 13 11 11
100% 20 12 9 8 12 8 7 6 6 4 4 4
               
Creatinine-adjusted concentration (ng/g creatinine)      
10% 606 470 424 401  415 332 305 291  399 351 335 327
25% 111 86 77 73  76 61 56 53  73 64 61 60
50% 33 26 23 22  23 18 17 16  22 19 19 18
100% 11 9 8 8  8 6 6 5  8 7 6 6
 
 
Between-subject variance contributed 49-59% towards the total variance of 1-
NAP, 3-FLUO, 3-PHEN, and 1-PYR (creatinine-adjusted, unless specified otherwise), 
and within-subject variance explained on average 41-60% for the seven days of sampling 
(Figure 5.4A). For the 8 subjects, within-day variance for 1-NAP, 3-FLUO, 3-PHEN, and 
1-PYR, contributed to 60%, 71%, 90% and 84% (average of 8 subjects) of the total 
variance, respectively (Figure 5.4B). The contributions of subject, day and hour effect to 
the total variance of all samples, first morning voids and 24-hour voids are given in Table 
5.4.  
The number of subjects needed per group to detect a difference of 10%, 25%, 
50% and 100% in urinary 1-PYR concentration is given in Table 5.5. Sample size 
calculations were performed to reflect three sampling methods: (i) spot sample collected 
anytime during the day; (ii) first morning void; and (iii) 24-hour void. Separate estimates 
of sample size are given for one through four repeated samples from each subject.  
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5.4 Discussion 
We measured 9 PAH metabolites formed from four parent compounds in 8 adults 
during one week of continuous sampling. We quantified and apportioned variance among 
the subject and day factors, evaluated the effect of creatinine adjustment, and compared 
different sampling approaches on the reliability of these urinary biomarkers for exposure 
assessment purposes. Based on our findings, we also calculated sample size requirements 
necessary for spot urine, first morning and 24-hour void sampling, as a reference for 
future biomonitoring study design.  
5.4.1 Concentrations and Profiles 
Overall, concentrations found in this adult population with no occupational PAH 
exposure were comparable to the reference levels established for the U.S. general adult 
population (Table 5.1). This is not surprising considering that the participants were non-
smoking professionals working in modern office buildings; thus their PAH exposure was 
relatively low. However, the number of subjects (N = 8) in this study is small and results 
in Table 5.1 were from repeated sampling from the 8 subjects. On the other hand, the 
NHANES survey that provided the reference levels for the U.S. general adult population 
included over 2000 subjects (Li et. al., 2008). Therefore, it is difficult to make a direct 
comparison between this study and the NHANES survey. Wet weight concentrations in 
first morning voids were significantly higher than in all samples and re-constructed 24-
hour voids. The differences diminished after creatinine adjustment, indicating that the 
higher wet weight concentrations in the first morning voids were caused by the more 
concentrated urine formed overnight and that creatinine adjustment is an effective 
normalization method.  
Within each subject, concentrations of the urinary OH-PAH metabolites varied 
throughout the day (Figures 5.1 and 5.2). An apparent diurnal pattern (i.e. higher 
concentration in the early and late hours of the day, and lower during the middle of the 
 89
day) on wet weight concentrations was observed in one subject during the weekdays but 
not during weekends (Figure 5.2). Creatinine normalization effectively removed or 
reduced this daily pattern, suggesting that urine dilution related to variation in water 
consumption throughout the day was the likely explanation for the higher concentrations 
(wet weight) at the beginning and the end of each day. 
  We designed and conducted this study with the intention to study variability of 
urinary OH-PAH levels in a non-occupationally exposed population and to conduct 
power calculations. Hence, we did not restrict diet and other activities during the study 
period. One of the subjects consumed barbecued chicken for lunch on Thursday and in 
the first urine sample taken 30 minutes after lunch, the creatinine-adjusted concentrations 
of the 9 metabolites were 1.9-6.6 folds higher than pre-exposure. Six hours later, 
metabolites of naphthalene and fluorene peaked with levels on average 22 times higher 
than pre-exposure, whereas 9 hours post exposure, metabolites of the larger PAHs, i.e. 
phenanthrene and pyrene, reached their highest level (41-104 fold higher than pre-
exposure, Figure 5.3). Differences in urinary excretion rates for OH-PAHs have been 
reported previously. In an occupational study conducted in France, the time needed for 
urinary 1-PYR to reach maximum after work shift was approximately 8 hours, whereas 
the lag time was 15 hours longer for urinary 3-hydroxybenzo(a)pyrene (Gendre et al. 
2004).  The excretion profile of urinary OH-PAHs in our study is consistent with 
previously reported urinary half-lives estimates for 1-PYR ranging from 4.4 to 15 hours 
(Brzeznicki et al. 1997; Buckley and Lioy 1992; Viau et al. 1995; Viau and Vyskocil 
1995).  
It is well known that PAHs are generally present as complex mixtures in the 
environment, and after entering the human body, they are transformed to an array of 
metabolites (ATSDR, 1995). Human exposure to PAHs has been quantified based on 
urinary metabolites levels, and 1-PYR is the most common — often the only — 
biomarker measured. Indeed, concentrations of urinary OH-PAHs have been found to be 
 90
well-correlated in a large epidemiological study (Li et al. 2008), supporting the use of one 
biomarker as a surrogate representing PAH exposure. In our study, however, we found 
that certain metabolites had distinct concentration profiles over time, compared to other 
metabolites from the same individual. For example, 1-NAP had an elevated peak in S8 
starting on Tuesday afternoon, whereas all other analytes including 1-PYR stayed at 
background levels during the same time period (Figure 5.3). The elevated 1-NAP 
concentrations could be traced back to the subject exercising at a health fitness center 
freshly sprayed with cleaner, and 1-NAP has been reported as a metabolite of carbaryl 
pesticide (Maroni et al. 2000). Similar large increases of only one or two metabolites 
occurred in other subjects but could not be explained by the information collected. The 
unique concentration profile specific to only one or two OH-PAHs demonstrated the 
individuality of each metabolite, the importance of a multi-analyte assay for exposure 
assessment, and the potential of using individual biomarkers as indicators of specific 
source-related exposure scenarios.  
5.4.2 Variability Analysis 
Few studies have reported within-subject variability of PAH metabolites in urine 
(Han et al. 2007; Siwinska et al. 1998). We found that levels of the PAH biomarkers 
spanned three orders of magnitude during a course of one week (Table 5.2). The CVs of 
wet weight OH-PAH concentrations within person ranged 64-270% in all samples and 
26-153% in first morning voids (Table 5.3), after excluding S8 due to the high dietary 
exposure. Creatinine adjustment reduced the variability by 35% and 29%, respectively, 
indicating that creatinine adjustment corrects for differences in hydration status and 
reduces variability. Therefore, creatinine-corrected concentrations were used for all 
further variance and sample size calculations. The re-constructed 24 hour voids were 
shown to be the most reproducible sampling approach, reducing the CVs by 58% and 
37%, compared to the individual samples and the first morning voids, respectively. No 
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significant difference in variability was observed after creatinine adjustment of the 24-
hour void concentrations, which is consistent with the premise that humans excrete 
creatinine at a relatively consistent rate; approximately 2% of body creatine is converted 
to creatinine every 24 hours (Barr et al. 2005). Therefore, creatinine adjustment is not 
necessary for 24-hour voids but is essential for spot samples and first morning voids.  
For individual subjects, within-day variance exceeded the between-day variance, 
contributing 72-89% to total variance (Figure 5.4B). This can be interpreted as the time 
of day is much more important than the day of the week when the sample is collected, a 
conclusion that stresses the importance of collecting samples at a well defined time of 
day in an epidemiological study. From these results, we recommend that if in a study we 
were to collect two samples from each subject to better reflect exposure, we would take 
samples on two different days at around the same time, rather than taking two samples 
from the same day.  
In general, between-subject variance outweighed the between-day variance for 3-
FLUO, 3-PHEN, and 1-PYR, whereas for urinary 1-NAP levels, the day effect 
contributed equally or more towards the total variance than the subject effect (Table 5.4). 
For spot samples, 38-56% of the total variances among the 4 metabolites could not be 
explained by either the subject or the day factor and could be attributed to the time of day 
effect — a finding that re-emphasizes the importance of collecting spot urine samples at a 
consistent time of the day if using this sampling approach. 
ICC value, calculated as the ratio of between-subject variance to the total 
variance, ranged from 0.30-0.55 for spot samples, 0.33-0.65 for first morning voids, and 
0.44-0.77 for 24-hour voids. The lower ICC values found in spot samples indicated 
higher within-subject variability and lower reproducibility from repeated urine 
collections from the same individual. On the other hand, 24-hour void was proven to be 
the most reproducible sampling technique, with markedly higher ICC values up to 0.77. 
As a comparison, the ICC values were 0.20-0.57 in first morning voids during an 8-
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consecutive day study on urinary metabolites of phthalates, another group of non-
persistent chemicals with similar half-lives (Fromme et al. 2007). In another study on 
urinary phthalate metabolites in spot urine samples taken over a 3-month period, the ICCs 
ranged from 0.28 to 0.52 (Hauser et al. 2004). The observed ICCs of urinary OH-PAH 
levels in our study were very similar to those reported on metabolites from other 
chemical classes with short half-lives, and there was a considerable degree of temporal 
reproducibility for these biomarkers over the study period of a week.  
5.4.3 Sample Size Recommendation 
In any cross-sectional or longitudinal epidemiological studies, investigators need 
to know in advance the approximate number of subjects required to achieve a desired 
statistical power. We found only one publication that reported sample size 
recommendations for urinary OH-PAH biomonitoring. Siwinska et al. (1998) calculated 
the minimum number of subjects for assessing exposure of a child population to 
environmental PAHs to be 164, based on variability of urinary 1-PYR concentrations in 6 
consecutive first morning voids from 30 children. The method used in that estimation, 
however, was based on the assumption that the data were independent, which could be 
problematic because urinary biomarker concentrations are correlated. The ICC for 1-PYR 
in our study were 0.55, 0.60, and 0.76, for spot samples, first morning voids and 24-hour 
voids, respectively, indicating considerable agreement between repeated measurements. 
Using the variability and correlation findings from our study, we calculated sample size 
requirements for urinary 1-PYR, with one to four repeated samples, simulating the three 
different sampling methods, cf. Table 5.5.  
As expected, number of subjects needed per group is the highest for spot samples, 
followed by first morning voids and 24-hour voids, due to the higher variability in the 
spot samples. Repeated sampling from the same subjects can reduce the sample size 
requirements, and the lower correlation and less reproducibility in spot samples makes 
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this approach benefit more from repeated sampling. For example, taking an additional 
sample per person reduces the sample size by 23%, 20% and 13% for spot samples, first 
morning and 24-hour voids, respectively. Sample size requirement can be further reduced 
by collecting additional repeated samples from each person; however, the benefit lessens 
with each additional sample, especially if 3 or more samples were taken per person. As 
expected, the sample size requirements when using wet weight concentration are 
significantly higher than for creatinine-adjusted concentrations in spot urine samples and 
first morning voids, which can be explained by higher variability in wet weight 
concentrations for these two sampling methods. For 24-hour voids, however, the sample 
size requirement is less when using wet weight concentrations, which is consistent with 
earlier conclusion that creatinine adjustment is not needed for 24-hour voids.  
To detect a difference of 10% in geometric mean with a statistical power of 80%, 
a total of 606 spot urine samples (creatinine adjusted) will be needed per group to reach 
the desired statistical difference while 296 24-hour void samples (unadjusted) would be 
sufficient to reach the same statistical power. Hence, it is of utmost importance that these 
considerations are taken into account when planning an epidemiological study since we 
will need to balance the additional labor of collecting 24-hour void samples against the 
costs of recruiting and analyzing more than twice as many samples to reach the same 
statistical power.  
Supplemental Material 
Conversion of differences on geometric means (GM) between two groups to differences 
on the means of log-transformed data  
 
Let: GM1 = geometric mean of original concentration in Group 1 
   M1 = mean of the log-transformed concentrations in Group 1 
  then:  M1 = log (GM1) 
Let: GM2 = geometric mean of original concentration in Group 2 
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 x = percent difference on GM between Group 2 and Group 1, i.e. GM2 = GM1(1 + x) 
                  M2 = mean of the log-transformed concentrations in Group 2 
  = log (GM2) 
  = log [GM1 (1 + x)] 
  = log (GM1) + log (1 + x) 
  = M1 + log (1 + x) 
Therefore:  
d = difference on means of log-transformed concentrations between Group 1 and 
Group 2  
   = M2 – M1 
   = log (1 + x) 
For a fixed x, there is a fixed d. For example:  
x = 10%, d = ln (1 + 10%) = 0.10 
x = 25%, d = ln (1 + 25%) = 0.22 
x = 50%, d = ln (1 + 50%) = 0.41 
x = 100%, d = ln (1 + 100%) = 0.69 
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CHAPTER 6 
ASSESSMENT OF NON-OCCUPATIONAL EXPOSURE TO 
POLYCYCLIC AROMATIC HYDROCARBONS THROUGH 
PERSONAL AIR SAMPLING AND URINARY BIOMONITORING 
  
 
Abstract 
Exposure to polycyclic aromatic hydrocarbons (PAH) can be assessed either 
through measuring PAHs in environmental samples (e.g. air samples) or through 
biomonitoring of urinary biomarker (hydroxy PAHs, or OH-PAHs) levels. This study 
was designed to assess non-occupational exposure to atmospheric PAHs through both 
personal air sampling and urinary biomonitoring. For 8-days, 8 subjects with 
occupational exposure to combustion sources and exposure to tobacco smoke, collected 
personal air samples while at home, at work or during commuting. All individual urine 
samples were collected from the subjects as well. We recorded detailed information on 
the duration and description of the personal air samples, time and volume of each urine 
excretion, as well as dietary intake, driving, and other activities of the participants during 
study period. Twenty-eight PAHs were measured in the personal air samples and 9 OH-
PAHs were measured in the urine samples. PAH concentrations varied widely in personal 
air samples taken at home, work or while commuting. Naphthalene was found at higher 
concentrations in indoor air samples at home, whereas large PAHs with 4 or more rings 
were found at higher concentrations or with higher detection frequencies in air samples 
taken while commuting to/from work through driving or jogging. Naphthalene 
concentrations were highly elevated in one of the households, which could be a result of 
fresh paint and/or heavy pesticide usage a few months prior to the study. Urinary OH-
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PAH biomarker levels varied throughout the study period and elevated biomarker 
concentrations were observed in all subjects following reported high inhalation (i.e. 
driving) or dietary exposures. Total inhaled naphthalene amount in 24-hour periods was 
well correlated with total excreted 1-naphthol, as did fluorene and its urinary metabolites. 
However, airborne phenanthrene and pyrene were not correlated with their urinary 
metabolites. These results suggest that for non-smoking reference populations without 
high occupational exposure, exposure to PAHs with 2-3 aromatic rings such as 
naphthalene and fluorene primarily through inhalation, while dietary ingestion is a major 
route for larger PAHs with 4 or more rings such as pyrene.  
 6.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are a group of carcinogenic and 
mutagenic substances formed during incomplete combustion processes and are 
ubiquitously distributed in air, soil, water, food, and many occupational settings (IARC, 
1983). Sources of PAHs include vehicle exhausts, forest fires, volcanic eruptions, and 
charbroiled or grilled meat. PAHs in the atmosphere, especially in densely populated 
areas, are primarily from anthropogenic emissions, such as automobile exhaust, fossil 
fuel combustion, biomass burning, cigarette smoke, and industrial activities. Human 
exposure to PAHs can occur through inhalation of polluted air or cigarette smoke, 
ingestion of food containing PAHs, and dermal absorption from soil or other PAH-
containing materials such as coal tar. For the general population, inhalation and ingestion 
are the two dominant routes of exposure, with ingestion reportedly being more important 
quantitatively (ATSDR, 1995; Bostrom et al., 2002). PAHs such as benzo(a)pyrene, 
benz(a)anthracene, and chrysene have been classified as probable human and animal 
carcinogens (ATSDR, 1995). PAHs have also been reported to possess reproductive, 
developmental, hemato-, cardio-, neuro-, and immuno-toxicities (ATSDR, 1995).  
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Human exposure to environmental pollutants such as PAHs can be assessed 
through environmental monitoring, in which external levels in the macro (e.g. ambient air 
sample) or micro-environment (e.g. personal air samples) are measured and daily intake 
is estimated to assess exposure (Weis et al., 2005). Traditionally, epidemiologic 
approaches to the study of health effects of air pollution include utilizing ambient 
monitoring data, health outcomes, and individual-level variables. Some studies have 
utilized geographic information system-based models to assess exposure (Gunier et al., 
2006). Numerous studies have reported on PAH levels in various matrices, such as in air 
(Gambaro et al., 2004; Li et al., 2009c; Ravindra et al., 2006), water or sediments (Akre 
et al., 2004; Oros and Ross, 2004; Zakaria et al., 2002), soil (Atanassova and Brummer, 
2004; Doick et al., 2005; Golobocanin et al., 2004), house dust (Chuang et al., 1999; 
Fromme et al., 2004; Offenberg et al., 2004),  and food (Falco et al., 2003; Stolyhwo and 
Sikorski, 2005).  However, from an exposure assessment point of view, the selection of 
particular sampling sites, the relative location of the study population to the sampling 
sites, and individual habits and lifestyles are factors that can have a large influence on the 
effectiveness of exposure assessment using environmental data. Alternatively, assessing 
exposure at the personal level has been used to provide more accurate quantitative 
measures of estimate at points of human contact. Personal air sampling is a common 
practice in occupational studies (Bieniek, 1998; Gundel et al., 2000; VanRooij et al., 
1993) as well as in studies of specific populations with suspected high exposure (Choi et 
al., 2008; Zmirou et al., 2000). In addition, exposure monitoring schemes can involve a 
combination of personal air sampling and indoor/outdoor sampling to get a better 
understanding of exposure at individual levels (Choi et al., 2008; Wilson et al., 1999). 
However, personal behavior such as physical activity and individual physiological 
differences can affect the uptake, absorption, distribution and metabolism of PAHs and 
other environmental pollutants, which present limitations of using external levels in 
exposure assessment.  
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Another method for determining exposure is biomonitoring, through which 
exposure is assessed by measuring the biomarkers in humans (Pirkle et al., 1995). 
Biomarkers of exposure refer to cellular, biochemical, analytical or molecular measures 
that are obtained from biological media such as tissues, cells, or fluids, and are indicative 
of exposure to a pollutant. Mono-hydroxylated PAHs (OH-PAHs), a group of metabolites 
of PAHs, have been used as urinary biomarkers of human exposure to PAHs, and 1-
hydroxypyrnee (1-PYR) is the most commonly used biomarker (Hansen et al., 2008). A 
number of studies have reported the levels of OH-PAHs in occupational groups such as 
coke oven workers and road pavers (Grimmer et al., 1993; Jongeneelen et al., 1990; 
Levin et al., 1995), as well as in the general population from various parts of the world 
(Hansen et al., 2005; Li et al., 2008; Mucha et al., 2006). The half-life for urinary 1-PYR 
after inhalation exposure has been reported to be 9.8 hours from five volunteers at an 
aluminum plant (Brzeznicki et al., 1997) and 6-35 hours from 56 coke oven workers 
(Jongeneelen et al., 1990). For oral ingestion exposure, the half-life was reported to be 
4.4 hours (Buckley and Lioy, 1992) or 12 hours (Viau et al., 1995a). Due to the short 
half-lives, quantitative determination of OH-PAH metabolites in urine is limited to 
provide information on a subject’s recent exposure to environmental PAHs. 
Biomonitoring provides unique information for health researchers to determine what 
toxicants and what internal doses may be linked with adverse health effects, and 
markedly decreases uncertainty in assessing human risk. However, several confounding 
factors can affect the levels of metabolites.  PAHs have rather fast clearance rate; 
therefore, the sampling time can have a large influence on the measurement results 
because urinary PAH metabolite levels reflect only recent exposure. Internal biomarker 
level reflects overall exposure of the subjects; however, it does not give route-specific 
information. In addition, individual differences in metabolism for different PAH 
compounds could also affect the levels of metabolites.   
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The objective of the present study was to investigate the feasibility of assessing 
exposure to ambient PAHs in an urban setting among a group of volunteers with no 
known occupational exposure and no or very low exposure to tobacco smoke by 
employing both personal air sampling and urinary biomonitoring. Eight volunteers took 
personal air samples while commuting to/from work, at work and at home over 8 days. 
All individual urine specimens excreted during the 8-day study period were also 
collected. The subjects followed a recommended diet plan, and maintained a detailed log 
with information on air samples, urine samples, dietary intake, driving and other outdoor 
activities. We measured 28 PAHs and methylated PAHs (Me-PAHs) in a total of 199 air 
samples and 9 major detectable OH-PAHs in 439 urine specimens. We studied levels of 
airborne PAHs in samples taken while commuting, at work and at home and computed 
the total amount of inhaled PAHs in each subject over 24-hour periods. We investigated 
excretion levels and profiles of urinary OH-PAHs and related the urine biomarker 
concentrations to information on driving, diet, and other activities. With the continuous 
air and urine sampling, we were able to study the correlation between inhaled PAHs and 
excreted OH-PAHs, which provided valuable information on exposure to ambient PAHs 
in this reference group.  
6.2 Experimental 
6.2.1 Study design 
The 8 subjects in this study were healthy volunteers between 31 and 62 years of 
age with no known occupational PAH exposure. They were non-smokers who were not 
subjected to second-hand smoke. The participants (3 males and 5 females) lived in the 
metropolitan Atlanta area, and the sampling took place in November - December, 2007. 
Seven of them drove to and from work in the morning and afternoon during weekdays 
(Monday–Friday), with median driving time of 45 minutes (one-way) and a median 
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distance of 25 km (one-way). One subject (S12) jogged to and from work as a means of 
commuting with a distance of 6.5 km and on average 45 minutes one-way. All subjects 
worked in a modern office building at the Centers for Disease Control & Prevention 
(CDC) and were not occupationally exposed to PAHs. The participants did not work 
during the weekend (Saturday–Sunday), during which they only drove sporadically.  
Detailed study design, sampling instructions and dietary recommendations are 
given in Appendix A. In brief, participants collected personal air and urine samples over 
8 days, including four weekdays and four days over weekends. During the study period, 
participants followed specific diet instructions, eating only low PAH-containing food on 
four days (2 weekdays and 2 weekend days) while consuming flame broiled burgers 
(high in PAH content) as lunch on the other four days. The 8 sampling days were 
separated into 4 segments of 2 days each, i.e. weekend with low PAH diet, weekday with 
low PAH diet, weekend with high PAH lunch and weekday with high PAH lunch. Each 
volunteer carried a personal air sampling device and collected air samples continuously. 
The air sampler was comprised of a personal air sampling pump (224-PCXR4 SKC Inc., 
Eighty Four, PA, USA) with a flow rate set at 2.5 L/min, connected to a air sampler tube 
(OSHA Versatile sampler tubes, SKC Inc.). The sampler tube contained a quartz filter to 
collect particles, followed by two XAD sorbent layers and two PUF layers to trap gas 
phase organics. During the weekdays, a total of four personal air samples per day were 
collected by each subject, including two samples taken during morning/afternoon 
commute, one sample taken at home overnight, and one sample taken during the daytime 
at work. During the weekends, subjects were asked to minimize driving and outdoor 
activities while collecting air samples continuously (1-2 samples/day).   
Meanwhile, participants collected all urine specimens throughout the study 
period. During each restroom visit, participants collected all urine excretions in a 
graduated beaker, recorded the volume and time of each excretion, and transferred a 
portion (~100 mL) to a pre-labeled sterile urine cup, which was then stored in an ice 
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cooler. The air and urine samples were retrieved from each participant daily (or after the 
weekend), brought back to the laboratory, and frozen at -70ºC until analysis. Participants 
kept detailed information on duration and start/end time of the air samples, time and 
volume of the urine samples, dietary intakes, driving, and other outdoor activities.  
6.2.2 Analytical methods 
Air samples were extracted through direct elution by dichloromethane (DCM) and 
quantified by isotope-dilution gas chromatography/high resolution mass spectrometry 
(GC/HRMS) (Li et al., 2009a). In brief, air sampler tubes were first fortified with a 
mixture of 18 isotopically labeled internal standards at 2 ng per compound, and then 
eluted with dichloromethane (DCM, 5 x 2 mL) at approximately 1 mL/min. The extracts 
were concentrated to ~50 µL under a gentle stream of nitrogen (5-10 psi, 40ºC), spiked 
with toluene (40 µL) and a recovery standard (13C12-labeled PCB105, 4 ng per sample) to 
measure recovery through the sample preparation process, and then transferred to GC 
vials for analysis. GC/HRMS analyses were performed on a MAT 95 XL HRMS 
instrument (Thermo Scientific, Waltham, MA, USA), coupled with a 6890 GC (Agilent 
Technologies, Palo Alto, CA, USA). The chromatographic separations were carried out 
on an RTX-440 column (30 m, 0.25-mm i.d., 0.25-µm film thickness; Restek Inc.) using 
helium (1 mL/min) as the carrier gas. The mass spectrometer was operated under selected 
ion monitoring (SIM) mode. Only the two most abundant ions from each compound were 
monitored as the quantification ion and confirmation ion. 
Nine major detectable OH-PAH metabolites were measured in urine samples 
using a semi-automated liquid-liquid extraction and isotope dilution GC/HRMS method 
(Li et al., 2006). In brief, urine samples (2 mL) were spiked with 13C-labeled internal 
standards and sodium acetate buffer (pH 5.5, 1M) containing β-glucuronidase enzyme 
(10 mg/sample). Samples were de-conjugated through overnight hydrolysis at 37 ºC, and 
then extracted by pentene through semi-automated liquid-liquid extraction (2 x 5mL) on a 
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Gilson 215 Liquid Handler (Gilson Inc., Middlerton, WI). The extracts were evaporated, 
re-constituted with 20 µL toluene, and derivatized to their trimethylsilylated derivatives. 
Finally, samples were analyzed on a GC/HRMS system at 10,000 resolution using a DB-
5MS column (30m x 0.25 µm x 0.25-mm i.d.). Urinary creatinine was measured on a 
Roche Hitachi 912 Chemistry Analyzer (Hitachi Inc., Pleasanton, CA) by use of the 
Creatinine Plus Assay, as described in Roche’s Creatinine Plus Product Application # 
03631761003.  
6.2.3 Quality assurance and quality control 
All air sample tubes were pre-purified by the manufacturer to ensure low 
background interferences. In addition, all tubes were pre-rinsed by 5 mL of DCM, dried 
in a vacuum oven, capped, sealed in zip-loc bags, and refrigerated before being handed 
out to subjects. The flow rate for air sampling pumps was set at 2.5 L/min; the flow rates 
for pumps were measured by a flow meter (DC-Lite flow meter, SKC Inc.) before and 
after each sampling period. Field and method blanks were analyzed to monitor 
background contamination. Method blanks were measured along with samples, and all 
results reported were blank-subtracted. Secondary sample tubes were installed after the 
primary sample tubes to study the breakthrough of PAHs. Levels of PAHs on the 
secondary tubes were in most cases below the limit of detection (LOD).  
Quality control (QC) samples were prepared by spiking a known amount of 
standard mixtures onto blank sample tubes (for air measurements) or into an 
anonymously collected urine pool (for urine measurement). In both air and urine 
methods, a set of samples was defined as 16 unknown samples, prepared and analyzed 
along with 2 blanks and 2 spiked QC samples. In addition, an external recovery standard 
and a calibration standard were analyzed on the GC/HRMS in parallel with the sample 
extracts. Analysis of a set of samples was considered valid only after fulfilling a series of 
 103
criteria on elution time, recovery and QC concentrations as described elsewhere (Li et al., 
2009a; Li et al., 2006). 
6.2.3 Data and statistical analysis  
All concentrations were blank-subtracted; concentrations below the LOD were 
substituted with the LOD divided by the square root of 2 prior to statistical analysis. All 
statistical analyses were performed using the Statistica 7.1 software (StatSoft Inc., Tulsa, 
OK). Correlation analysis between inhaled PAHs and excreted OH-PAHs were carried 
through both linear regression analysis and non-parametric Spearman correlation 
analysis. Both methods gave comparable results; therefore, only results from the linear 
regression analysis are shown here. Results are considered statistically significant if the 
p-value was less than 0.05 and marginally significant when the p-value was between 0.05 
and 0.1.  
A total of 199 air samples were collected by the 8 subjects and all individual 
samples were measured for PAH (gas and particle phase combined). The 24-hour total 
inhaled PAH was calculated by summing up amount of PAHs from all air samples 
collected from one subject during a 24-hour period (~10 pm on day 1 – 10 pm on day 2) 
and normalizing to reference daily inhaled air volume (0.5 m3/hr or 12 m3/day for adults 
with sedentary activities) (U.S.EPA, 1997). Subject S17 did not collect continuous air 
samples; therefore, the 24-hour total inhaled PAH data were not available for this subject.  
A total of 439 urine samples were collected from the 8 subjects. The 24-hour total 
excreted OH-PAH amount was calculated by summing up amount of OH-PAHs in all 
urine specimens collected by an individual during a 24-hour period starting at mid-day 
(12 pm – 12 pm). Subject S11 did not follow dietary plan and had limited number of 
urine samples with as low as 2 samples a day; therefore, urine results from this subject 
were excluded in the 24-hour total excretion calculation. When conducting correlation 
analysis on total inhaled PAHs and total excreted OH-PAH metabolites, we used a lag of 
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12 hours between the start of the air sampling and the start of urine sampling to account 
for biological half-lives in humans. Due to extremely high 1-NAP levels in subject S17 
during the first weekend that was not likely related to PAH exposure, 1-NAP data from 
this subject for those two days were excluded from the correlation analysis.  
6.3 Results and Discussion 
Exposure assessment using both personal air sampling and biomonitoring has 
been applied often to study high exposure in various occupations, such as coke oven 
workers (Bieniek, 1998; Grimmer et al., 1993; Pan et al., 1998), electrode paste plant 
workers (Bentsen et al., 1998b), fireproof stone producing plant workers (Gundel et al., 
2000), pavers/roofers (Hatjian et al., 1995; Vaananen et al., 2003) and policemen 
(Szaniszlo and Ungvary, 2001). However, studies on non-occupationally exposed 
reference populations are scarce. In our study, we aimed at investigating exposure of 8 
volunteers to ambient PAHs and studying whether biomonitoring can capture low level 
exposure to environmental PAHs in an urban setting. The subjects collected personal air 
samples continuously and collected all urine specimens during the 8-day study period. 
Twenty-eight PAHs and Me-PAHs were measured in personal air samples, and 9 OH-
PAH metabolites formed from 4 parent compounds were measured in urine samples. 
Levels of PAHs in the air samples and PAH metabolites in the urine samples in this study 
were, not surprising, up to orders of magnitudes lower than those found in occupational 
settings. We studied the concentrations and profiles of the airborne PAHs and urinary 
PAH metabolites. We also investigated correlations between the inhaled PAHs and 
excreted OH-PAH levels, and explored assessment of low-level exposure scenarios using 
a combination of personal air sampling and urinary biomonitoring.  
6.3.1 PAHs in personal air samples 
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The median and quartile concentrations, detection frequencies and LODs of the 
28 PAHs and Me-PAHs in personal air samples (gas + particle phases) are given in Table 
6.1, stratified by the description of the samples, i.e. samples taken inside an automobile 
while computing to/from work, samples taken while jogging to/from work (as a mean of 
commuting, 1 subject), samples taken at work and at home. Since we combined the filter 
and sorbents during sample extraction and analysis, the results given in this study are a 
combination of both gas phase and particle phase. In general, concentrations of the PAH 
compounds were inversely related to their ring sizes, i.e. the lower the molecular weight, 
the higher the concentration in air samples. The median concentration of naphthalene 
(NAP) was as high as 3629 ng/m3, followed by the two methyl naphthalenes (MNap), 
while concentrations of PAHs with 5-6 aromatic rings were up to 5 orders of magnitude 
lower, and in most cases, were below the detection limits (Table 6.1). This pattern is 
consistent with observations in previous studies that NAP is the most abundant PAH in 
ambient air and is predominantly found in the gas phase, as do the rest of small PAHs 
with 2-3 aromatic rings (Eiguren-Fernandez et al., 2004; Fang et al., 2004b; Ohura et al., 
2004). Total concentrations (sum of gas + particle phases) of larger PAHs with 4 or more 
rings are generally lower, but they exist primarily in the particle phase (Fang et al., 
2004b; Terzi and Samara, 2004; Tsapakis and Stephanou, 2005). Therefore, it is 
important to understand phase distribution when conducting research on ambient levels 
of semi volatile organic compounds such as PAHs.  
PAH concentrations were different in air samples taken at different locations, and 
the variation pattern was compound specific. Overall, PAH concentrations were at the 
lowest levels in samples taken at work, which is not surprising because all subjects 
worked in a modern office building with advance air filtration devices and minimum 
indoor PAH sources. Large PAHs with 4 or more aromatic rings were found at higher 
concentrations or with higher detection frequency in samples taken while driving and 
jogging through traffic, compared to samples taken at home. Notably, the average 
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sampling volume and duration of the drive and jog samples were around 1 hour or 0.15 
m3 air sampled, which were more than 10 folds less than samples taken at home (10.4 
hour or 1.56 m3 air sampled). Yet, the jogging samples had the highest detectable rate for 
large PAHs despite of the smallest sampling volume and shortest sampling time, 
indicating that the jogging samples had the highest concentrations for the large PAHs 
(Table 6.1). This is consistent with conclusions from previous studies that mobile sources 
or vehicle exhausts can be the major contributors to PAHs, especially for large PAHs 
with higher molecular weight, in urban and suburban areas (ATSDR, 1995; Eiguren-
Fernandez et al., 2004; Fang et al., 2004a).  
NAP and MNap, on the other hand, were found at higher levels in samples taken 
at home than in samples taken while commuting (Table 6.1). It has been reported that 
these small PAHs are associated more with indoor sources such as combustion of 
biomass and fossil fuel at home and the use of NAP-containing moth repellent; and their 
concentrations in indoor air have been shown to be more elevated than in outdoor air 
(ATSDR, 2005; Sanderson and Farant, 2004). In our study, even though we did not 
collect simultaneous indoor and outdoor air samples, the fact that NAP and MNap 
concentrations were substantially higher in samples taken at home than in drive and jog 
samples is consistent with the notion that indoor sources for these small PAHs can be 
more important than outdoor sources. Interestingly, NAP concentrations varied largely 
among the air samples taken at the 8 homes, as shown in Figure 6.1 and Table B.1. 
Samples taken at Subject S18’s home had the highest level of NAP at on average 18,700 
ng/m3, followed by those from S12’s home at 4,810 ng/m3, while the NAP concentrations 
ranged 118-1580 ng/m3 in the other 6 households. S18 moved to the current house four 
months prior to the time when this study took place. The house was freshly painted and 
sprayed with pesticides. The flooring (half carpet and half hardwood) went through deep 
cleaning before the move and new carpet was installed in the basement, an area of 
approximately 167 m2 or 1800 ft2. NAP is not only a major product from in-complete 
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combustion processes and a constituent in fuel and creosote, but it also is a common 
industrial chemical used in the production of dyes, plasticizers, pesticides and 
pharmaceuticals. Therefore, the highly elevated NAP levels in S18’s house could be a 
result of the fresh paint, pesticide usages and other activities in this household. Indoor 
concentrations of larger PAHs such as pyrene did not vary as much in the individual 
households as did naphthalene (Figure 6.1B and Table B.1). Interestingly, contrary to 
naphthalene levels, pyrene was found at the lowest concentration in samples taken at 
S18’s 5-year-old house, which was the newest among the 8 households and presumably 
with the best insulation. This is consistent with previous conclusion that PAHs with 3 or 
more aromatic rings in indoor air without substantial combustion activities were mostly 
resulted from the infiltration of outdoor air (Li et al., 2005; Sanderson and Farant, 2004).  
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Figure 6.1 Average naphthalene (A) and pyrene (B) concentrations (with standard 
deviation) at individual households. Also givens are numbers of air samples taken at each 
home.  
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Figure 6.2 Calculated daily inhaled PAHs in 7 volunteers for naphthalene (A), pyrene (B) 
and summed PAHs (C), stratified by weekend and weekdays.  
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Average concentrations of the 16 EPA criteria PAHs and benzo(e)pyrene in air 
samples taken in the 8 households are given in Table 6.2. The indoor NAP concentrations 
in this study, as shown in Table 6.2, are similar to those reported in North Carolina, USA 
(Chuang et al., 1999; Day et al., 1992) and Canada (Sanderson and Farant, 2004), but are 
lower than the homes in Taiwan (Hung et al., 1992) and China (Liu et al., 2001). 
Concentrations of other PAHs, especially the ones with 4 or more aromatic rings, were 
much lower in this study than other published studies, including wood-burning and 
reference homes in Sweden (Gustafson et al., 2008), low-income homes and daycare 
centers in North Carolina, USA (Chuang et al., 1999; Wilson et al., 1999), homes in 
Canada (Sanderson and Farant, 2004), Taiwan (Hung et al., 1992), and China (Liu et al., 
2001). It has been reported that in homes without substantial indoor sources, PAHs other 
than NAP were mostly attributable to the infiltration of outdoor air (Li et al., 2005; 
Sanderson and Farant, 2004). The lower concentration on larger PAHs in this study 
indicated overall lower PAH concentrations in the ambient air of this region and 
potentially better insulation in the homes involved in this study.   
Overall, PAHs were not well correlated with each other when studying all air 
samples (n = 170, Table B.2), with the exception of the isomeric Me-PAHs. However, 
when only considering samples taken at work, the PAHs were highly correlated despite 
their low concentrations (Table B.4), which is consistent with the fact that all subjects 
worked in the same building with a homogenous indoor environment. In general, the 
correlations between PAH are higher when at a specific home, or at work, or driving, 
than the correlations for all samples (Tables B.2 -14). Specifically, PAHs with 4 or more 
aromatic rings were only detectable in jogging samples and were very well correlated 
with each other, supporting the suggestions that these large PAHs are mainly from mobile 
exhaust sources (Eiguren-Fernandez et al., 2004; Fang et al., 2004a). This suggests that 
the distributions are functions of the environment and might be useful as fingerprints for 
environmental exposure.    
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Calculated total inhaled NAP, pyrene (PYR) and summed PAHs (∑PAH) over a 
24-hour period (assuming 12 m3 air inhaled/24-hour) for 7 subjects are given in Figure 
6.2. S17 was excluded due to in-complete air sampling. Large inter-subject variations 
were observed for all compounds. The variation on total inhaled NAP can be attributed to 
the differences on indoor NAP levels, as discussed above. Variation pattern for ∑PAH is 
similar to that of NAP, which is caused by the high NAP contribution to the ∑PAH (on 
average 62% among all air samples). PYR, on the other hand, presented a different 
variation pattern. The daily inhaled PYR levels were higher during weekdays than 
weekends in 5 out of the 7 subjects. This is consistent with the suggestion that exposure 
of larger PAHs such as PYR are predominantly through outdoor sources, and PAHs in 
urban air of heavily trafficked and populated areas are primarily from mobile sources 
(Fang et al., 2004a). Therefore, inhalation exposure of large PAHs would have less inter-
subject variation and could potentially be different between weekdays and weekends due 
to different driving/outdoor activity patterns.  
In traditional environmental epidemiological studies, air quality data from 
stationary monitoring sites are used to estimate exposure of study participants to air 
pollutants. This approach can pose a great amount of uncertainties because, as shown 
above, pollutant concentrations vary largely in the air that comes in direct contact with 
individual subjects. In addition, air toxicants such as NAP exist at higher concentrations 
in indoor environments and people generally spend more time indoor than outdoor. 
Therefore, using data from stationary sampling locations might not give a good indication 
of the actual exposure among study subjects and personalized exposure assessment might 
be a necessary measure to provide a better understanding of the true exposure. 
6.3.2 OH-PAHs in urine samples 
We quantified 9 OH-PAH metabolites in 439 samples collected from 8 subjects 
during 8 days. The OH-PAHs reported here are metabolites of 4 parent PAH compounds, 
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i.e. naphthalene, fluorene, phenanthrene and pyrene. The median, minimum and 
maximum concentrations from each subject are given in Table 6.3. The detection rates 
were over 95% for all reported metabolites with the exception of 2-hydroxyphenanthrene 
(2-PHEN, 86%). During the 8-day study period, each of the 8 subjects collected an 
average of 55 urine samples (36–84 samples/subject, Table 6.3). Overall, the median 1-
PYR concentration found in this adult population with no occupational PAH exposure 
were at similar levels as the reference range established for the U.S. adult population (Li 
et al., 2008) and a group of male university students in Korea (Kim et al., 2001), residents 
in Frankfort, Germany (Heudorf and Angerer, 2001) and a small group of subjects in 
Atlanta, USA (Li et al., 2009b), but were lower than those reported in Canada (Viau et 
al., 1995b), Italy (Roggi et al., 1997) and Germany (Goen et al., 1995) (Table 6.4).  
Concentrations of 3-hydroxyfluorene (3-FLUO) from 3 subjects (S12, S14 and 
S15) during the whole study period are given in Figure 6.3, and concentrations of all 9 
OH-PAHs in all 8 subjects are given in Appendix C. Levels of urinary PAH metabolites 
in each subject varied throughout the day, as exemplified in Figure 6.3. Elevated 
biomarker concentrations can be observed after self-reported exposure. For example, 3-
FLUO concentration in S14 peaked after morning rush traffic during the weekdays 
(Figure 6.3A); and in S17, 3-FLUO increased from 55 ng/g creatinine to 173 ng/g 
creatinine after driving for 225 km (~2 hours) (Figure 6.4). Similarly, increased urinary 
biomarker concentrations after ingesting high PAH-containing food (flame broiled 
burgers) have been noticed in several subjects, as shown in Figure 6.3B and Figure 6.4. 
Notably, it appears that different subjects had different exposure patterns, although their 
occupations were all of office nature and they worked at the same location at the time of 
the study. S14 in general had lower exposure and less variable biomarker levels during 
weekends than weekdays, suggesting that this subject’s 1-hour commute through 
congested highway might result in higher exposure during weekdays (Figure 6.3A). Diet 
appeared to be the major source of exposure in S15, potentially due to the shorter  
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Table 6.4 Comparison of median 1-hydroxypyrene (1-PYR) concentrations (creatinine-
adjusted, ng/g creatinine) in selected published non-occupational studies. 
 
Population; country Age (years) N 
Median 
concentration 
(range) 
Reference 
Adults; Atlanta USA 31-62 8 (439)1 67 (17-5839) This study 
Adults; Atlanta USA 25-58 8 (427)2 58 (7-1963) Li et al., 2009 
US population; USA ≥20 1625 41 (15-233)3 Li et al., 2008 
University students; Korea 23 129 58 (19-540) Kim et al., 2001 
Adults; Germany ≥20 495 88 (LOD-1172) Heudorf and Angerer, 2001
Adults; Canada n/a 140 154 (39-617) Viau et al., 1995 
Non-smoking adults; Italy 22-81 327 149 (52-654)4 Roggi et al., 1997 
Adults; Germany n/a 69 450 (<40-600) Goen et al., 1995 
1. A total of 439 samples were taken from 8 subjects 
2. A total of 427 samples were taken from 8 subjects 
3. Median concentration with 10th and 95th percentiles 
4. Median concentration with 5th and 95th percentiles 
 
 
commute (~25 min) which led to less inhalation exposure (Figure 6.3B). Interestingly, 3-
FLUO levels in S12 were consistently higher during weekends than in weekdays 
regardless the diet (Figure 6.3C), indicating that this subject might be engaged in 
activities during weekends which resulted in higher PAH exposure. 
Concentrations of 3-hydroxyfluorene (3-FLUO) from 3 subjects (S12, S14 and 
S15) during the whole study period are given in Figure 6.3, and concentrations of all 9 
OH-PAHs in all 8 subjects are given in Appendix C. Levels of urinary PAH metabolites 
in each subject varied throughout the day, as exemplified in Figure 6.3. Elevated 
biomarker concentrations can be observed after self-reported exposure. For example, 3-
FLUO concentration in S14 peaked after morning rush traffic during the weekdays 
(Figure 6.3A); and in S17, 3-FLUO increased from 55 ng/g creatinine to 173 ng/g 
creatinine after driving for 225 km (~2 hours) (Figure 6.4). Similarly, increased urinary 
biomarker concentrations after ingesting high PAH-containing food (flame broiled 
burgers) have been noticed in several subjects, as shown in Figure 6.3B and Figure 6.4. 
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Notably, it appears that different subjects had different exposure patterns, although their 
occupations were all of office nature and they worked at the same location at the time of 
the study. S14 in general had lower exposure and less variable biomarker levels during 
weekends than weekdays, suggesting that this subject’s 1-hour commute through 
congested highway might lead to higher exposure during weekdays (Figure 6.3A). The 
commuting effect was not as clear on S15, potentially due to shorter commute (~25 min);  
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Figure 6.3 Concentration of 3-hydroxyfluorene over the 8-day study period (4 periods, 2 
days in each period) in subjects S14 (A), S15 (B) and S12 (C). 
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Figure 6.4 Concentration of 1-naphthol (A), 1-hydroxypyrene (B) and 3-hydroxyfluorene 
(C) over the 8-day study period in subject S17. 
 
 
therefore, the diet was the major influence on the exposure and biomarker levels in this 
subject (Figure 6.3B). Interestingly, 3-FLUO levels in S12 were consistently higher 
during weekends than in weekdays regardless the diet, indicating that this subject might 
be engaged in activities during weekends which resulted in higher PAH exposure (Figure 
6.3C).   
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It is well recognized that PAHs are generally present as complex mixtures in the 
environment, and are metabolized into an array of metabolites including hydroxylated 
metabolites (ATSDR, 1995). 1-PYR is the most common—often the only—biomarker 
measured to assess exposure to PAHs. Indeed, concentrations of urinary OH-PAHs have 
been found to be well correlated to each other in a large epidemiological study (Li et al., 
2008), supporting the use of one biomarker as a surrogate representing PAH exposure. In 
this study, we measured 9 major detectable OH-PAHs, metabolites of NAP, fluorene, 
phenanthrene and PYR. Generally, the metabolites followed similar profiles, especially 
when high exposure occurred (Figure 6.4 B and C, Appendix C). However, we found that 
certain metabolites had distinct concentration profiles over time, compared to other 
metabolites from the same individual. For example, 1-naphthol (1-NAP) had a sharp 
increase in S17 after dining out at a friend’s house, to 625,467 ng/g creatine, over 300 
times higher than the median 1-NAP (1881 ng/g creatinine) for S17. At the same time, all 
other analytes, including 2-naphthol (2-NAP) and 1-PYR, stayed at background levels 
(Figure 6.4, Appendix C). 1-NAP has been reported as a metabolite of carbaryl pesticide 
(Maroni et al., 2000); therefore, the highly elevated 1-NAP could be a result of exposure 
to an agent(s) other than PAHs. As a result, 1-NAP data from S17 during the affected 
days were excluded in correlation analysis as introduced below. Concentrations of the 
fluorene metabolites, as exemplified in Figure 6.3, responded with both reported 
extended driving and high dietary PAH intake. 1-PYR, meanwhile, had the largest 
increase after high diet exposure in multiple subjects, as shown in Figure 6.4B, which is 
consistent with an earlier study reporting the increased OH-PAH levels after ingestion of 
barbecued chicken (Li et al., 2009b).  
Among the 8 subjects, only S17 had a potential high inhalation exposure event 
(140 mile drive) and a high ingestion exposure (flame broiled burger), c.f. Figure 6.4 and 
Figure C.7 (Appendix C). In order to study the metabolite distribution under each 
exposure route, we calculated the percentage of each metabolite to the ∑OH-PAHs, and 
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plotted the percentages of the FLUO, PHEN and PYR metabolites around the time points 
when the long driving/burger took place, c.f. Figure 6.5. Concentrations of the two 
naphthalene metabolites did not have large variation during both event (Figure C.7), 
which is consistent with their sources being primarily indoor air; their percentages in 
∑OH-PAH were as high as 53% during the time periods, overwhelming those of the rest 
of the metabolites; therefore, they are not included in Figure 6.5. Percentage and 
concentration of 9-FLUO appeared to be elevated approximately 5.75 hours after the long 
drive trip; the trend continued and reached maximum at mid-night, 12 hours post-driving. 
Levels of 2- & 3-FLUO also increases after the driving, although the trends were not as 
profound as for 9-FLUO (Figure 6.5A). This observation, though interesting, should be 
used with caution since we did not have another high inhalation exposure event and 
therefore, could not confirm the results. The percentages and concentrations of the PHEN 
and PYR metabolites, on the other hand, were not affected by the 2-hour long driving. 
After consuming a flame broiled burger, concentrations of all OH-PAH metabolites 
increased drastically (Figure 6.4 and Figure C.7). Specifically, 1-PYR had the largest 
increase in relation to the rest of the OH-PAHs; its percentage in total OH-PAHs 
increased from 3% before the burger consumption to 15% and 16% at 5 and 10 hours 
post the ingestion exposure (Figure 6.5 B). Therefore, 1-PYR had both highest increase in 
concentration and in percentage in relations to the rest of OH-PAHs, suggesting that 1-
PYR is a more specific sensitive indicator to dietary input in reference populations with 
low PAH exposure. 
It is well known that a number of enzymes are involved during the metabolism of 
xenobiotics such as PAHs and it has been suggested that under different exposure 
scenarios, different enzymes could be activated to potentially form isomeric metabolites 
preferentially (Baum et al., 2001; Rushmore and Kong, 2002; Wrighton and Stevens, 
1992). To explore this hypothesis, we calculated the percentages of individual isomeric 
metabolites among the metabolites from the same parent compound, e.g. 9-FLUO/sum of 
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2-, 3-, and 9-FLUO, and 3-PHEN/sum of 1-, 2-, and 3-PHEN. We identified three 
subjects who had high biomarker spikes after consuming flame broiled burgers (Figures 
B.3, B.5 and B.7, Appendix C) and studied the variation of isomeric metabolite 
percentages around the high exposure event among the three subjects. As shown in 
Figure 6.6, after consuming the flamed burgers, percentage of 9-FLUO in comparison to 
the rest of the FLUO metabolites increased in all three subjects, indicating that out of the 
three FLUO metabolites measured, 9-FLUO might be a preferred metabolite formed after 
an ingestion exposure.  
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Figure 6.5 Percentage of individual metabolites to ∑OH-PAHs in subject S17 around a 
long driving trip on one day (A) and the consumption of a flame broiled burger on 
another day (B).  
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Figure 6.6 Percentages of individual fluorene metabolite to total fluorene metabolites in 
three subjects after consuming flame broiled burger 
   
To sum up, we found that in this group of reference population with low over 
exposure, 1-PYR and 9-FLUO might be more related to ingestion exposure, comparing to 
the rest of the OH-PAH metabolites. We also noticed the unique concentration profiles of 
the individual OH-PAHs, which demonstrated the importance of a multi-analyte assay for 
exposure assessment, and the potential of using individual biomarkers as more specific 
indicators of source-related exposure scenarios.  
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6.3.3 Relationship between total inhaled PAHs and total excreted OH-PAHs 
We found that the total inhaled NAP within 24-hour periods ranged from 2.3 
µg/24-hr to 228 µg/24-hr during days with low PAH diet, while the total excreted OH-
NAP in the sample period (with 12-hour lag) were 2.5 – 21.7 µg/24-hour, or on average 
60.1% of the inhaled level (Figure 6.7). The lower excreted metabolite levels compared 
to inhalable NAP amount can be a result of respiration uptake rate, actual volume of the 
air breathed, and alternative metabolites of inhaled NAP. In contrast, total 24-hour 
inhaled pyrene ranged from 1.3 – 14.5 ng/24-hour on low PAH-diet days, while excreted 
urinary 1-PYR in a 24-hour period were 35-677 ng (Figure 6.7) – an average of 24 folds 
(5.9-74 folds) higher than inhaled PYR, demonstrating that inhalation is not the main 
route of exposure for pyrene, and ingestion is likely the prime source for urinary 1-PYR 
in this reference group.  
 
Table 6.5 Correlation coefficients between inhaled PAHs and excreted OH-PAH 
metabolites on low PAH diet and high PAH diet days. 
 
  Low PAH diet days  High PAH diet days 
  NAP FLUO PHEN PYR ∑PAH   NAP FLUO PHEN PYR ∑PAH
1-NAP  0.89 1 - - - -  0.76 - - - - 
2-NAP  0.42 - - - -  0.20 - - - - 
∑OH-NAP 0.87 - - - -  0.63 - - - - 
9-FLUO - 0.22 - - -  - 0.27 - - - 
3-FLUO - 0.67 - - -  - 0.52 - - - 
2-FLUO - 0.68 - - -  - 0.54 - - - 
∑OH-FLUO - 0.55 2 - - -  - 0.41 - - - 
3-PHEN  - - 0.09 - -  - - 0.31 - - 
1-PHEN  - - -0.17 - -  - - 0.18 - - 
2-PHEN  - - -0.03 - -  - - 0.23 - - 
∑OH-PHEN - - -0.09 - -  - - 0.13 - - 
1-PYR - - - 0.38 -  - - - 0.11 - 
∑OH-PAH - - - - 0.84  - - - - 0.78 
1. Numbers in bold italic are statistically significant 
2. Numbers in italic are marginally significant 
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Figure 6.7 Correlations between 24-hour inhaled PAHs and 24-hour excreted OH-PAH 
metabolites for (A) naphthalene and 1-naphthol, (B) fluorene and 3-hydroxyfluorene, (C) 
pyrene and 1-hydroxypyrene, and (D) ∑PAHs and ∑OH-PAHs. 
 
 
The total inhaled NAP was well correlated to 1-NAP even during the days with 
high PAH diet (Figure 6.7A), suggesting that 1-NAP is a prime metabolite formed from 
inhaled NAP and inhalation is the major route of exposure. Total excreted 2-NAP, 
another metabolite of NAP, was not correlated with inhaled NAP (Table 6.5). This is 
surprising, since 1-NAP and 2-NAP are the two major metabolites for NAP, they are the 
most abundant urinary PAH metabolites and are often present at similar levels, so they 
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both have been proposed as biomarkers for NAP or airborne PAHs exposures (ATSDR, 
2005; Preuss et al., 2003; Yang et al., 1999). Moreover, due to the potential pesticide 
origin for urinary 1-NAP as confirmed in this study, 2-NAP has been suggested as a more 
specific marker for inhalation exposure to PAHs in ambient air (Kang et al., 2002; Preuss 
et al., 2003). The un-expected finding on non-correlated airborne NAP and urinary 2-
NAP in our study could be a result of small sample size (6 subjects with matching 
air/urine results and 2 data points/subjects in each diet category).  
Among the rest of the PAH – OH-PAH pairs (Table 6.5 and Figure 6.7), airborne 
fluorene were significantly correlated with 2- and 3- hydroxyfluorene during low-diet 
days, but not with 9-hydroxyfluorene; correlation only existed between fluorene in air 
and 2-FLUO on days with high PAH diet, indicating that 2-FLUO might be the preferred 
metabolite formed from inhaled fluorene. None of the phenanthrene and pyrene 
metabolites were correlated with their parent compound levels in air, suggesting that 
inhalation might not be their major route of exposure in this group of subjects. Total 
summed OH-PAH in urine were well correlated with total PAHs in air, which was likely 
driven by the NAP and 1-NAP contributions (NAP accounted for on average 62% 
towards the total PAHs in air and 1-NAP accounted for 34% of the summed OH-PAHs). 
Overall, correlations between inhaled PAH and excreted metabolites decreased during 
high PAH-diet days compared to days with low PAH diets. Biomonitoring results on 
urinary metabolites reflect exposure from all routes including ingestion and inhalation; 
therefore, when dietary input is large, correlations between inhaled PAH and urinary 
metabolites worsens.   
Most studies reported relationships between airborne PAHs and urinary OH-PAH 
metabolites were focused on workers exposed to high levels of PAHs. Vaananen et al. 
(2003) found that among a group of pavers, urinary 1-NAP, sum of 1- and 2-NAP, and 1-
PYR were significantly correlated with NAP, PYR, 2-3 ring PAHs, 4-6 ring PAHs and 
the total PAHs measured in personal air samples; urinary hydroxyphenanthrenes (OH-
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PHEN), however, was not correlated with airborne phenanthrene levels (Vaananen et al., 
2003). In another study on 170 German workers, both urinary 1-PYR and sum of OH-
PHEN were correlated with PYR and phenanthrene in personal air samples (Rihs et al., 
2005). Urinary 1-PYR in a group of Italian policeman exposed to traffic emissions was 
found to be well correlated to PYR, benzo(a)pyrene and total PAHs in the breathing 
zone; the correlation was further improved on samples taken during winter in the high-
traffic area (Perico et al., 2001). Urinary 1-PYR in 18 electrode paste plant workers was 
also found to be correlated with PYR measured in the personal air samples (Bentsen et 
al., 1998b). However, in another study conducted by the same researchers, no significant 
correlation was found between urinary 1-PYR and PYR in inhalable aerosol samplers 
(Bentsen et al., 1998a). Studies on non-occupationally exposed populations using such 
methods were limited. Our results are consistent with a study on a group of Korean 
middle school students in which urinary 2-NAP was found significantly correlated with 
total suspended particulate (TSP) levels in the ambient air, but 1-PYR was not correlated 
with any TSP data (Kang et al., 2002).   
Our results suggest that a major exposure route for NAP both for general 
population with low exposure and for many occupational groups is generally through 
inhalation. Results on other hydroxylated PAH metabolites such as 1-PYR and OH-
PHEN were mixed. In general, 1-PYR was correlated to airborne PYR in occupations 
with suspected high inhalation exposure (Perico et al., 2001; Rihs et al., 2005), whereas 
such correlation did not exist when alternative exposure route such as dermal absorption 
(Bentsen et al., 1998a) dominated. In this study on a reference group with overall low 
environmental exposure, the main source for phenanthrene and PYR exposure is most 
likely through dietary intake.  
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
Polycyclic aromatic hydrocarbons (PAHs) are distributed ubiquitously in the 
ambient air, soil and water environments, which lead to wide exposure in the general 
populations (ATSDR, 1995; Li et al. 2008). PAHs in the atmosphere can come from 
natural sources, such as forest fires and volcanic eruptions. However, their presence, 
especially in densely populated areas, is significantly affected by anthropogenic 
emissions, such as automobile exhaust, fossil fuel combustion, biomass burning, cigarette 
smoking, and industrial activities. PAHs have been reported to be carcinogenic and 
mutagenic, and possess toxicities towards a variety of target organs/systems, such as liver 
and immune system (ATSDR, 1995). Airborne PAHs, when bound to particulate matters 
especially the fine particles (PM2.5), may increase potential health effects because 
particles carrying the toxic compounds can penetrate and deposit deep in the bronchioles 
and alveoli of the lungs.  
Particulate matter pollution is of interest in metropolitan Atlanta, Georgia, one of 
the fastest growing regions in the United States. Currently, the twenty-county Atlanta 
metropolitan area is in non-attainment for PM2.5 and ozone (U.S.EPA, 2007). PM source 
apportionment analyses by two groups of researchers indicated that 30 to 40% of 
Atlanta’s PM2.5 can be attributed to mobile sources and biomass burning (Kim et al., 
2004; Marmur et al., 2007), and a recent epidemiologic study indicated that these 
components are associated with both cardiovascular and respiratory emergency room 
visits in Atlanta (Sarnat et al., 2008).  
For general population, major routes of PAH exposure are inhalation of polluted 
air or cigarette smoke and ingestion of food containing PAHs. Assessment of human 
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exposure to environmental chemicals such as PAHs can be accomplished by two general 
approaches. That is, either through environmental monitoring in which concentrations of 
PAHs in environmental samples (air, food, water, soil, etc.) are measured to assess 
human intakes, or through biomonitoring in which internal levels of PAHs in human 
body (e.g. urinary hydroxylated PAHs, or OH-PAHs) are determined as indicators for 
assessing overall exposure to PAHs.  
This dissertation focused on charactering PM2.5-bound PAHs in Atlanta and 
assessing non-occupational exposure to PAHs through both biomonitoring and personal 
air monitoring. The first part of this thesis addressed PAHs levels in PM2.5 samples 
collected at three sampling sites (urban, suburban-highway and rural) in the Atlanta area. 
Chapter 2 described the development of a method measuring 28 PAHs and methyl-
substituted PAHs (Me-PAH) on PM2.5 samples using a novel direct elution extraction 
method followed by isotope dilution gas chromatography/high resolution mass 
spectrometry (GC/HRMS) analysis. The method was then used to measure archived 
PM2.5 samples collected in Atlanta during 2003-2004 periods, which was described in 
Chapter 3. In-depth analyses were carried out on seasonal and spatial variation of PAH 
concentrations, correlations of PAHs to other air pollutants (e.g. PM2.5, OC, EC and 
potassium ion), and potential markers for specific sources (such as retene as an indicator 
for biomass burning and methyl phenanthrenes for petroleum sources). The second part 
of the thesis focused on biomonitoring. Chapter 4 introduced a method that was 
developed to measure 24 urinary biomarkers – OH-PAH metabolites in human, using 
enzymatic de-conjugation, automated liquid-liquid extraction, evaporation and 
derivatization, and isotope dilution GC/HRMS determination. A study was then designed 
and carried out to study intra- and inter-personal variability of these urinary biomarkers 
in a group of non-occupational exposed volunteers and conduct sample size calculations 
utilizing the study findings, which comprised Chapter 5. Finally in Chapter 6, a study was 
designed and conducted to evaluate non-occupational exposure to atmospheric PAHs 
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through both personal air sampling and biomonitoring. Given below are conclusions from 
individual chapters in this dissertation.   
Determination of 28 PAHs and Methyl-PAHs in Air Particulate Matter Samples 
using Direct Elution and Isotope Dilution GC/MS 
We developed a method for measuring particle-bound PAHs in PM samples using 
direct elution and GC/HRMS determination. The extraction method is by far the most 
time-efficient method requiring the least amount of labor. The instrument analysis using 
isotope dilution GC/MS operated at 10,000 resolution gave high accuracy, precision and 
sensitivity, which enables measuring PAHs on low-flow PM samples. The recovery of 
this method was evaluated by calculating the spiked isotopically labeled internal 
standards. The accuracy of the method was evaluated by measuring PM2.5-bound PAHs 
from NIST reference material RM8785 and determined concentrations were consistent 
with the reference value. This method was used to analyze PM2.5 samples collected from 
three sites in the metropolitan Atlanta area and again the results were consistent with an 
earlier investigation studying PAH concentrations on PM2.5 samples from the same 
locations using ASE. Distinct seasonal and site variations were observed in both studies, 
which were discussed in detail in Chapter 3. 
Characterization of PM2.5-bound Polycyclic Aromatic Hydrocarbons in Atlanta 
Concentrations, seasonal and spatial variations of atmospheric particle-bound 
PAHs at three sites in and near Atlanta were reported in two studies, first a pilot study 
followed by an expanded study. We found strong seasonal variation of PAHs, with 
highest levels during the winter months. PAHs were correlated with PM2.5, OC, EC and 
K+ and the correlations have a temperature-dependency. PM2.5-bound PAH 
concentrations were more elevated at the highway-impacted suburban site, followed by 
the urban site, and were the lowest at the rural site. Relative concentration of methylated 
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phenanthrenes to its parent compound phenanthrene suggest that this can be used as a 
crude indicator for petrogenic sources, with fuel evaporative sources playing a relatively 
larger role during the summer. Interestingly, retene was noted in both studies for its 
unique profiles compared to other PAHs. It was found to be a better indicator than 
potassium ion of forest burning events in which brush and leaves are the predominant 
fuel. These results have implications for PM source apportionment methodologies as well 
as for gaining a better understanding of ambient PAH levels in the southeastern United 
States. 
Measurement of Urinary Mono-Hydroxy Polycyclic Aromatic Hydrocarbons Using 
Automated Liquid-Liquid Extraction and Isotope Dilution GC/HRMS 
We have developed a method to measure 24 urinary OH-PAH metabolites, 
utilizing enzymatic hydrolysis, automated liquid-liquid extraction, and GC/HRMS. The 
sample preparation method is highly automated and required a minimum of manual labor, 
which contributes to high throughput desired for conducting large biomonitoring studies.  
De-conjugation kinetics was studied and all parameters were optimized to give the 
highest yield. The method was among one of the most sensitive reported with its limits 
and detection at low parts per trillion levels. It has been used to analyze samples from a 
number of studies including the National Health and Nutritional Examination Survey, an 
on-going survey reports biannually the level of biomarkers in a statistically representative 
sample of the U.S. population..  
Variability of Urinary Polycyclic Aromatic Hydrocarbon Metabolite Levels in 
Adults 
Levels of urinary PAH metabolites in a group of non-occupationally exposed non-
smoking adults varied widely both within-subject and between-subjects. There was also 
considerable temporal variation within a day that far exceeded the between-day variation. 
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Creatinine adjustment is crucial for spot samples and first morning urine sampling but not 
for the 24-hour voids. Taking 24-hour void specimens, though burdensome on the study 
subjects with potential non-compliance, was the most reliable and reproducible sampling 
practice, and it also requires the fewest number of subjects in epidemiological studies, 
less than half of what would be required if spot urine samples were taken. Hence, it is of 
utmost importance that these considerations are taken into account when planning an 
epidemiological study since investigators will need to balance the additional labor of 
collecting 24-hour void samples against the costs of recruiting and analyzing more than 
twice as many samples to reach the same statistical power.  
Assessment of Non-occupational Exposure to Polycyclic Aromatic Hydrocarbons 
through Personal Air Sampling and Urinary Biomonitoring 
We studied exposure to PAHs on 8 non-smoking subjects with no known 
occupational exposure through both personal air sampling and biomonitoring of urinary 
OH-PAH metabolites. Concentrations of 28 PAHs and Me-PAHs varied largely, in 
personal air samples collected at different locations/activities within each subjects, and 
among samples collected in the 8 households. Smaller PAHs such as naphthalene 
primarily came from indoor sources while larger PAHs with 4 or more aromatic rings 
originated from outdoor sources such as traffic emission. Our results stressed the 
importance of personalized exposure approaches in environmental epidemiological 
studies. Urinary biomonitoring can capture both inhalation and ingestion exposure, 
although the urinary metabolite levels alone can only give an indication on overall 
exposure levels and can not distinguish exposure routes. By combining personal air 
sampling and urinary biomonitoring, we were able to deduce exposure sources and we 
found that inhalation is the major route for naphthalene exposure while ingestion is the 
main route of exposure for phenanthrene and pyrene in this group of non-occupationally 
exposed reference population.  
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Future Directions 
PAHs in Ambient Air 
PAHs in ambient air were studied in two sections in this thesis. First, PM2.5-bound 
PAHs in the Atlanta area were investigated through two segments in Chapter 3, i.e. a 
pilot study on daily samples taken at three stationary sites in one summer month (June 
2004) and one winter month (December 2003), followed by an extended study measuring 
PAHs in PM2.5 samples collected in all 12 months during 2004 (5 samples/site/month). 
Second, in Chapter 6, combined gas phase and particle phase PAHs were measured in 
personal air samples taken by 8 subjects while at home, at work, and during commuting 
(driving or jogging through traffic). Due to the small volumes of air sampled on each 
personal air samples (0.12 – 1.60 m3/sample), we were not able to analyze the filter and 
sorbents separately to obtain information on gaseous and particulate PAHs, and results 
from the personal air samples were a combination of the gaseous and particulate phases. 
In both sections, valuable information was obtained regarding the concentration, pattern 
and profile of PAHs in the ambient air. From environmental epidemiology point of view, 
it would be very useful to get an understanding on how pollutant levels from stationary 
monitoring sites compared to those from personal level and how well the air monitoring 
results from routine monitoring sites represent actual personal exposure. In this thesis, 
however, we could not make such direct comparison on PAHs in air samples collected at 
three sites in Atlanta to the personal air samples collected by subjects living in the 
Atlanta area, because particle phase PAHs were studied in the ambient air study whereas 
the data available from personal air samples were a combination of gas phase and particle 
phase. Therefore, one future direction would be carrying out a study that collect separate 
particle and gas phase air samples from both stationary sites and from personal levels, 
and compare concentrations of gaseous and particular PAHs in central sites to those at 
personal exposure levels, to better understand exposure to ambient PAHs. When 
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designing such a study, one thing to keep in mind is to increase the personal air sampling 
time or flow rate in order to increase the air volume and pollutant mass sampled and 
therefore, increase the detection frequency of the pollutants on the personal air samples.   
An interesting point that this thesis discovered was the potential of retene as a 
marker for biomass burning. We found that retene did not have the same site variation 
and was not well correlated to the other PAHs, indicating its unique source, formation 
and environmental fate. Concentrations of retene at all three sites peaked in March, 2004, 
coinciding with the highest amount of prescribed and un-planned fires in the state of 
Georgia. December was the month with the second highest retene concentrations, which 
was consistent with elevated residential wood burning in that month. In comparison, 
potassium, a biomass burning marker used in source apportionment, was elevated in 
December but not in March, which lead to the conclusion that retene might be a better 
marker for general biomass burning, while potassium might be a better marker for wood 
burning. However, retene is not a common analyte measured in air samples. Therefore, it 
is worthy to take on further research on retene, and confirm its association with biomass 
burning. In addition, levoglucosan, a breakdown product from thermal decomposition of 
cellulose in plants and vegetations (Fraser and Lakshmanan, 2000), has also been 
proposed as a biomass combustion marker in aerosols. Thus, it would be interesting to 
study in depth retene, levoglucosan and PAHs on the specificity and sensitivity of these 
compounds as biomass burning markers.   
Biomonitoring 
Urinary OH-PAH metabolites have been established as biomarkers for exposure 
to PAHs. However, there are several limitations on using such approach for exposure 
assessment. Metabolites of large PAHs with 4 or more aromatic rings have been reported 
to be excreted primarily through feces, instead of urine (ATSDR, 1995); thus they are 
mostly undetectable in urine samples. Therefore, assessing exposure to the larger PAHs 
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using urinary biomonitoring can be misleading due to the alternative excretion routes. In 
addition, OH-PAHs are only one group of metabolites resulted from PAH exposure; 
additional possible markers include dihydrodiols in urine (Grimmer et al., 1993), 
DNA/protein adducts in blood and/or tissue (Paleologo et al., 1992; Lodovici et al., 
1998), and parent PAHs in breast milk (Grova et al., 2002). Specifically, PAH adducts 
have been reported to have long half-lives up to 120 days, and thus information on the 
adducts enables assessment of long term exposure (Needham et al., 2005). Furthermore, 
PAHs undergo relatively fast metabolism rate and the OH-PAH metabolites are usually 
excreted within hours after exposure; thus, OH-PAH levels reflect recent exposure to 
PAHs, instead of long-term exposure. Lastly, biomarker levels reflect exposure from all 
routes, and cannot distinguish specific sources. In the interest of exposure assessment, 
especially in occupational groups and/or sensitive demographic groups such as children, 
it is necessary and important to obtain source-specific information. Therefore, developing 
source specific-biomarker in biomonitoring studies is of utmost interest. One possibility 
would be using available sources-specific markers such as retene and studying the 
potential of retene metabolites as biomarkers for inhalation exposure to biomass burning. 
In summary, future development on biomonitoring of human exposure to PAHs can be 
extended on the following directions, i) study the potential of alternative biomarkers, 
such as urinary dihydrodiols and DNA/hemoglobin adducts; ii) study the potential of 
alternative matrices, including blood, breast milk and feces; iii) develop biomarkers for 
source-specific or route-specific exposure scenarios.  
Assessing Human Exposure to PAHs through Personal Air Sampling and 
Biomonitoring 
We designed and conducted a study to assess non-occupational exposure to 
atmospheric PAHs through simultaneous personal air sampling and biomonitoring. The 
study gave rise to valuable information on exposure of a group of non-smoking subjects 
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with no known occupational exposure to PAHs. However, we did not observe a direct 
causal effect between inhalation exposure to traffic emissions and biomarker 
concentrations. This is mostly due to the low-level inhalation exposure that the 8 
volunteers in this study were subjected to and the small number of subjects enrolled. The 
highest potential inhalation event in this study was a 140-mile or 2-hour long driving trip 
from Atlanta to a mountainous rural area in the northern part of the state. We only 
observed slight increase on the levels of the fluorene metabolite, but not on the rest of the 
OH-PAHs. The driving trip, although long compared to routine commuting and thus 
regarded as a high exposure scenario, potentially is not as a high exposure as we 
interpreted, because the subject was in a car with vent closed and was driving in mostly 
rural areas with assumed light traffic. Unfortunately, this hypothesis cannot be confirmed 
since the subject did not take any air samples while traveling. Among the rest of the 
subjects with up to 2-hour/day accumulative commuting, we also did not observe 
consistent increase in biomarker levels. Concentrations of small PAHs such as 
naphthalene and fluorene were not elevated in driving air, which explained the 
metabolites of those PAHs were not increased following driving. On the other hand, 
pyrene levels in personal air samples taken while commuting were higher than at home or 
at work. However, the main exposure route for pyrene in this group of subjects was 
through dietary ingestion, not inhalation; therefore, we could not link the 1-PYR levels 
with inhalation exposure either. On the other hand, it is still of great interest to study 
exposure of citizens to urban air pollution caused by traffic, especially in metropolitan 
areas such as Atlanta. When planning future studies, instead of taking on reference 
populations with low exposure, researchers should focus on specific occupations or 
demographic groups, such as roadway workers and motorcycle patrol policemen who are 
exposure consistently to traffic emissions. In addition, the study design can be simplified 
to have only two exposure scenarios, i.e. workdays with high exposure and off-work days 
(e.g. weekends) with limited exposure. One thing that we learned from this study is that 
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ingestion can be a dominant route, and therefore, diet should be strictly controlled and 
kept consistent in the future studies. Further, with a more simple study design and thus 
less burdensome on study subjects, more subjects should be included in such a study to 
increase statistical power desired to distinguish various exposure scenarios.   
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APPENDIX A 
STUDY DESIGN AND INSTRUCTION FOR THE PERSONAL AIR 
SAMPLING AND BIOMONITORING STUDY  
 
This Appendix includes the participant instructions in the study discussed in 
Chapter 6 that titled, “Assessment of Human Exposure to Polycyclic Aromatic 
Hydrocarbons Employing Personal Air Sampler and Urinary PAH Biomonitoring”.  
Instructions for Study Participation  
Total study duration: 2 weeks (Monday through Sunday) 
Sampling days: 4 days/week, i.e. Tuesday, Wednesday, Saturday and Sunday. In 
total, there will be 8 sampling days in this study (Table A.1). Non sampling days: 
Monday, Thursday and Friday. In total, there will be 6 non-sampling days in this study. 
 
Table A.1 Study design for the personal air sampling and biomonitoring study 
 
No. Week Day Driving PAH-containing food 
1 Week 1 Tuesday-Wednesday High Low 
2 Week 1 Saturday-Sunday Low Low 
3 Week 2 Tuesday-Wednesday High High 
4 Week 2 Saturday-Sunday Low High 
 
During the 8-day sample collection period 
• Eat only the foods that are on the list of food that we recommend. 
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• Collect a ~60 mL urine sample into urine cups every time you urinate. Estimate 
and record the total volume of urine excreted each time. 
• Carry a portable air pump connected to an air sampling tube at all time. Change 
the sampling tubes four times a day, and record the sampling duration and time of 
change.   
• Complete the Daily Activity Log (Log).  Note on the Table at what time you 
visited the restroom and the total volume of urine excreted, time of air sampler 
change, duration of air sampling, as well as driving and dietary information. 
• Every Wednesday and Thursday morning, we will collect your coolers with 
samples and any waste items, and give you 2 other coolers (one for air samplers 
and one for urine samples) with fresh cold packs and one-day supplies. For the 
weekends, we will give you two-day supplies on Friday afternoon, collect 
samples and waste items on Monday morning. 
During the 6 non-sampling days 
• No urine and air samples will be collected 
• We will not provide food. But please avoid BBQ, grilled, smoked food, and fast-
food hamburger. If you eat those foods, please note the type and amount of food, 
and time of the intake on the questionnaire sheet. 
Urine Sampling Instruction 
Instruction for urine sample collection, transport and storage 
1. Collect all urine excreted in a disposable graduated beaker 
2. Label a urine specimen cup with labels that we provided 
3. Read and record the total volume and time of urination on the Log, with the 
correct sample number from the label (e.g. S1-U01). 
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4. Pour ~ 60 mL of urine into the specimen cup and cap the cup. 
5. Put the sample cup in the cooler 
6. Discard the rest of urine, and seal the beaker in a 12 x 12 Zip-loc bag 
7. If you prefer to use gloves for this procedure, please put the used gloves in the 
Zip-loc bag 
8. We will collect the samples and wastes on Wednesday, Thursday, and Monday 
morning 
Air Sampling Instruction 
During the 8-day sample collection period 
• Please collect personal air samples continuously for the 9 days. 
• During weekdays, please change air samplers 4 time a day, at the following 
intervals 
o In the morning before leaving home for work (e.g. 7 am) 
o In the morning after arriving work (e.g. 8 am) 
o In the afternoon before leaving work (e.g. 5 pm)  
o In the afternoon after arriving home (e.g. 6 pm) 
• During the weekends  
o Avoid driving 
o If you will be driving (minimum 30 min), changing the air samplers before 
and after driving 
o If you will be driving for less than 30 minutes, do not change the air 
sampler 
o Otherwise, change air samplers at the same time points as the weekday 
Instruction for personal air sample collection, transport and storage 
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1. Read the time of air sampling from the pump timer for the existing tube (e.g. S1-
A01) and record it on the Log. 
2. Label a new air sample tube with labels that we provided (e.g. S1-A02), take off 
caps from both ends. 
3. Turn off the pump (this will reset the timer), disconnect the existing tube (e.g. S1-
A01) from the pump, cap the tube from both ends, and place it in a cooler.  
4. Connect the new tube (e.g. S1-A02) to the pump, turn on the pump, and the time 
will start from zero minute. 
5. Record time of air sampler change with the corresponding air sample number.  
6. We will collect the samples and wastes on Wednesday, Thursday, and Monday 
morning. 
Instructions on Dietary Intake 
Recommended food for sampling days (Tue, Wed, Sat, Sun).  
• Beverages: Yes Water, juice, milk, and soda (limited) 
No Coffee 
• Snacks: Yes Assorted nuts, most diary products, non-chocolate candies, 
assorted non-chocolate cookies, jelly, egg 
No Yogurt (flavored/frozen), chocolates, pies, cottage cheese 
• Fruits and Vegetables: 
Yes Cantaloupe, Cole slaw, strawberry, grapefruit, beans and 
peas 
No most greens  
• Breakfast: Yes Blueberry muffin, corn muffin, whole oat cereal, corn 
flakes, bran cereal, bread (not toasted) 
No Grits, oatmeal, cooked cereal, toasted food 
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• Lunch (See below) 
• Dinner: Yes Pre-packaged (preferred) or home-cooked roasted or 
strewed meat, steamed rice and vegetable 
No Grilled, barbecued, smoked, and deep fried food 
 
 
Table A.2 Lunch recommendation during study period. 
 
Low PAH-containing diet (week 1) High PAH-containing diet (week 2)
Meals 
Type  Portion Type  Portion
Pan fried burger from 
McDonald’s or equivalents 112 g 
Grilled burger from Burger 
King or equivalents  176 g Lunch  
Potato chip 42 g Fries  102 g 
 
 
During non-sampling days (Mon, Thu, Fri) 
Avoid BBQ, grilled, smoked food, and fast food hamburgers. If you eat those 
foods, please note the type and amount of the food, and time of intake on the 
questionnaire.  
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APPENDIX B 
PAH CONCENTRATIONS IN INDIVIDUAL HOMES AND 
CORRELATION MATRICES IN AIR SAMPLES 
 
 
This Appendix gives the concentration of 28 PAHs and Me-PAHs in personal air 
samples taken at 8 individual homes in the study discussed in Chapter 6. The study was 
titled, “Assessment of Human Exposure to Polycyclic Aromatic Hydrocarbons 
Employing Personal Air Sampler and Urinary PAH Biomonitoring”. Correlation matrices 
among PAH compounds with over 50% detection frequency are also given in this 
appendix according to the following categories.  
• All air samples 
• Air samples taken at home 
• Air samples taken at work 
• Air samples taken while driving 
• Air samples taken while jogging 
• Air samples taken in individual homes 
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APPENDIX C 
OH-PAH CONCENTRATIONS FROM INDIVIDUAL SUBJECTS IN 
THE PERSONAL AIR SAMPLING AND BIOMONITORING STUDY 
 
 
This Appendix gives the concentration profiles of 9 major detectable OH-PAH 
metabolites measured in 8 participants in the study discussed in Chapter 6. The study was 
titled, “Assessment of Human Exposure to Polycyclic Aromatic Hydrocarbons 
Employing Personal Air Sampler and Urinary PAH Biomonitoring”. The concentrations 
were all creatinine-adjusted to correct for urine dilution, and the unit for the 
concentrations is ng/g creatinine. The 9 OH-PAHs are listed below.  
• 1-NAP: 1-naphthol 
• 2-NAP: 2-naphthol 
• 9-FLUO: 9-hydroxyfluorene 
• 3-FLUO: 3-hydroxyfluorene 
• 2-FLUO: 2-hydroxyfluorene 
• 3-PHEN: 3-hydroxyphenanthrene 
• 1-PHEN: 3-hydroxyphenanthrene 
• 2-PHEN: 3-hydroxyphenanthrene 
• 1-PYR: 1-hydroxypyrene 
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Figure C.1 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S11 
over 8 days 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.2 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S12 
over 8 days 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend           weekday             weekday             weekday 
  low PAH diet     low PAH diet     high PAH diet     high PAH diet
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Figure C.3 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S13 
over 8 days  
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.4 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S14 
over 8 days  
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.5 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S15 
over 8 days  
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.6 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S16 
over 8 days  
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.7 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S17 
over 8 days  
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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Figure C.8 Concentrations (ng/g creatinine) of 9 OH-PAH metabolites in subject S18 
over 8 days   
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
       weekend             weekday              weekday              weekday 
  low PAH diet      low PAH diet       high PAH diet    high PAH diet 
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